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ABSTRACT 
The c-Jun N-terminal kinases (JNKs) are mitogen-activated protein kinases (MAPKs) that are 
activated by the dual phosphorylation of a canonical threonine and tyrosine residue. While it 
is well known that the activation of JNK mediates many important cellular processes such as 
differentiation, proliferation, and apoptosis, the mechanisms by which phosphorylation 
induces its activation are not known. An understanding of the structural and biophysical basis 
for the activation of JNK is highly desirable however, as dysregulation of the kinase has been 
implicated in numerous prominent diseases. Aiming first to improve upon the previously 
reported inadequacies in acquiring active JNK, this work describes a novel method for the 
purification of large yields of pure and phosphorylated JNK1β1, the most abundant JNK 
isoform. Using codon harmonization as a precautionary measure toward increasing the 
soluble overexpression of the kinase raised unique questions about the role of translation 
kinetics in both the heterologous and natural co-translational modification of kinases. After 
purifying the upstream activating kinases of JNK, phosphorylation of JNK1β1 was achieved 
by reconstituting the MEKK1 → MKK4 → JNK MAPK activation cascade in vitro. 
Activated JNK1β1 was thereafter able to phosphorylate its substrate, ATF2, with high 
catalytic efficiency. Characterising the nature of JNK1β1 modification by MKK4, mass 
spectrometry revealed that the latter kinase phosphorylates JNK1β1 not only at its activation 
residues (T183 and Y185), but also at a recognised yet uncharacterised phospho-site (S377) 
as well as two novel phospho-residues (T228 and S284) whose phosphorylation appear to 
have functional significance. Unfolding studies and amide hydrogen-deuterium exchange 
(HX) mass spectrometry (MS) were then used to investigate the changes to the stability and 
structure/conformational dynamics of JNK1β1 induced by phosphorylation and nucleotide 
substrate binding. Increased flexibility detected at the hinge between the N- and C-terminal 
domains upon phosphorylation suggested that activation may require interdomain closure. 
Patterns of solvent protection by the ATP analogue, AMP-PNP, reflected a novel mode of 
nucleotide binding to the C-terminal domain of a destabilised and open domain conformation 
of inactive JNK1β1. HX protection at both domains following AMP-PNP binding to active 
JNK1β1 revealed that the domains close around nucleotide upon phosphorylation, 
simultaneously stabilising the kinase. This reveals that phosphorylation activates JNK1β1 in 
part by enhancing the flexibility of the hinge to enable interdomain closure and the formation 
of a functional active site. This work thus offers novel insight into the unique molecular 
mechanisms by which JNK1β1 is regulated by nucleotide binding and phosphorylation by 
MKK4, and by the complex interplay that exists between them. 
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CHAPTER 1 
INTRODUCTION 
Cells respond to external stimuli and variations in the chemical and physical properties of 
their environment. These responses are induced partly by the cooperation of many 
intracellular signalling pathways that serve to transmit, integrate, and amplify a variety of 
signals, resulting finally in alterations in genomic and physiological activity. The mitogen-
activated protein kinase signalling cascade is one of the major pathways that relay 
extracellular signals into cells, and like most signalling pathways, employ protein 
phosphorylation as its means of signal propagation. 
1.1. Protein phosphorylation 
Protein phosphorylation is the addition of a phosphate group (PO42-) to a protein, a 
modification that elicits a change in the activity of the target protein by modifying enzyme 
function, interaction with other proteins, or cellular location [1]. Protein phosphorylation is 
enzymatically catalysed by protein kinases, a diverse range of enzymes that are employed 
widely to transduce signals and mediate complex cellular processes. These enzymes transfer a 
single phosphoryl group from a nucleoside triphosphate (commonly the γ-phosphate of ATP 
or GTP) and covalently attach it to the free hydroxyl group of one of three amino acids 
(Figure 1). Many kinases act upon both serine and threonine residues, others act on the 
phenolic group of tyrosine, and many others act on all three (dual-specificity kinases) [2,3]. 
Protein phosphorylation and dephosphorylation are regarded as two of the most significant 
post-translational protein modifications since they play roles in the regulation of nearly all 
cellular systems, and are the major intracellular mechanisms by which cells respond to 
extracellular stimuli [4]. Intermediary metabolism, DNA transcription and replication, RNA 
splicing, trafficking of organelles, cell cycle control, and cell differentiation are just a few of 
the numerous biological processes controlled by protein phosphorylation [5]. It has been 
proposed that up to 30% of all human proteins are subject to reversible phosphorylation, 
mediated by the at least 518 different kinases that have been identified in humans by 
cataloguing the protein kinase complement of the genome using genomic, complementary 
DNA, and expressed sequence tag sequences [6,7].  
CHAPTER 1 – INTRODUCTION 
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Figure 1. Generic protein phosphorylation reaction. (A) Kinases catalyse the transfer of the gamma-
phosphate of ATP to the hydroxyl group of specific serine, threonine, or tyrosine residues of their protein 
substrates, producing a phospho-residue and ADP. An example of the chemistry that can take place during 
phospho-transfer is indicated. (B) Threonine is used as an example of the resulting phospho-residue, 
illustrating that since the phosphorylation reaction does not involve any bonds to the two carbon 
stereocenters, the stereochemical configuration of the residue does not change. 
Reversible phosphorylation of proteins is therefore a critical regulatory mechanism during 
signal transduction in both prokaryotes and eukaryotes, where its ready reversibility makes it 
ideal for the controlled and rapid responses required in the internal cellular response 
pathways [8]. 
As protein kinases have significant effects on the functioning of a cell, their functioning is 
highly controlled. Not only are they themselves activated or deactivated through 
phosphorylation (which may be performed by the kinase itself through cis-phosphorylation/ 
autophosphorylation), but also by interacting with regulatory proteins, or by controlling their 
location within the cell relative to their target molecules [8-10]. Their enormous diversity and 
the fact that almost every known signalling pathway eventually impinges on a protein kinase, 
also makes them potentially important targets for therapeutic drugs. Kinases are thus avidly 
studied for their ability to control the many phosphorylation-dependant processes, whose 
dysfunction may cause an extensive array of diseases ranging from cancer to diabetes [11]. 
1.2. The mitogen-activated protein kinases 
The mitogen activated protein kinases (MAPK) are an important group of enzymes conserved 
in fungi, plants and mammals that regulate cell proliferation in response to mitogen signalling 
[12,13]. The MAPK pathway involves a tiered cascade containing at least three protein 
kinases in series. Specific stimuli trigger the activation of MAPK kinase kinases (MAP3Ks), 
CHAPTER 1 – INTRODUCTION 
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which then phosphorylate and activate the downstream MAPK kinases (MAP2Ks), which in 
turn phosphorylate and activate MAPKs (Figure 2) [12]. These MAPKs have been shown to 
control gene expression by catalysing the phosphorylative activation of several transcription 
factors [14]. In mammals there are three main subfamilies of MAPK classified according to 
their sequence homology. These include the kinases of the extracellular signal-regulated 
kinase (ERK) subfamily that mediate all signalling pathways initiated by polypeptide 
mitogens, and the stress-activated protein kinases of p38 and c-Jun N-terminal kinase (JNK) 
[5]. JNK and p38 therefore mediate the central pathways activated in response to 
inflammatory cytokines and extra-cellular environmental stresses such as UV irradiation, heat 
and osmotic shock, and the deprivation of growth factors [12].  
The members of all three families are serine/threonine-specific kinases that require dual 
phosphorylation for full activation, entailing the addition of a phosphate to both the  
well-conserved threonine residue located in the activation lip of all kinases, as well as on a 
tyrosine residue conserved in all MAP kinases [10]. These sites conform to the consensus 
tripeptide sequence Thr-X-Tyr, where X corresponds to Glu, Gly, and Pro, in ERK, JNK and 
p38 respectively [10]. 
 
Figure 2. Mitogen- and stress-activated MAPK signalling pathways. The MAPKs are activated by dual 
phosphorylation on Thr and Tyr residues of the tripeptide motif (Thr-X-Tyr), induced by members of the 
MAP2K group of protein kinases. Upstream, a group of MAP3Ks mediate the activation of the MAP2Ks 
through phosphorylation. Signalling is thus activated through the sequential actions of a MAP3K,  
a MAP2K, and a MAPK (Adapted from [15]). 
CHAPTER 1 – INTRODUCTION 
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1.3. c-Jun N-terminal kinase 
The JNK signalling cascade constitutes one class of MAP kinases that is activated mainly by 
exposure to cytokines (e.g., tumour necrosis factor and interleukin-1), growth factors, UV 
radiation, and other environmental stress stimuli (for a review see [16]). JNK is activated 
directly by the MAP2Ks of MKK4 and MKK7, dual specificity protein kinases that are each 
able to phosphorylate JNK at both of its activating Thr and Tyr residues (Figure 3) [17]. 
There are three JNK genes in mammals, namely JNK1, JNK2, and JNK3 located on three 
different chromosomes [18]. JNK1 and JNK2 are ubiquitously expressed, whereas the 
expression of JNK3 is limited predominantly to the neurons of the central nervous system and 
to a lesser extent to cardiac muscle and the testes [13]. As they are MAPKs, the three JNK 
forms contain all 12 conserved protein kinase subdomains (section 1.3.1). However, structural 
complexity is added to the JNK forms through differential splicing of the three JNK genes. 
This results in the generation of ten distinct JNK isoforms ranging from 46-55 kDa, splicing 
products essentially with or without an N- and C-terminal extension (Figure 4) [14]. JNK1 
and JNK2 undergo further alternative splicing, resulting from the selection for one of two 
specific exons encoding the amino acids located between subdomain IX and X (Figure 4) 
[14]. The Thr-Pro-Tyr motif situated within the activation lip of protein kinase subdomain 
VIII is the defining amino acid sequence for all ten JNK variants, the phosphorylation of 
which induces their activation [5]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. The JNK MAPK phosphorylative activation cascade. An example of the signalling cascade 
that leads to the phosphorylation and activation of JNK and its subsequent activation of downstream 
transcription factors. Here, the sequential actions of active MEKK1 (a MAP3K, in red) and MKK4  
(a MAP2K, in green) activates JNK (blue). 
 CHAPTER 1 – INTRODUCTION 
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Figure 4. Comparison of the structural features of the JNK isoforms. The JNK group of MAPKs possess all 11 conserved protein kinase subdomains, 
the relative positions of which are indicated by I – XI. The activation lip is situated between domains VII and VIII, a region containing the threonine (T) 
and tyrosine (Y) residues that must be phosphorylated (P) for complete activation of the kinase. Alternative splicing of the three JNK genes (JNK1 – 
green, JNK2 – blue, JNK3 – orange) result in the production of ten different isoforms of JNK, whose differences are indicated by the relevant symbols and 
alternately coloured rectangles. The segment between subdomains IX and X constitutes one splicing site of the JNK1 and JNK2 genes, the resulting splice 
forms of which show altered substrate specificity, while another alternative splicing site occurs at the C-terminus of the protein. This site facilitates the 
production of protein isoforms differing in length by 42 or 43 amino acids (where the total number of amino acids in each isoform is indicated) so that 
each short isoform has a longer counterpart. 
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Although the significance of these distinct variants are yet to be fully understood, the ten 
alternative JNK isoforms can be differentially activated and possess varying affinities for 
Elk-1, ATF2, and c-Jun transcription factors [19], implying that the individual members may 
selectively and temporally target specific transcription factors within the cell. The various 
JNK isoforms therefore have specific and differential functions in the different cell types of 
multicellular organisms, which have been found to include gene expression, apoptosis, and 
metabolism (reviewed in [20]). JNK thus acts as a multifunctional kinase implicated in many 
critical physiological and pathological processes, playing its largest role in apoptosis and 
several cell death processes [13,16]. Consequently, the JNK pathway has been connected to 
the survival and/or death responses of cells to extra-cellular stimuli, as well as to many 
developmental processes and oncogenic transformation [21]. 
With respect to how it participates in these events, JNK was named as such because it was 
initially found to phosphorylate the Ser63 and Ser73 residues of the N-terminal domain of  
c-Jun, thereby enhancing its ability to activate the expression of its associated genes [22]. 
Nevertheless, JNK is also able to modify a number of substrates that include a variety of  
non-nuclear proteins and other transcription factors such as JunD, c-Fos, and ATF2 [23].  
In association with c-Jun, these transcription factors form heterodimers to become activator 
protein-1 (AP-1) that mediates and controls the expression of numerous stress-receptive 
genes [19]. JNK however does not only mediate apoptosis through its influence on gene 
transcription, but additionally through transcriptional-independent mechanisms. It has been 
shown that JNK is able to modify both anti- and pro-apoptotic elements (e.g. Bcl-2 or  
Bcl-xL, and Bim or Bmf, respectively) and regulate their activity [13,15]. 
Therefore, due to the involvement of JNK in the many developmental activities and the 
survival/death responses of cells, as well as its corresponding implication in numerous related 
diseases upon its dysfunction, the JNK signalling cascade has recently become a significant 
focus of attention. These diseases include neurological disorders such as Parkinson’s disease 
and amyotrophic lateral sclerosis, in addition to different tauopathies comprising Alzheimer’s 
disease, Pick’s disease and familial frontotemporal dementia [13,24-28]. The JNK signalling 
pathway also plays additional pathological roles in disorders such as type 2 diabetes, heart 
disease, cancer, and inflammatory diseases [19,29-31]. Knowledge about the biophysical 
basis of the activation of JNK is therefore highly desirable, and may facilitate the discovery 
of drugs that may interfere or enhance the functioning of the kinase. 
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1.3.1. Structure of JNK 
Comparing the amino acid sequences and the X-ray crystallographic models of the more than 
30 different protein kinases (including MAPKs) whose structures have been elucidated 
reveals that they display a common globular kinase fold comprising an N-terminal domain of 
~85 amino acids that is mostly β-sheet in structure, and a larger C-terminal domain of  
~170 amino acids that comprises mainly α-helices (as represented by the structure of JNK3 in 
Figure 5) (reviewed in [12]). The common globular fold, called the kinase domain, is also 
typically subdivided into 12 subdomains based on conserved motifs involved in ATP and 
peptide substrate binding, and are identified using the nomenclature I–XI [10]. The two 
terminal domains are connected by a small linker region that generates a binding pocket for 
ATP and the protein substrate (Figure 5). The adenine ring of ATP is deeply buried within 
the active site cleft that exists at the interface between the two domains, while the  
γ-phosphate group of the nucleotide is directed toward the periphery of the catalytic cleft 
where other protein substrates bind [10,12]. 
With respect to JNK specifically, the overall architecture of JNK1, 2 and 3 are highly 
equivalent to each other as a result of the high homology of their sequences, having  
92% identity [32]. Their overall fold is typical of the monomeric protein kinases described, 
consisting of two domains with an active site cleft (Figure 5). The N-terminal domain of the 
JNKs (subdomains I-IV) contains seven β-strands and two α-helices, and assists in the 
binding and positioning of ATP [33]. Their C-terminal domain (subdomains VIA-XI) 
comprises a bundle of seven α-helices, five short 310 helices and three β-strands (Figure 5), 
and is involved in recognition of the protein substrate and anchoring the phosphates of ATP 
[33]. The N-terminal domain is linked to the C-terminal domain by two loops; the first is 
located between β7 and β8 (a loop referred to as the hinge as it has been shown to act as the 
pivot point for interdomain movements), while the other is a long connector of α13 to  
α14 [33]. A deep cleft between the N- and C-terminal domains constitutes the nucleotide-
binding site and active site, where the “glycine-rich phosphate anchor flap” (a consensus 
glycine-rich sequence found within all protein kinases) of the JNKs form a well-defined  
β-strand–turn–β-strand flap structure that covers the nucleotide almost completely (Figure 5) 
[32]. The phosphorylation or activation lip exists within the C-terminal, a region containing 
the JNK regulatory phosphorylation sites of Thr183 and Tyr185 (Figure 5) [32]. 
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Figure 5. JNK3 crystal structure. A ribbon diagram demonstrates the three-dimensional crystal 
structure of the inactive (non-phosphorylated) form of JNK3, with the secondary-structure elements 
labelled as previously described by Zhang et al [34]. AMP-PNP (grey ball-and-stick model) is bound 
within the active site cleft created between the N-terminal (green) and C-terminal (blue) domains. The 
“hinge” domain linker is presented in grey. The two canonical phosphorylatable residues of JNK3, Thr221 
and Tyr223 (Thr183 and Tyr185 in JNK1) are shown in the activation lip (red) as ball-and-stick models, 
while parts of the disordered regions (lacking electron density) are presented as a dotted line. The image 
was rendered using PyMOLTM v. 0.99 (DeLano Scientific, 2006) using the PDB code 1JNK [32]. 
1.3.2. The active site of JNK 
Structural data for the nucleotide-bound form of the JNKs had been revealed first by the 
crystallisation of JNK3 with Mg2+ and the ATP analogue, adenosine  
5′-(β,γ-imido)triphosphate (AMP-PNP) [32]. Since the amino acids involved in ATP binding 
are generally conserved among the different JNK isoforms, this data is likely to reflect that 
which may be present in the other variants. 
Within the JNK3 structure, AMP-PNP is located deep within the active site cleft formed 
between the N- and C-terminal domains, while the Gly-rich flap of JNK3 extends almost 
completely over the nucleotide (Figure 6) [32]. The adenine base of the nucleotide binds 
toward the rear of the active site cleft, and interacts with both Met149 and Glu147 (Figure 6). 
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Figure 6. The active site of JNK3. The residues of JNK3 that interact via hydrogen bonds and electrostatic 
forces with the ATP analogue AMP-PNP within the active site of inactive (non-phosphorylated) JNK3 are 
illustrated. The two essential divalent metal ions, Mg2+, required for the coordination of the phosphoryl 
oxygen atoms of AMP-PNP are labelled M1 and M2 (A & B) and represented by orange spheres (B). The 
water molecules involved in the indirect hydrogen bonds formed between selected residues and AMP-PNP 
are indicated by W1 and W2 (A & B), and shown as cyan spheres (B). (A) A schematic representation of the 
binary complex formed between AMP-PNP (green) and non-phosphorylated JNK3. Hydrogen bonds and 
electrostatic interactions are represented by blue and red dotted lines, respectively, yet are not drawn to 
scale. (B) A three-dimensional representation of the binary complex, in which the relevant interactions are 
indicated by green dashed lines. Oxygen, nitrogen, and phosphorus atoms are shown in red, blue, and green, 
respectively. The distal location of Asp189 in inactive JNK3 is indicated, a residue proposed to function in the 
correct positioning of the hydroxyl group of the substrate for catalysis in active JNK3 when the residue is 
positioned correctly upon JNK3 phosphorylation. The image was rendered using PyMOLTM v. 0.99 (DeLano 
Scientific, 2006) using the PDB code 1JNK [32]. 
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Specific residues from the Gly-rich flap and from β7 form nonpolar interactions on both sides 
of the purine ring, while the side chain of Asn152 and the carbonyl group of Ser193 from a 
hydrogen-bonding network to the O2′ and O3′ hydroxyls of the ribose sugar [32]. Many 
hydrogen bonds, both direct and indirect, are formed between the triphosphate group and a 
number of the invariant amino acids of the protein kinases. The main chain amide and side 
chain carbonyl oxygen of Gln75, as well as the side chain amine of the conserved Lys93 
interact with the β- and α-phosphate oxygen atoms, respectively (Figure 6) [32]. The  
JNK3–AMP-PNP complex also comprises two magnesium ions (M1 and M2). M2 contacts 
the side chain group of Asn194, allowing it to bridge the oxygens of the α- and γ-phosphoryl 
groups of AMP-PNP, while M1 interacts via water molecules with the carboxylate oxygens 
of Glu111 and Asp207 (a strictly conserved residue), allowing it to chelate the β- and  
γ-phosphoryl group oxygens (Figure 6) [32]. 
1.3.3. Catalytic mechanism of JNK 
The JNK isoforms exhibit a random sequential reaction in that either protein substrate or 
ATP may bind to the active site of the kinase first, proceeded by the binding of the other 
substrate [35]. Kinases are then known to transfer the γ-phosphate of ATP to their protein 
substrates with inversion of its stereochemical configuration [36]. There is increasing 
evidence that this is a result of the hydroxyl group of the substrate directly displacing the 
phosphate in a single step, without the incorporation of any phospho-enzyme covalent 
intermediates (see [3] for a review). Although there is a possibility that other complex 
mechanisms entailing multiple covalent intermediates may be utilised to facilitate protein 
phosphorylation, the active site of kinases do not provide an adequate nucleophile in 
proximity to the terminal γ-phosphate of ATP for such a mechanism to be viable [36]. It has 
therefore been proposed that kinases facilitate a single direct displacement of the γ-phosphate 
by the hydroxyl group of their substrate without the creation of any intermediates. 
In respect to how this is achieved, it is known based on primary and tertiary structural 
comparisons that most protein kinases place a conserved aspartate residue (Asp189 in JNK3) 
in hydrogen bonding distance to the substrate hydroxyl group (Figure 6) [5,37-40]. 
Mutational studies have also shown this residue to be critical for efficient catalysis, as the 
replacement of this aspartate with alanine in a variety of kinases decreases their kcat by  
2-3 orders of magnitude [41,42]. It has been illustrated through kinetic studies upon a number 
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of protein kinases that this residue does not have a role as a general-base catalyst [43-46], but 
it has rather been suggested that the carboxyl group may orient the substrate’s hydroxyl 
group for efficient attack of the γ-phosphate of ATP. The hydrogen bond formed between 
these groups would immobilise a productive hydroxyl rotamer to allow an effective attack 
geometry to be attained [45], where upon phosphorylation of the hydroxyl group of the 
substrate, the negatively charged aspartate could facilitate dissociation by repelling the 
phospho-product [47]. The essential Mg2+ ion that protein kinases require for catalysis (M1) 
is seen to chelate the β- and γ-phosphates of ATP and Asp207 in JNK3, and has been 
proposed to orientate the terminal γ-phosphate group to facilitate its direct transfer to the 
hydroxyl acceptor (Figure 6). It is therefore likely that protein kinases utilise a mechanism 
that incorporates a positioning function for the two aspartate residues described, usually with 
the participation of a metal ion such as Mg2+ (M1) that helps to stabilise the negative charge 
that develops on the leaving group [44]. 
1.4. Mechanisms of kinase regulation and activation through phosphorylation 
1.4.1. Autoinhibition 
The control of protein kinases can be separated into two general yet distinct categories based 
on the mechanism through which regulation occurs. The first is regulation by autoinhibition, 
a mechanism in which a pseudosubstrate domain located within a polypeptide extension of 
the kinase catalytic core inhibits catalytic activity by interacting with the active site. Kinase 
activation occurs upon displacement of the autoinhibitory domain from the active site, 
indicating that this autoregulation relies on an inhibition mechanism commonly deemed 
competitive with regard to the interaction of protein substrates within the catalytic cleft [12]. 
An example includes the binding of cyclic adenosine monophosphate (cAMP) to the 
regulatory subunit of cAMP-dependent protein kinase (PKA) [48]. The regulatory subunit is 
an autoinhibitory domain formed from a discrete polypeptide subunit, whose binding to 
cAMP displaces it from the catalytic core of PKA to allow for binding of its substrate [26]. 
Protein phosphorylation is also known however to play an important role in autoinhibitory 
function, as observed within the displacement of the C-terminal tail from the active site of the 
Src tyrosine kinase upon its phosphorylation [49].  
The phosphorylated and non-phosphorylated crystal structures of these and numerous other 
protein kinases have driven many to propose that the activation lip, the site at which kinases 
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are phosphorylated on select serine, threonine, and tyrosine residues, has an autoregulatory 
role [49]. These non-phosphorylated structures place the activation lip partly in the catalytic 
cleft, where phosphorylation causes extensive movements in the loop, supposedly enabling 
improved access of substrates to the active site [50,51]. The activation lip may thus function 
as “door” to the active site cleft and substrate binding pocket, thereby allowing the large 
enhancements to catalytic turnover observed upon phosphorylative activation. This 
corresponds to the model that the loop acts as a competitive inhibitor for the protein substrate 
when the kinase is inactive. Considering that the activation lip is positioned over the substrate 
binding site in non-phosphorylated inactive JNK3 (Figure 7), the autoinhibitory model 
described may also apply to this MAP kinase.  
A few kinases however display an increase in activity independent of an increase in ATP and 
substrate binding affinity when phosphorylated. Within these kinases, the activation lip does 
not behave as a competitive inhibitor for either nucleotide or protein substrate, and must thus 
facilitate the phosphoryl transfer step via alternative mechanisms [3]. When comparing the 
phosphorylated and non-phosphorylated forms of a variety of other kinases, it is seen that 
while phosphorylation may modulate the dynamic motions of the activation lip, the character 
of the motions do not seem to be the conserved across the kinase superfamily. For example, 
the activation lip in the insulin receptor kinase (InRK) appears to obstruct the ATP and 
protein substrate binding pockets [51], while the loop in fibroblast growth factor receptor 
(FGFR) kinase exhibits localised changes in conformation upon phosphorylation that has 
been shown not to affect the binding of ATP [52]. Phosphorylation of the activation lip of 
some kinases may thus regulate kinase activity in a manner that is distinct from 
autoinhibitory mechanisms. Within this role, phosphorylation has been proposed to 
appropriately position the activation lip, which nucleates a network of interactions within the 
active site cleft essential for activity [12]. 
 
 
 
 
 
CHAPTER 1 – INTRODUCTION 
22 
  
 
 
 
 
 
 
 
 
 
 
Figure 7. Structural features proposed to be involved in the activation of JNK3 upon 
phosphorylation. A ribbon representation of JNK3 illustrates the Gly-rich flap in blue, the hinge 
sequence in yellow, and the activation lip (including the regulatory phosphorylation sites of T221 and 
Y223) in red. The misalignment of the functionally important residues D184 and D207, situated in the 
catalytic loop (teal) and DFG motif (purple) respectively, are indicated in this inactive form of the kinase. 
The AMP-PNP molecule bound within the active site of JNK is shown as a green ball-and-stick 
representation. The disordered region of R212–T216 does not have visible electron density, and is 
represented as a dotted line. The image was rendered using PyMOLTM v. 0.99 (DeLano Scientific, 2006) 
using the PDB code 1JNK [32]. 
1.4.2. Remodelling of the active site 
The optimisation of substrate binding and phosphoryl transfer through the remodelling of the 
active site represents the second type of kinase regulation. In illustration, phosphorylation is 
thought to activate ERK2 by inducing both local and global changes in conformation and 
conformational flexibility. The N-terminal and C-terminal domains of inactive ERK2 are 
situated ~17° further apart than the equivalent domains of active PKA [53], and 
phosphorylation has been shown to rotate the two domains to cause the closure of the 
catalytic cleft and the alignment of the functional residues [54,55]. Due to the highly 
conserved properties of the core kinase structure [38], an account of PKA, the first kinase 
structure to be elucidated using X-ray diffraction [56], is also useful here as it embodies the 
major characteristics of all the members of the superfamily. The phosphorylated amino acid 
in the activation lip of active PKA interacts with specific basic residues located within the  
CHAPTER 1 – INTRODUCTION 
23 
  
N-terminal domain to stabilise the closed domain form of the kinase [57]. The closed state of 
ERK2 may be stabilised by similar interactions, where domain rotation is brought about by 
homologous basic residues binding its phosphorylated Thr183 [53]. 
When comparing the structures of inactive JNK3 and active PKA, it is revealed that the  
N-terminal and C-terminal domains of JNK3 are also rotated further apart when compared to 
their relative positions in PKA [32,58]. This results in the misalignment of the two halves of 
the active site of JNK3, which comprise the catalytic loop (Arg188-Asn194) and the DFG 
motif (Asp207-Gly209) (Figure 7) [32]. As described above, the conserved residues of 
Asp189 and Asp207 and their correct orientation are thought to be essential for catalysing 
phosphoryl transfer, functioning to direct the hydroxyl group of the protein substrate for 
attack on the γ-phosphate of ATP [41]. Asp207 interacts via an H2O molecule (W2) with M1, 
which in turn coordinates with the β- and γ-phosphoryl group oxygens (Figure 6) [32]. The 
equivalent residue in PKA (Asp184) however binds both M1 and M2 directly, an important 
difference that might contribute to the reduced catalytic activity of the non-phosphorylated 
form of JNK3 [53]. The direct interaction of the aspartic residue with the metal ion is 
significant because metal chelation has been proposed to be an important function for Asp184 
in PKA [44]. Thus, as Asp207 is located within the misaligned DFG motif of  
non-phosphorylated JNK3, it is suggested that phosphorylation results in the reconfiguration 
of the activation lip and rotation of the two domains through the “hinge region”, bringing 
Asp207 closer to the nucleotide to allow its direct interaction with the metal ion (Figure 5  
and 6) [32]. The critical importance of Asp189 and Asp207 therefore suggest that the open 
conformation of the two domains of JNK3 plays a role in the low activity of the  
non-phosphorylated form of the enzyme [3,32]. 
Ultimately, the data accumulated from structural and kinetic studies indicate that a common 
means of regulation through the activation lips of kinases does not exist. Phosphorylation 
induced changes of the activation lip may differ from kinase to kinase, while loop mediated 
regulation involves conformational changes in additional structural elements in the kinase 
core distant from the activation lip. The structures of JNK that have been determined are also 
only of the non-phosphorylated, inactive conformation of the kinase. Thus, due to the lack of 
a conserved means of phosphorylative kinase activation and of phosphorylated JNK 
structural data, the mechanisms through which JNK is activated upon its phosphorylation has 
not yet been fully elucidated. Although the misplacement of the catalytic residues associated 
with the open conformation of the N- and C-terminal domains, and the obstruction of the 
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catalytic cleft by the activation lip may be the causative factors of the low activity of  
non-phosphorylated JNKs, structural and biophysical data of phosphorylated JNK are 
required to confirm these proposals and uncover the exact nature of its mechanisms of 
activation. 
1.5. Aim and objectives 
The precise mechanisms by which phosphorylation facilitates the activation of JNK are not 
fully understood, as the crystal/solution structure of phosphorylated and active JNK has not 
yet been solved. The models proposed are thus based on the conformational changes 
(whether local or global) that occur within other protein kinases upon their activation, yet 
even separate kinases of the same family do not exhibit a conserved means of 
phosphorylative activation. The aim of this research was thus to elucidate the changes to the 
structure, stability, and dynamics of JNK1β1 (the most abundant JNK isoform [59]) that are 
induced by phosphorylation and to reveal how these changes facilitate its activation. 
To this end, the specific objectives of this research were to: 
1. Express and purify recombinant JNK1β1. 
2. Develop a system for producing fully phosphorylated and active JNK1β1 by 
reconstituting the MAPK phosphorylation cascade in vitro. 
3. Determine the effect that phosphorylation has on the specific activity of JNK1β1. 
4. Characterise the nature of JNK1β1 phosphorylation by active MKK4 using mass 
spectrometry to identify the location of phospho-sites. 
5. Compare the secondary and tertiary structural conformations of phosphorylated and  
non-phosphorylated JNK1β1 using spectroscopic techniques. 
6. Assess the effect that nucleotide binding and phosphorylative activation has on the 
stability of JNK1β1 through thermal denaturation as well as equilibrium and kinetic 
unfolding studies. 
7. Establish the changes to the dynamics of JNK1β1 that occur upon nucleotide binding 
and phosphorylation using amide hydrogen-deuterium exchange mass spectrometry. 
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PUBLICATION 1 
High yield purification of JNK1β1 and activation by in vitro reconstitution 
of the MEKK1 → MKK4 → JNK MAPK phosphorylation cascade 
GAVIN R. OWEN, IKECHUKWU ACHILONU, AND HEINI W. DIRR 
Protein Expression and Purification 87, 87-99 (2013) 
This publication describes a unique system for expressing and purifying JNK1β1, as well as a 
novel means of phosphorylating the kinase by reconstituting the MAPK activation cascade  
in vitro. The impact of phosphorylative activation on the catalytic activity of JNK1β1 was 
also determined. 
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The c-Jun N-terminal kinase (JNK) pathway forms part of the mitogen-activated protein kinase (MAPK)
signaling pathways comprising a sequential three-tiered kinase cascade. Here, an upstream MAP3K
(MEKK1) phosphorylates and activates a MAP2K (MKK4 and MKK7), which in turn phosphorylates and
activates the MAPK, JNK. The C-terminal kinase domain of MEKK1 (MEKK-C) is constitutively active,
while MKK4/7 and JNK are both activated by dual phosphorylation of S/Y, and T/Y residues within their
activation loops, respectively. While improvements in the purification of large quantities of active JNKs
have recently been made, inadequacies in their yield, purity, and the efficiency of their phosphorylation
still exist. We describe a novel and robust method that further improves upon the purification of large
yields of highly pure, phosphorylated JNK1b1, which is most suitable for biochemical and biophysical
characterization. Codon harmonization of the JNK1b1 gene was used as a precautionary measure toward
increasing the soluble overexpression of the kinase. While JNK1b1 and its substrate ATF2 were both puri-
fied to >99% purity as GST fusion proteins using GSH-agarose affinity chromatography and each cleaved
from GST using thrombin, constitutively-active MEKK-C and inactive MKK4 were separately expressed in
E. coli as thioredoxin-His6-tagged proteins and purified using urea refolding and Ni2+-IMAC, respectively.
Activation of JNK1b1 was then achieved by successfully reconstituting the JNK MAPK activation cascade
in vitro; MEKK-C was used to activate MKK4, which in turn was used to efficiently phosphorylate and
activate large quantities of JNK1b1. Activated JNK1b1 was thereafter able to phosphorylate ATF2 with
high catalytic efficiency.
 2012 Elsevier Inc. All rights reserved.Introduction
The c-Jun N-terminal kinases (JNKs)1 are one sub-group of the
Ser/Thr kinases that form the last tier of the eukaryotic mitogen-acti-
vated protein kinase (MAPK) signaling pathway, comprising a highly
conserved, sequential three-tiered kinase cascade. Here, upon activa-
tion by extracellular and cellular stimuli, an upstream MAP3K (e.g.
MEKKs, MLK, ASK1) phosphorylates and activates a MAP2K (e.g.
MKKs), which in turn phosphorylates and activates the downstream
MAPKs (such as the JNKs, ERKs, or p38 kinases) [1,2].
The JNK MAPK pathway is activated primarily by cytokines and
exposure to environmental stresses such as UV irradiation [3],
osmotic shock, and oxidative stress [4]. JNKs were originally
identified by their ability to phosphorylate the N-terminal of thell rights reserved.
r).
e; MAPK, mitogen-activated
ng kinase kinase; MKK, mito-
transcription factor 2; GST,
atography; TH-, thioredoxin-
IMAC, immobilized metal iontranscription factor c-Jun, thereby initiating a variety of transcrip-
tion events [5]. They have since been found however to be multi-
functional kinases involved in many physiological processes that
include proliferation, apoptosis, motility, differentiation and DNA
repair [6–8]. Consequently, dysfunction in JNK signaling has been
shown to contribute to many pathological processes associated
with neurodegeneration, diabetes, heart disease, and cancer [9].
This makes this family of protein kinases attractive drug targets
for Parkinson’s disease, Alzheimer’s disease, obesity, arteriosclero-
sis and stroke [9]. Therefore, the production of active recombinant
forms of these kinases remains vital for therapeutic development.
The JNKs are encoded by three separate and alternatively
spliced genes (JNK1, JNK2, and JNK3), resulting in 10 distinct JNK
isoforms [10]. The predominant isoforms JNK1 and JNK2 are ex-
pressed ubiquitously and have four isoforms each (a1, a2, b1,
and b2), while JNK3, possessing an N-terminal amino acid exten-
sion and expressed primarily in the nervous system, has only 2 iso-
forms (a1 and a2) [6,10].
JNKs are activated by dual phosphorylation of the T183 and
Y185 residues of the T-P-Y motif located in the activation loop, a
modification catalyzed by the two upstream dual specificity
MAP2Ks, MKK4 and MKK7 [11]. MKK4 and MKK7 are themselves
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including, to name just a few, MEKK1–4, ASK1, ASK2, MLK2, and
MLK3 [2]. Once activated by phosphorylation, JNKs are in turn able
to phosphorylate a variety of substrates that include a few cyto-
plasmic proteins and other nuclear transcription factors such as
ATF2, Elk-1, JunD, c-Fos, and c-Myc [6,10]. Together with c-Jun,
these proteins form heterodimers that constitute activator pro-
tein-1 (AP-1) transcription factors that regulate and control the
expression of several stress-responsive genes [12].
The complete activation of JNKs requires phosphorylation on
both the T183 and Y185 residues, modifications initially found to
be catalyzed by the synergistic activity of both MKK4 and MKK7
[11,13,14]. This was due to the preference that MKK4 and MKK7
had shown for phosphorylating the threonine and tyrosine resi-
dues, respectively. Nevertheless, studies of in vitro phosphorylative
activation of JNK has shown that high concentrations of active
MKK4 is sufficient to phosphorylate both the T183 and Y185 resi-
dues of JNK, thereby activating it [6,15].
Many approaches have been attempted in the production of
high yields of active JNKs. These can be described by three funda-
mentally similar methods; transient expression of JNKs within
mammalian cells stressed to induce activation of the natural JNK
MAPK pathway [16], co-expression of both JNKs and their up-
stream activating MAPKs in E. coli or other non-mammalian
expression hosts [17,18], and recombinant purification of inactive
JNKs followed by their later in vitro phosphorylation by commer-
cially available (often only partially) active upstream kinases
[19]. Unfortunately, expression using mammalian cell culture com-
monly results in very low yields of active kinases, while the latter
methods often lead to large variations in the effectiveness of acti-
vation of the downstream target kinase. In part this is because the
unpredictable and uncontrollable in vivo, cellular systems in which
the target or their upstream kinases are phosphorylated (such as
during the bacterial co-expression of MAPK cascade proteins) are
only able to produce inconsistent degrees of partially phosphory-
lated kinases.
Within the current study, we describe an alternative method for
the expression, purification and activation of the most abundant
human JNK isoform, JNK1b1, which can be easily employed for
the isolation and phosphorylation of any other JNK isoform. Aiming
first to improve the yield of soluble MAP kinase during overexpres-
sion, the JNK1b1 open reading frame was recoded by harmonizing
the usage frequency of its codons with those observed in an E. coli
expression host (full codon usage harmonization). We were thus
able to recreate the natural rate at which JNK1b1 is translated in
its native human host, hoping that it will lead to the production
of soluble, correctly folded protein in E. coli. Removing the incon-
sistencies present in biological systems that rely on co-expression
of active upstream kinases for in vivo phosphorylation of down-
stream kinase targets (as described in Refs. [17,18] and others),
we obtained controlled and consistent levels of active, phosphory-
lated JNK1b1 by reconstituting the full JNK MAPK activation cas-
cade in vitro by purifying both active MEKK1 and its downstream
kinase MKK4. Offering full control over its in vitro activation, this
robust yet flexible method is applicable for the acquisition of large
quantities of any JNK isoform in a fully active or inactive state.Material and methods
Codon usage harmonization of the JNK1b1 open reading frame
The codon usage frequencies of the human JNK1b1 open reading
frame (accession No. NM_139046.1), encoding full-length JNK1b1
(1–384) (EC 2.7.11.24) (accession No. AAI44064.1), when ex-
pressed naturally in its native human host and recombinantly inan E. coli K12 expression host, as well as the usage frequency of
each of the known 64 codons in each of the described hosts, were
computed using the Graphical Codon Usage Analyser (GCUA v 2.0)
web-interface software (www.gcua.schoedl.de; [20]).
The JNK1b1 codons that do not possess the same usage fre-
quency when expressed in E. coli as compared to their expression
in their native human host were manually adjusted by substitution
with synonymous codons computed to be expressed within E. coli
with a usage frequency identical or similar to their corresponding
natural codons. For example, the triplet codon AGA of R3 possesses
a natural codon usage frequency of 100% when expressed in H.
sapiens, but has a codon usage frequency calculated to be 5% in
E. coli (Supplementary Table S1). This AGA triplet codon was thus
changed to CGC, a synonymous arginine encoding codon that has
a calculated codon usage frequency of 100% in E. coli. The entire
JNK1b1 open reading frame was thus redesigned with synonymous
E. coli codons having usage frequencies that match as closely as
possible those that occur naturally in the human. This approach,
termed ‘‘codon usage harmonization’’, is significant for heterolo-
gous protein expression in E. coli as it assists in the production of
correctly folded, soluble and functional proteins [21]. See Supple-
mentary Table S1 for a table illustrating the full procedure for co-
don usage harmonization of the JNK1b1 open reading frame.
Supplementary Fig. S1 presents the natural H. sapiens and codon-
harmonized JNK1b1 DNA sequences used, highlighting the nucleo-
tide changes made in the codon harmonization process, while
Fig. S2 shows the identical wild-type JNK1b1 protein product
resulting upon translation of each DNA sequence.Cloning, expression, and purification of JNK1b1 and its substrate ATF2
The methods for cloning synthetic codon-harmonized JNK1b1
and human ATF2 (residues 17–96) open reading frames into
pGEX-4T-1 vector are described in the supplementary material.
Various conditions of cell type (E. coli BL21(DE3)pLysS and T7
Express Iq cells), culture media (LB, 2  YT, and TB media), IPTG
concentration (0–1 mM IPTG in 0.1 mM intervals), induction time
(2, 4, 6, 8, and 16 h) and growth temperature (18, 20, 22, 25, 30,
and 37 C), and the numerous combinations thereof, were screened
using SDS–PAGE and Western blot to obtain maximal yield of sol-
uble GST-JNK1 and GST-ATF2. Greatest yields of GST-JNK1 were
produced when 1 L of BL21(DE3)pLysS cell cultures in 2  YT med-
ia were grown at 37 C to an OD600nm of 0.6, induced with 0.6 mM
IPTG and grown at 22 C for 6 h. The best production of soluble
GST-ATF2 occurred when 1 L T7 Express Iq cell cultures in 2  YT
media were grown at 37 C to an OD600nm of 0.6, induced with
0.5 mM IPTG and grown at 37 C for 2 h. Cells were harvested
and resuspended in ‘‘Tris-Lysis Buffer’’ (10 mM Tris–HCl buffer,
pH 8.0, comprising 150 mM NaCl, 1 mM EDTA, 1 mM DTT, 1 mM
benzamidine, 2 mM phenylmethylsulfonyl fluoride (PMSF) and
0.02% (w/v) NaN3), and stored at 20 C. Cells were thawed, Triton
X-100 added to a final concentration of 1% (v/v), and disrupted by
sonication. The soluble fraction was clarified by centrifugation
(27000g, 30 min, 4 C) and subjected to GSH-agarose (Sigma–Al-
drich) affinity chromatography. After washing the column with
Tris-Lysis Buffer containing 1% Triton X-100 and 1 M NaCl, the
bound GST-fusion was eluted with ‘‘Glycine-Elution Buffer’’
(10 mM glycine, pH 10.0, 1 mM EDTA, 1 mM DTT and 0.02% (w/v)
NaN3). The eluted fraction was dialysed for 16 h at 4 C against
Tris-Lysis Buffer, concentrated by ultracentrifugation at 4 C and
the concentration of fusion protein was determined by Bradford
assay and by measuring the absorbance at 280 nm. At this point,
the GST-JNK1 fusion-protein form of JNK1b1 was used in its subse-
quent dephosphorylation and/or dual phosphorylation (the proce-
dures of which are described below). This allows for the isolation of
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ing GSH-agarose affinity chromatography.
Using 0.4 U thrombin/mg fusion protein at 20 C, the optimum
time for cleavage of GST-JNK1 was established to be 15 min,
whereas that of GST-ATF2 was determined to be 6 h (see Supple-
mentary Information for the details of the thrombin cleavage tri-
als). After cleavage, thrombin was immediately removed using
2 ml of heparin-agarose resin (GE Healthcare Bio-Sciences AB, Upp-
sala, Sweden) pre-equilibrated with Tris-Lysis Buffer, immediately
followed by the removal of the GST tag by GSH-agarose as previ-
ously described. Recombinant JNK1b1 and ATF2 were concentrated
and further purified using Sephacryl S-200 size-exclusive chroma-
tography (SEC) (0.8 cm  70 cm, 30 cm/h) (GE Healthcare Bio-Sci-
ences AB) pre-equilibrated with Tris-Lysis Buffer.
Cloning, expression, and purification of MEKK-C
The methods for cloning the MEKK-C open reading frame (the
constitutively active C-terminal kinase domain of MEKK1) into
pET-32a vector are described in the supplementary material.
TH-MEKK-C was purified from inclusion bodies by urea refold-
ing of the insoluble cell fraction in which it was expressed. Upon
testing for the optimum conditions for its overexpression, the
greatest yield of insoluble TH-MEKK-C was observed when 1 L of
BL21(DE3)pLysS cell cultures in 2  YT media were grown at
37 C to an OD600nm of 0.6, induced with 0.5 mM IPTG, and grown
at 37 C for a further 6 h. The cells were harvested, resuspended in
Tris-Lysis Buffer, and stored at 20 C. The cells were thawed and
sonicated, and the insoluble cell fraction was collected by centrifu-
gation (27000g, 30 min, 4 C). The pellet was washed once with 2%
(w/v) deoxycholate solution, followed by two similar washes with
distilled water. The insoluble constituents remaining were pelleted
as before, and resuspended in 50 ml of ‘‘Refolding Buffer’’ (50 mM
Tris–HCl, pH 8.0, 0.5 M NaCl, 10% (v/v) glycerol, 0.02% (w/v) NaN3)
containing 6.5 M urea. The pellet was allowed to solubilize for 1 h
on a rotary mixer and the insoluble fraction removed by centrifu-
gation. The supernatant was dialyzed against Refolding Buffer con-
taining 4 M urea overnight at 4 C. Insoluble precipitate was
pelleted and the supernatant diluted 5 by drop-wise addition into
Refolding Buffer containing 2 M urea and 5 mM DTT. The resulting
solution was dialysed overnight at 4 C against Refolding Buffer
comprising 1 M urea and 2 mM DTT, and then against Kinase-Reac-
tion Buffer at 4 C (2 changes, 12 h/change). Any additional
aggregated protein at this point was removed by centrifugation.
The TH-MEKK-C was concentrated by ultracentrifugation and the
concentration determined by measuring the absorbance at
280 nm.
Cloning, expression, and purification of wild-type and phosphomimetic
MKK4 variants
The methods for cloning the wild-type MKK4 open reading
frame into pET-32a vector and the generation of a phosphomimetic
MKK4 variant (S257E/T261D) are described in the supplementary
material.
Screening various expression conditions as previously de-
scribed, optimal yields of both TH-wtMKK4 and TH-pmMKK4,
was obtained when 1 L T7 Express Iq cell cultures in 2 YT media
were grown at 37 C to an OD600nm of 0.6, induced with 0.2 mM
IPTG and grown at 20 C overnight. TH-wtMKK4 and TH-pmMKK4
were then purified separately according to the following proce-
dure; Cells were harvested, resuspended in ‘‘Phosphate-Lysis Buf-
fer’’ (20 mM sodium phosphate buffer, pH 8.0, comprising
500 mM NaCl, 1 mM benzamidine, 2 mM PMSF and 0.02% (w/v)
NaN3), and stored at 20 C. Cells were thawed and sonicated,
where after the soluble cell fraction was clarified by centrifugation(27000g, 30 min, 4 C) and recombinant TH-wtMKK4 and TH-
pmMKK4 were purified using a 5 ml HisTrap™ Ni2+-immobilized
metal ion affinity chromatography (IMAC) column (GE Healthcare)
pre-equilibrated with Phosphate-Lysis Buffer. The matrix was first
washed with Phosphate-Lysis Buffer followed by a 500 ml linear
imidazole gradient consisting of Phosphate-Lysis Buffer and the
same buffer containing 100 mM imidazole. The bound TH-fusion
proteins were then eluted with a one-step gradient of Phosphate-
Lysis Buffer comprising 250 mM imidazole. The eluted fractions
were dialysed overnight at 4 C against ‘‘Kinase-Reaction Buffer’’
(10 mM Tris–HCl, pH 8.0, comprising 150 mM NaCl, 1 mM DTT,
0.02% (v/v) Triton X-100, and 0.02% (w/v) NaN3), concentrated by
ultracentrifugation at 4 C and the concentration of protein deter-
mined by measuring the absorbance at 280 nm.
In vitro dephosphorylation of partially phosphorylated GST-JNK1
purified from E. coli and purification of inactive JNK1b1
Complete inactivation of partially phosphorylated JNK1b1 by
dephosphorylation was achieved by incubating GST-JNK1 with
shrimp alkaline phosphatase (SAP, Thermo Scientific) at 5 U SAP/
mg phosphoprotein in Kinase-Reaction Buffer supplemented with
10 MgCl2 and 0.2 mg/ml bovine serum albumin (BSA). The mixture
was incubated at 25 C for 5 h during which time samples were re-
moved at regular intervals and immediately treated for reducing
SDS–PAGE. Upon complete dephosphorylation of GST-JNK1, SAP
was removed by passing the reaction mixture through a column
of GSH-agarose affinity chromatography resin pre-equilibrated
with Kinase-Reaction Buffer. After washing the matrix with Ki-
nase-Reaction Buffer, the bound dephosphorylated GST-JNK1 fu-
sion protein was eluted with Glycine-elution buffer. SAP-
dephosphorylated JNK1b1 was then purified as previously
described.
In vitro phosphorylation of TH-wtMKK4 and GST-JNK1, and
purification of active JNK1b1
To obtain active MKK4 for later use in the phosphorylation of
JNK1b1, TH-wtMKK4 was incubated with constitutively-active
TH-MEKK-C in a 10:1 molar ratio (typically 10:1 lM, respectively)
in Kinase-Reaction Buffer containing 10 MgCl2, 1 mM ATP and
0.2 mg/ml BSA. The reaction mixture was incubated overnight at
25 C to allow for the complete phosphorylative activation of TH-
wtMKK4 (producing TH-ppMKK4). The TH-ppMKK4/TH-MEKK-C
mixture was then used directly for the phosphorylation of JNK1b1
by mixing GST-JNK1 with the active upstream-kinase reaction
mixture to produce a 10:1:0.1 molar ratio of GST-JNK1, TH-
ppMKK4 and TH-MEKK-C, respectively, in Kinase-Reaction Buffer
containing 10 mM MgCl2, 1 mM ATP and 0.2 mg/ml BSA. The mix-
ture was incubated at 25 C, during which time samples were re-
moved at regular intervals for analysis by SDS–PAGE and
Western blot.
As a control for the possibility of autophosphorylation under
these conditions, GST-JNK1 in Kinase-Reaction Buffer was incu-
bated at similar concentrations with 10 mM MgCl2, 1 mM ATP
and 0.2 mg/ml BSA without the addition of its upstream kinases,
and the reaction monitored.
The pmMKK4 variant was then tested to ascertain whether it
could be used to phosphorylate and activate JNK1b1. This was per-
formed by incubating GST-JNK1 with TH-pmMKK4 in a 10:1 molar
ratio in Kinase-Reaction Buffer containing 10 mM MgCl2, 1 mM
ATP and 0.2 mg/ml BSA, and monitoring the reaction as described.
Upon complete dual phosphorylation of GST-JNK1 (producing
GST-ppJNK1), the TH-ppMKK4 and TH-MEKK-C proteins were re-
moved by passing the reaction mixture through GSH-agarose affin-
ity chromatography resin pre-equilibrated with Kinase-Reaction
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bound phosphorylated GST-ppJNK1 fusion protein was eluted with
Glycine-elution buffer. Active, dual phosphorylated JNK1b1
(ppJNK1b1) was then purified as described.Enzymatic assays of JNK1b1 and determination of its specific activity
To determine the specific activity of phosphorylated, active
JNK1b1, an ATP Bioluminescent Assay Kit (Sigma) was used to
monitor the depletion of ATP during the dual phosphorylation of
ATF2. When ATP is the limiting reagent, this kit allows for the
quantitative bioluminescent determination of the amount of ATP
in a sample, as the firefly luciferase included in the kit catalyses
the ATP-dependent oxidation of D-luciferin, emitting light that is
proportional to the ATP present [22]. An ATP standard curve was
first generated by mixing increasing concentrations of ATP in Ki-
nase-Reaction Buffer (90–120 lM ATP in a final volume of
250 ll) with 250 ll ‘‘ATP Assay Mix’’ (diluted 5 with ‘‘ATP Assay
Mix Dilution Buffer’’) in a 1 ml quartz cuvette with a 1 cm path-
length, and immediately determining the amount of light emitted
for each ATP concentration. Emitted light intensity measurements
were performed using a Jasco FP-6300 spectrofluorometer without
using the excitation bulb, and measuring the amount of light of
550 nm produced over a 6 s interval. The amount of light generated
within this period was integrated, the experiment repeated inde-
pendently, and the average data plotted against the concentration
of ATP present. A linear function was fit to the data and the slope of
this standard curve, in bioluminescence intensity (arbitrary units)/
lM of ATP, was used to calculate the amount of ATP hydrolysed at
each JNK1b1 concentration in the subsequent kinase assay.
The JNK1b1 kinase assay reactions were conducted by incubat-
ing 25 lM ATF2, 120 lM ATP, 5 mM MgCl2, and 0.2 mg/ml BSA in
Kinase-Reaction Buffer with increasing concentrations of dephos-
phorylated or phosphorylated JNK1b1 (0–100 nM) for 1 min at
25 C. Two hundred and fifty microliters of each reaction was then
immediately mixed with 250 ll diluted ATP Assay Mix, and the
amount of light produced over a 6 s period was measured as de-
scribed for the ATP standard curve. The light generated within this
time was integrated and converted to the concentration of ATP
hydrolyzed by subtracting the concentration of ATP remaining
(determined using the slope of the ATP standard curve) from the
initial concentration of ATP (120 lM). The data was fit to a linear
function and the slope of this curve, in lM of ATP hydrolyzed/
nM of JNK1b1, was used to calculate the specific activity of phos-
phorylated JNK1b1, in lmol of phosphorylated ATF2/min/mg of ki-
nase, assuming the stoichiometry that 2 ATP molecules are
hydrolyzed per ATF2 protein that is dually phosphorylated. The
phosphorylated JNK1b1 kinase assay was performed twice in two
independent experiments, while the dephosphorylated JNK1b1 ki-
nase assay was performed once merely for comparison and ensure
that it was indeed dephosphorylated.SDS–PAGE and Western blot analysis
Samples comprising JNK1b1, MKK4, or MEKK-C (those samples
whose primary analysis did not concern ATF2) were resolved by
Laemmli SDS–PAGE on a 12.5% Tris–glycine gel [23], while samples
containing ATF2 were resolved by Tricine–SDS–PAGE on a 16%
Tris-Tricine gel [24]. Gels were stained with Coomassie Blue R-
250 solution. Protein resolved by SDS–PAGE were transferred to
BioTrace™ NT nitrocellulose membrane (Pall) using ‘‘Blotting Buf-
fer’’ (50 mM Tris–HCl, 200 mM glycine, pH 8.3, containing 0.1% (w/
v) SDS and 20% (v/v) methanol) at 350 mA for 1 h on ice. Mem-
branes were blocked with 5% (w/v) fat-free milk powder (Elite)
in Tris-buffered saline (TBS; 0.2 M NaCl and 20 mM Tris–HCl, pH7.4) for 1 h at room temperature. Membranes were then washed
3 with TBS (5 min/wash).
To detect total JNK1b1, polyclonal rabbit antibodies raised
against the C-terminus of human JNK1 (anti-JNK1; BioLegend)
were utilized. To test for dual phosphorylation of JNK1b1, mono-
clonal rabbit antibodies specific to JNK1 phosphorylated at both
T183 and Y185 residues (anti-pT183/pY185 JNK1; Cell Signaling
Technology) were employed. Polyclonal rabbit anti-Schistosoma
japonicum GST antibodies (anti-GST; USBiological) were used to
detect GST-ATF2 fusion. To test for the dual phosphorylation of
ATF2, monoclonal rabbit antibodies against ATF2 phosphorylated
at both T69 and T71 (anti-pT69/pT71 ATF2; Cell Signaling Technol-
ogy) were used. Anti-GST primary antibody was diluted 1:10000 in
TBS containing 0.5% (w/v) BSA (TBS-BSA), while all other primary
antibodies were diluted 1:1000 in TBS-BSA. Membranes were incu-
bated with their relevant primary antibodies for 3 h at room tem-
perature, washed with TBS (3, 5 min/wash) and incubated with
donkey anti-rabbit IgG secondary antibody (1:1000 dilution in
TBS-BSA) conjugated to horseradish peroxidase (BioLegend) for
1 h at room temperature. After washing with TBS (4, 5 min/
wash), membranes were incubated in substrate reagent (0.06%
(w/v) 4-chloro-1-naphthol, 0.0015% (v/v) H2O2, and 20% (v/v)
methanol in TBS) and the image captured with the GelDoc™ XR
imaging system (Bio-Rad).Results and discussion
Recent work by Thevenin et al. [18] describes an efficient meth-
od for the purification and activation of various JNK a isoforms
(including JNK1a1, JNK1a2, and JNK2a2). While it can be appreci-
ated as an advancement in the pursuit to acquire large amounts of
pure and active JNKs, minor inadequacies in their purification still
exist. Within this current work, we sought to further improve upon
the purification of large yields of highly pure, phosphorylated JNK
by using the most abundant yet less studied JNK isoform, JNK1b1.
To achieve this, we first hoped to improve the soluble expres-
sion of JNK1b1 by harmonizing the codon usage frequencies of
its open reading frame to those of an E. coli expression host
(Fig. 1), as well as by employing the GST protein solubility tag
(Fig. 2C). We then sought to obtain active, phosphorylated JNK1b1
by reconstituting the JNK MAPK activation cascade in vitro. This
was accomplished by purifying both the constitutively-active C-
terminal domain of MEKK1 and its downstream kinase MKK4 to
use in phosphorylation experiments of inactive JNK1b1 (Fig. 2
and Fig. 3). Providing full control over its in vitro activation, this
method allowed for the purification of large yields of active JNK1b1
that was able to phosphorylate its substrate, ATF2, with high cata-
lytic efficiency.Harmonization of JNK1b1 codon usage frequencies and overexpression
of GST-JNK1
The Escherichia coli expression system is the foremost choice for
recombinant protein expression in a heterologous system due to
the robustness of the bacteria, cost, high-level protein yield and
simplicity of the system, compared to other expression systems
such as the baculovirus, mammalian and the yeast expression sys-
tems [25,26]. However, the E. coli expression system has several
shortcomings, including production of incorrectly folded insoluble
protein, truncated protein products, and in the worst case, no pro-
tein production. Several factors are believed to result in the mis-
folding of recombinant proteins, one of which has shown to be
the disparity in codon usage frequency between prokaryotes and
eukaryotes [27]. There is accumulating evidence indicating that
co-translational protein folding is modulated by subtle variations
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sion. MEKK-C (A) and wtMKK4 (B) were each expressed as thioredoxin(Trx)-His6
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tography. A thrombin cleavage sequence (TCS) exists between the GST tag and each
target protein, which allows cleavage of the fusion protein by thrombin. The
hierarchical cascade of phosphorylative activation of the MAPK proteins is
represented, a pathway that was recreated in vitro for the activation of JNK1b1.
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developing secondary structure in nascent proteins [28,21]. Fail-
ures in recombinant protein expression by heterologous expres-
sion hosts may thus be attributable to differences in synonymous
codon usage frequencies between expression and natural hosts
[21].
Adjusting target gene sequences for heterologous expression in
E. coli by substituting the native codons with synonymous ones
possessing the same or similar usage frequencies in the expression
host (termed ‘‘codon harmonization’’) may provide the optimal
translational kinetics for its soluble overexpression [21]. Studies
have shown that improving synonymous codon usage frequenciesin heterologous genes by codon harmonization can result in a more
than 40-fold increase in the yield of soluble, recombinant protein
[21,29]. Because the expression and purification of JNK is notori-
ously difficult, we used codon harmonization within this study to
recode the entire open reading frame of the JNK1b1 gene as a pre-
cautionary measure to possibly enhance the production of soluble,
correctly folded protein during expression in E. coli. This was based
on the method described by Angov et al. [21]. However, a full co-
don harmonization approach was employed in this study, selecting
synonymous codons from the E. coli expression host having usage
frequencies that best reflect the usage frequencies of the native
JNK1b1 gene in its human host (potential link/end segments were
not specifically considered). Although Angov et al. [21] concluded
that their algorithm enhances heterologous protein expression of
particular codon-harmonized Plasmodium falciparum proteins,
attempting to fully replicate the native translation kinetics of hu-
man JNK1b1 within E. coli was an attractive means of potentially
facilitating soluble overexpression.
When the native H. sapiens JNK1b1 gene sequence is introduced
for expression into E. coli, a significant shift in its natural codon
usage frequencies occurs (Fig. 1). This shift is well illustrated by
the codons encoding the first 20 N-terminus amino acids (M1-
F20) as there is a particularly large discordance in the codon usage
patterns of this region when comparing its expression in each host
(Supplementary Fig. S9A). Several codons within this region,
namely R3, K5, D7, E14, G16, S18, and T19 are used at high fre-
quency in the native host but are used at a dramatically lower fre-
quency in E. coli. The usage frequency for the residue R3 (AGA), for
example, dropped from 100% in H. sapiens to 5% in E. coli (Supple-
mentary Fig. S9A).
Following full codon harmonization, the codon usage patterns
were in good agreement with those of the JNK1b1 gene in its native
host (Fig. 1. and Supplementary Fig. S9B) highlighting the potential
of the harmonization process to assist in its increased soluble over-
expression. For example, the usage rate for R3 increased from 5% to
100%, identical to the natural 100% codon usage frequency in H.
sapiens. The interdomain connecting segments (residues 110–112
and 330–345) representing the major link/end segments of JNK1b1
also show good accordance between native and codon-harmonized
frequencies (Fig. 1). Fath et al. [29] recently reported that ‘‘multi-
parameter DNA sequence optimization’’ of JNK1 (isoform not spec-
ified), although a method that uses a different algorithm to that
Fig. 3. Outline of the expression, purification and phosphorylation of the MAPK cascade proteins used to produce pure and active JNK1b1. A pGEX-4T-1 plasmid containing
JNK1b1 (pGX-JNK1) in E. coli BL21(DE3)pLysS cells was induced with IPTG to express soluble, ‘‘inactive’’ GST-JNK1, which was purified using GSH-agarose affinity
chromatography (‘‘inactive’’ indicates that partial phosphorylation of GST-JNK1 occurred during expression). Concurrently, pET-32a plasmids containing wild-type MKK4
(pT-wtMKK4) in E. coli T7 Express Iq cells, and constitutively-active MEKK1 (MEKK-C) (pT-MEKK-C) in E. coli BL21(DE3)pLysS cells, were induced to express inactive TH-
wtMKK4 and active TH-MEKK-C, respectively. Inactive TH-wtMKK4 was purified using HisTrap™ Ni2+-IMAC, while the insoluble yet constitutively-active TH-MEKK-C was
purified by urea unfolding and refolding. Inactive TH-wtMKK4 was then mixed with active TH-MEKK-C as well as MgCl2 and ATP, and incubated overnight at 25 C to
phosphorylate and activate TH-wtMKK4. The activated upstream-kinase mixture was mixed with inactive GST-JNK1, along with MgCl2 and ATP, and incubated at 25 C until
the JNK1b1 was fully phosphorylated. The active MAP kinase mixture was then subjected to GSH-agarose affinity chromatography to isolate active GST-ppJNK1. Thrombin
was added to GST-ppJNK1 to cleave the GST-tag, and the thrombin and GST removed by heparin- and GSH-agarose affinity chromatography, respectively. SEC was then
performed to obtain pure and active ppJNK1b1.
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fold compared to the wild-type gene.
Unfortunately, due to the lack of a non-codon harmonized
JNK1b1 gene fragment control to compare with, the soluble protein
expression observed within the system employed cannot be as-
cribed to the codon harmonization process alone. Nonetheless,
there was at least a 2-fold improvement in the soluble overexpres-
sion of JNK1b1 over that produced from previous attempts re-
ported in the literature [16–19].
To further improve the production of soluble JNK1b1, the de-
gree of expression of soluble GST-JNK1 was examined under manydifferent combinations of experimental conditions (see Materials
and methods). It was established that induction with a final IPTG
concentration of 0.6 mM for a period of 6 h at 22 C, expressed in
BL21(DE3)pLysS cell cultures in 2  YT media would result in the
highest yield of soluble GST-JNK1, although substantial amounts
of the insoluble form was also expressed under these conditions
(Fig. 4 and Supplementary Fig. S10). That there is a degree of insol-
uble overexpression and that different degrees of soluble JNK1b1
production occur when expressed under different bacterial culture
conditions (e.g. complete and considerable insoluble overexpres-
sion occurred at 37 C; see Supplementary Fig. S10) indicates that
Fig. 4. Expression and purification of JNK1b1. (A) 12.5% acrylamide SDS–PAGE and (B) Western blot analyses of the purification procedure (employing anti-JNK1 antibodies
for detection of GST-JNK1 fusion and JNK1b1) illustrated that upon efficient soluble overexpression and purification of GST-JNK1 by GSH-agarose (GSH-ag) affinity
chromatography (lanes 1 and 4, respectively), cleavage of the 65 kDa fusion by thrombin (TC) was successful (lane 5). The contaminating thrombin (undetectable) and GST tag
(27 kDa) proteins remaining were then separated from JNK1b1 (44 kDa) using heparin-agarose (Heparin-ag) affinity chromatography (lane 6), followed by a second GSH-
agarose affinity chromatography step (lane 8) for the removal of thrombin and GST, respectively. Only small quantities of JNK1b1 bound to either column (lanes 7 and 9) and
the contaminants that still remained were effectively removed by size-exclusion chromatography (SEC), resulting in large yields of highly pure JNK1b1 (lane 10).
Densitometric analysis revealed that the resulting protein solution comprised >99% JNK1b1.
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translational folding [21]. For example, the expression of JNK1b1
at the lower temperature of 22 C may have reduced the kinetics
of off-pathway protein aggregation (which occurs increasingly at
37 C) relative to its folding reaction, resulting in higher yields of
properly folded JNK1b1 [30].
Protein solubility may have also been enhanced by expressing
the recombinant protein as a fusion with the highly soluble poly-
peptide GST. Not only does it allow for its simple purification,
the high solubility of GST has been shown to impart to the hybrid
a lower propensity to aggregate [31].
The combination of regulation of JNK1b1 translation kinetics
through codon harmonization and the alteration in the kinetics
of its folding by a reduced cultivation temperature of 22 C, as well
as its concurrent expression with the highly soluble GST, may thus
be major complementary factors that possibly facilitated the redi-
rection of the previously insoluble to soluble overexpression of
JNK1b1.
Purification of human JNK1b1 and ATF2
Upon optimizing the soluble overexpression of both GST-JNK1
and GST-ATF2, each fusion and their respective target proteins
(JNK1b1 and ATF2) were purified according the same protocol; a
simple method that can be easily employed when using the GST-
fusion system to purify target proteins (Fig. 3). The large quantities
of each GST-fusion protein present within the soluble E. coli cell
fractions after expression were isolated using GSH-agarose affinity
chromatography, with only small amounts unable to bind and lost
in the flow-through (Figs. 4 and 5). After eluting each fusion, the
optimal time that GST-JNK and GST-ATF2 needed to be incubated
with thrombin for the complete cleavage of each target from the
GST tag (while also preventing their degradation) was determined
in a thrombin cleavage time trial (see Supplementary Information
and Figs. S11–S13 for the results and discussion of these trials).
Upon efficient cleavage of each fusion, the contaminating thrombin
and GST tag proteins remaining were effectively separated from
the JNK1b1 and ATF2 targets (Figs. 4 and 5). The small, undetect-
able quantity of thrombin was assumed confidently to have been
removed by efficient binding to the heparin column, as no further
undesirable proteolytic degradation of JNK1b1 (see Supplementary
Information) took place after purification and within the weeks
thereafter. Although a small proportion of the JNK1b1 bound tothe heparin- and GSH-agarose columns, the majority of JNK1b1
was present within the eventual flow-through (Fig. 4). Any addi-
tional contaminants remaining were then effectively removed by
Sephacryl S-200 SEC. Densitometric analysis of the SDS–PAGE puri-
fication profiles revealed that the final purity of both JNK1b1 and
ATF2 after SEC was >99% pure, with final yields of ±60 mg and
±8 mg of protein/liter of E. coli culture, respectively (Table 1). This
is significant when considering that recent studies were able to
purify JNK1 (of various isoforms) in the lower range of 20–50 mg
protein/liter culture, and with slightly less purity [18]. The expres-
sion and purification system described within this study is thus an
effective means of acquiring high levels of JNK1b1.Expression and purification of MEKK-C and MKK4 variants
In an effort to obtain large quantities of dually phosphorylated
JNK1b1, two alternate methods were employed. Within the first
approach, we attempted to generate a constitutively-active MKK4
that does not require phosphorylation by upstream kinases to be-
come active, as reported by [32]. To this end, a phosphomimetic
form of MKK4 (S257E/T261D) was produced through site-directed
mutagenesis by substituting its phosphorylatable residues (S257
and T261) with negatively charged residues (glutamate and aspar-
tate, respectively) that mimic the geometry and charge of the
phosphoserine and phosphotheronine (Supplementary Fig. S5).
The alternate approach entailed the purification and use of the
constitutively-active C-terminal kinase fragment of MEKK1,
termed MEKK-C, to first phosphorylate and activate MKK4. Active
ppMKK4 would then be used to dually phosphorylate JNK1b1.
In order to purify the wild-type and phosphomimetic variants
of MKK4, each were expressed with a thioredoxin-His6 fusion-tag
on their N-terminus (Fig. 2), allowing their purification by
HisTrap™ Ni2+-IMAC (Fig. 6). Significant soluble overexpression
of each was achieved after testing many expression conditions, as-
sisted possibly by the presence of the thioredoxin tag, with only
slightly higher quantities of insoluble MKK4 being produced
(Fig. 6). Almost all of each MKK4 variant bound to the HisTrap™
column with little found in each flow-through, yet a small degree
of both proteins were washed off during the necessary low concen-
tration imidazole wash. Nevertheless, upon elution, both TH-
wtMKK4 and TH-pmMKK4 were purified to sufficiently high purity
(Fig. 6) with total yields of ±13 mg protein/L culture (Table 1).
A B 
Fig. 5. Expression and purification of ATF2. Samples taken at each step of the purification of ATF2 (17–96) were analyzed by (A) 16% acrylamide Tricine–SDS–PAGE and (B)
Western blot (employing anti-GST antibodies for detection of GST-ATF2 fusion) and illustrated that the success of each step was comparable to that of the identical protocol
used for JNK1b1 (see Fig. 3 legend). In brief; Lane 1 and 2 – soluble and insoluble cell fraction, respectively, showing the extensive soluble overexpression of GST-ATF2
(35 kDa); Lanes 3 and 4 – flow-through (FT) and eluted samples from the first GSH-agarose (GSH-ag) affinity chromatography step for purification of GST-ATF2; Lane 5 – after
6 h thrombin cleavage (TC) of purified GST-ATF2, demonstrating its successful cleavage; Lanes 6 and 7 – FT and eluted samples from Heparin-agarose (Heparin-ag) affinity
chromatography for removal of thrombin (undetectable); Lane 8 and 9 – FT and eluted samples from the second GSH-ag affinity chromatography step, showing the successful
removal of the GST tag (27 kDa); Lane 10 – ATF2 after the final size-exclusion chromatography (SEC) step, illustrating the resulting high purity of ATF2.
Table 1
Final yields of the JNK MAPK cascade proteins after purification.
Purified protein Yield (mg protein/L of culture)
MEKK-C 3
MKK4 (both wt and pm variants) 13
JNK1b1 60
ATF2 8
wash eluted 
HisTrapTM Ni2+-IMAC 
116
64.2 
45
35
25
18.4 
14.4 
TH-pmMKK4
TH-wtMKK4 
sol 
116
64.2 
45
35
25
18.4 
kDa 1 2 3 4 5 
FTinsol 
A 
B 
expression 
Fig. 6. Expression and purification of the MKK4 variants. 12.5% acrylamide SDS–
PAGE analyses of the purification procedures of the (A) TH-wtMKK4 and (B) TH-
pmMKK4 variants (62 kDa each) illustrate that although both MKK4s are expressed
largely in an insoluble form (lane 2), large quantities of the solubly expressed
protein (lane 1) were isolated using HisTrap™ Ni2+-IMAC (lane 5) employing their
His6-tag. The flow-throughs (FT) of both variants (lane 3) indicates that while the
majority of each bound to the HisTrap™ column, a small degree of each was
removed during the necessary low concentration imidazole wash (lane 4).
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nately only insignificant quantities of soluble TH-MEKK-C were
produced under the expression conditions screened (Fig. 7). The
thioredoxin tag did not therefore assist in promoting the soluble
overexpression of MEKK-C. However, due to the extensive quanti-
ties of insoluble TH-MEKK-C fusion consistently expressed by this
plasmid, purification by urea refolding was reasoned to be an
achievable means of obtaining functional MEKK-C for the phos-
phorylative activation of MKK4. Upon overexpression of insoluble
TH-MEKK-C and washing the resulting pelleted insoluble cell frac-
tion with 2% deoxycholate, the insoluble cell fraction was well sol-
ubilized in 6.5 M urea. This fraction contained large amounts of
unfolded and solubilized TH-MEKK-C (Fig. 7). During its subse-
quent refolding by dialysis and dilution into lower concentration
of urea, notable quantities of TH-MEKK-C were lost through aggre-
gation when the urea concentration was dropped to 1 and 0 M urea
(Fig. 7). Nevertheless, since only small concentrations of the up-
stream kinase are required for the activation of MKK4, sufficient
quantities of refolded, soluble and adequately pure TH-MEKK-C
(at a yield of ±3 mg/L culture; Table 1) was remaining for this pur-
pose (Fig. 7).Preparation of inactive (dephosphorylated) and active
(phosphorylated) JNK1b1
Within our first attempts to phosphorylate GST-JNK1 using ac-
tive MKK4, it was revealed that even before the purified GST-JNK1
fusion had encountered the components thought necessary for
activation (i.e. before the addition of active MKK4, ATP, or MgCl2),
JNK1b1 already exhibited a significant degree of dual phosphoryla-
tion (initial trial data not shown, but see Fig. 8). In order to eluci-
date the means by which this JNK1 isoform is already partially
phosphorylated without additional in vitro modifications or treat-
ment after purification from E. coli, a few further experiments were
conducted;
To determine whether JNK1b1 was undergoing phosphorylation
within the E. coli BL21(DE3)pLysS cells during overexpression,
samples of the soluble and insoluble cell lysates were tested for
dually phosphorylated GST-JNK1 (Fig. 8). Phosphorylated JNK1b1
was indeed detected in large quantities in the soluble cell fraction,
comprising almost all of the soluble JNK1b1 expressed, while only
Fig. 7. Expression and purification of MEKK-C. Since little TH-MEKK-C (43 kDa) was expressed in a soluble form (lane 1), urea refolding of the large quantities of insolubly
expressed TH-MEKK-C was performed for its purification. After expression of insoluble TH-MEKK-C and washing the resulting insoluble cell lysate with 2% deoxycholate (lane
2), the remaining insoluble protein comprising large amounts of TH-MEKK-C was well solubilized in 6.5 M urea (lane 3 and 4). In the course of refolding the denatured TH-
MEKK-C (lanes 5 through to 11), steadily less soluble kinase was available as protein was lost by aggregation, particularly when the urea concentration was dropped to 1 M
and 0 M urea (Kinase-Reaction Buffer; KRB) (lanes 10 and 11). Nonetheless, adequate quantities of soluble TH-MEKK-C were available once refolding was complete (lane 10).
Efforts were made to analyse the relative amounts of protein that was available after each step of the refolding.
Fig. 8. JNK1b1 is phosphorylated in E. coli BL21(DE3)pLysS during expression.Western blot analyses of the soluble and insoluble bacterial cell lysates after overexpression of
GST-JNK1 employing anti-pT183/pY185 JNK1 antibodies illustrates that a large quantity of dually phosphorylated JNK1b1 is present in the soluble cell fraction, with little
occurring in the insoluble fraction. This indicates that JNK1b1 is phosphorylated during production in E. coli BL21(DE3)pLysS cells.
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phosphorylation (Fig. 8).
To confirm that the untreated JNK1b1 was in fact already phos-
phorylated, and to test that the monoclonal anti-pT183/pY185
JNK1 antibodies that we employed indeed bind their specified res-
idues only when they are phosphorylated, we dephosphorylated
GST-JNK1 using the non-specific phosphatase Shrimp Alkaline
Phosphatase (SAP), and monitored the reaction overtime by Wes-
tern blotting analysis using the anti-pT183/pY185 JNK1 antibodies.
This would also ensure that we could generate completely non-
phosphorylated JNK1b1 for future comparative studies of its active
and inactive forms. We found that SAP is able to dephosphorylate
the untreated GST-JNK1 within 5 h (Fig. 9B), with the intensity of
the anti-ppJNK1 bands before and after treatment with SAP indi-
cating a drastic decrease in the population of active JNK1b1
(Figs. 9B and 10). This verified that the antibody binds only the
phosphorylated form of T183/Y185 of JNK1b1 (and not non-specif-
ically to their unmodified form), and proved that the kinase had
been phosphorylated by some means within E. coli. Following this,
the GST-JNK1 was isolated from SAP by GSH-agarose affinity chro-
matography (confirmed by the ability to later phosphorylate the
newly dephosphorylated kinase), and the dephosphorylated
JNK1b1 purified as described.There are a few possibilities why JNK1b1 may become phos-
phorylated during expression in E. coli. It is a well-known observa-
tion that many kinases undergo autophosphorylation during
heterologous protein expression. It has been suggested that as
the expression host is inundated with recombinant protein during
overexpression from strong promoters, the high concentrations of
inactive kinase are able to phosphorylate the newly-produced ki-
nase polypeptides during co-translational or post-translational,
cytoplasmic folding [33]. In this way, phosphate groups may be
introduced at both the natural canonical sites of phosphorylation
(at the known T/S/Y residues of the activation loop whose phos-
phorylation enables kinase activation), and/or at non-standard
yet sites that may or may not be surface exposed at all. Due to
the inaccessibility of some of the phospho-residues upon final fold-
ing of the protein, these phosphate groups may not be able to be
removed by subsequent treatment with phosphatases, or cannot
be achieved during in vitro autophosphorylation experiments (i.e.
the fully folded protein cannot catalyse these phosphorylations
on themselves in vitro) [34,35].
Shrestha et al. [33] analyzed the conditions under which spe-
cific human kinases (including a brief analysis of JNK1a1) exhib-
ited autophosphorylation during bacterial overexpression. They
showed that reducing the rate of protein production by either low-
A 
B 
C 
D 
E
F 
Fig. 9. Preparation of dephosphorylated and phosphorylated GST-JNK1 using SAP and MKK4 variants respectively; (A) Coomassie blue staining to indicate the total,
consistent amounts of GST-JNK1 (10 lM), BSA (0.2 mg/ml) and modifying enzyme (SAP or MKK4 variant) in each reaction over time. (B-F) Western blot analysis of each
reaction profile employing anti-pT183/pY185 JNK1 antibodies to detect dually phosphorylated JNK1b1; (B) Dephosphorylation of unmodified GST-JNK1 (purified from E. coli)
by SAP, illustrating that at 25 C, partially-phosphorylated GST-JNK1 is dephosphorylated within 5 h. (C) Reaction control for potential autophosphorylation, indicating that
10 lM GST-JNK1 does not phosphorylate itself over time at 25 C. (D) Inactive, phosphomimetic TH-pmMKK4 negative phosphorylation control, demonstrating that
phosphomimetic MKK4 is unable to phosphorylate GST-JNK1, and is thus not constitutively-active in vitro. (E) Partial phosphorylation of GST-JNK1 by unmodified TH-
wtMKK4, indicating that TH-wtMKK4 may become partially active by phosphorylation during expression in E. coli. (F) Dual phosphorylation of GST-JNK1 by active, TH-
ppMKK4 (previously activated by MEKK-C). JNK1b1 is completely phosphorylated within 3 h of incubation with 1 lM TH-ppMKK4 at 25 C.
Fig. 10. Summary of JNK1b1 phosphorylation states. To demonstrate the relative degree of phosphorylation before and after treatment of unmodified, partially-
phosphorylated GST-JNK1 with the modifying enzymes SAP and ppMKK4, and to illustrate the success of the dephosphorylation and re-phosphorylation respectively,
Western blotting was used to analyze samples of these GST-JNK1 modifications. The JNK1b1 resulting from the subsequent processing of their corresponding modified GST-
JNK1 is included to illustrate that the phosphorylation state of JNK1b1 is unaltered during the subsequent processing.
96 G.R. Owen et al. / Protein Expression and Purification 87 (2013) 87–99ering the induction temperature and/or inducer concentration
leads to a reduction in the level of phosphorylation during expres-
sion, and suggested that proteins that fold ‘‘faster’’ may be less sus-
ceptible to autophosphorylation at internal sites [33].
The phosphorylation of JNK1b1 observed during overexpression
within this current study may thus be the product of this ‘‘co-fold-
ing autophosphorylation’’ phenomenon. Since this has not been
observed or reported to a large extent during the overexpression
of JNK1 elsewhere, we believe that the unique translation and fold-
ing kinetics of our JNK1b1 provided by the codon harmonization of
its open reading frame performed here, may have allowed for the
observed phosphorylation to occur during co-translational folding.
Nevertheless, as we were able to efficiently dephosphorylate
JNK1b1 after purification (Fig. 9B), optimizing the expression con-
ditions to minimize this phosphorylation was unnecessary, espe-
cially when maximizing the overall production of soluble protein
was of most importance. As illustrated by Shrestha et al. [33],
expression of JNK1b1 at the lower temperatures used (22 C)
may be best in minimizing the cellular phosphorylation anyway.We can also now not discount the fact that other endogenous
bacterial E. coli S/T/Y protein kinases may be catalyzing the ob-
served JNK1b1 phosphorylation while within the expression host.
A recent growing body of evidence indicates that, while relatively
few kinases capable of phosphorylating proteins at S/T/Y residues
have been directly identified in E. coli, more than 80 bacterial
proteins are naturally phosphorylated on S/T/Y residues [36]. Gi-
ven the recently realized potential for eukaryotic-like kinases in
E. coli to phosphorylate proteins at these residues, we now can-
not assume that eukaryotic proteins expressed in bacterial cells
will purify in a homogenous nonphosphorylated form [36].
Therefore, it may be possible that E. coli protein kinases are rec-
ognizing JNK1b1 in a manner that is comparable to the recogni-
tion by its natural activator, MKK4, thereby enabling the dual
phosphorylation displayed. As this has not been observed or re-
ported before, this possible means of phosphorylation would also
occur during co-translational folding, since the novel yet natural
translation kinetics of JNK1b1 provided here through codon har-
monization may now allow the E. coli kinases to recognize phos-
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folding.
To determine whether the potential autophosphorylation we
observed during JNK1b1 overexpression was occurring during fold-
ing of newly synthesized JNK1b1 polypeptides (co-translationally),
or between fully-folded native JNK1b1 proteins (post-translation-
ally), in vitro autophosphorylation experiments were performed.
Here we incubated dephosphorylated GST-JNK1 at both low
(10 lM; Fig. 9C) and high concentration (60 lM; data not shown)
to mimic the high concentrations of protein that may exist in the
cell during overexpression, with only BSA, MgCl2, and ATP, at
25 C, and monitored the potential phosphorylation over time.
Notably, the temperature at which the autophosphorylation was
performed was similar to that at which the GST-JNK1 was ex-
pressed (25 vs. 22 C), eliminating temperature-dependant factors
affecting the autophosphorylation analysis. Western blot analysis
demonstrates that native JNK1b1 does not phosphorylate itself
(autophosphorylate) in vitro in the absence of its activating up-
stream kinases under the conditions tested, at neither low
(Fig. 9C) nor high concentrations. Concentrations higher than
60 lM JNK1b1 could not be achieved for extended periods due to
the instability of the kinase and its tendency to aggregate.
Investigating the autophosphorylation activity of all 10 JNK iso-
forms, Tsuiki et al. [37] discovered that only 5 isoforms exhibit
autophosphorylation in the absence of upstream kinase, the stron-
gest activity of which was presented by the four JNK2 isoforms (in
order of autophosphorylation activity strength; JNK2a2 > JNK2b2 >
JNK2a1 > JNK2b1, with JNK3a2 showing very little activity).
Importantly though, not a single isoform of JNK1 demonstrated
even the slightest autophosphorylation activity [37]. Cui [38] pro-
ceeded to illustrate that the ability of JNKs to autophosphorylate
depends on the amino acids at position 218–226 between subdo-
main IX and X. Specifically, they found that the amino acid se-
quence LVKGCVIFQ at that position in JNK2a2 is crucial for its
autophosphorylation, and the C-terminal extension present the in
a2/b2 isoforms (residues 383–424) drastically enhance autophos-
phorylation [38]. It is therefore to be expected that JNK1b1, a
JNK1 isoform that do not possess neither the C-terminal extension
nor the required amino acids at position 218–226 (having
MIKGGVLFP), does not display autophosphorylation in vitro in this
study. These results then affirm that if the JNK1b1 phosphorylation
that we observe during expression is due to autophosphorylation,
this process occurs during the now naturalized co-translational
folding of the kinase, and not post-translationally between native
JNK1b1 molecules. Moreover, since phosphorylated JNK1b1 was
only detected in the soluble cell fraction, is it possible that either
the co-translational phosphorylation of JNK1b1 promotes it to fold
into a soluble state by shifting it onto its native folding pathway, or
perhaps only those JNK1b1 polypeptides presently following the
native folding pathway are able to be phosphorylated during
translational.
Upon generating non-phosphorylated JNK1b1 and eliminating
the possibility of in vitro autophosphorylation, we sought to gener-
ate dual phosphorylated, fully active JNK1b1. The first means by
which we attempted to achieve this was by using a phosphomi-
metic variant of MKK4 (S257E/T261D) (TM-pmMKK4) that has
been reported previously to be a constitutively-active in transfec-
ted cells (in vivo) [32]. Upon incubating dephosphorylated GST-
JNK1 with TH-pmMKK4 in vitro however, no JNK1b1 phosphoryla-
tion (using several experimental conditions) was detectable over
time (Fig. 9D). The phosphomimetic S257E/T261D MKK4 variant
is thus unable to catalyse the in vitro dual phosphorylation of
JNK1b1, implying that the phosphomimetic, now non-phosphoryl-
atable (glutamate and aspartate) residues in fact eradicate all
in vitro kinase activity so that it becomes constitutively-inactive.
Nevertheless, the pmMKK4 variant thereafter acted as a usefulnegative control for JNK1b1 phosphorylation by MKK4, re-high-
lighting the incidence of phosphorylation of kinases during heter-
ologous expression when we later analyzed wild-type MKK4 (see
below). Therefore, although pmMKK4may be active in vivo, phosp-
homimetics cannot be employed to effectively generate perpetu-
ally active MKK4 for use in downstream in vitro protein
phosphorylation applications.
The next approach by which we generated active, dual phos-
phorylated JNK1b1 entailed the reconstitution of the full JNK MAPK
cascade in vitro, in which we used constitutively-active MEKK-C to
activate MKK4, which in turn was used to phosphorylate JNK1b1
(Fig. 2 and Fig. 3). To assess the success of the subsequent phos-
phorylative activation of MKK4 by MEKK-C, and to control for
the effect that unmodified wild-type MKK4 has on JNK1b1, we first
incubated untreated TH-wtMKK4 with dephosphorylated GST-
JNK1, and monitored the change in the state of JNK1b1 phosphor-
ylation over time. Interestingly, we detected a slight degree of
JNK1b1 phosphorylation by the wild-type MKK4 that had not been
treated with MEKK-C (Fig. 9E). This indicates that when recombi-
nantly expressed in E. coli, wild-type MKK4 also becomes phos-
phorylated to a small degree (by any of the means discussed) as
observed for JNK1b1. The level of cellular phosphorylative activa-
tion of TH-wtMKK4was consistently low however, as the effective-
ness of JNK1b1 phosphorylation was poor (Fig. 9E). Nevertheless,
this fact reiterated the importance of evaluating the homogeneity
and phosphorylation state of heterologously expressed proteins
before performing downstream analyses that may be influenced
by these undesired modifications.
Efficient activation of JNK1b1 was then achieved by incubating
TH-ppMKK4 that had been previously activated by overnight incu-
bation with TH-MEKK-C, with dephosphorylated GST-JNK1 (Fig. 3).
Monitoring its activation with anti-ppJNK1 antibodies, it was dem-
onstrated that full phosphorylation of JNK1b1 was reached within
3 h (Fig. 9F). As Thevenin et al. [18] confirmed confidently that ac-
tive MKK4 alone is able to phosphorylate both T183 and Y185 in
the activation loop of JNK1 as reported originally by Lawler et al.
[11], we felt it adequate to assume that both residues were phos-
phorylated in our activation of JNK1b1. Furthermore, it is also sig-
nificant that previously SAP-dephosphorylated GST-JNK1 is able to
be re-phosphorylated by TH-ppMKK4, confirming the initial suc-
cessful removal of SAP and its innocuous effect on JNK1b1.
Upon dual phosphorylation of GST-JNK1, active TH-ppMKK4
and TH-MEKK-C were efficiently removed by passing the mixture
through GSH-agarose affinity chromatography, where after the ac-
tive, phosphorylated JNK1b1 was purified as described (Fig. 3).
Western blot analysis was thereafter used to confirm that the final
phosphorylation state of each JNK1b1 resulting from the subse-
quent cleavage and processing of their corresponding modified
GST-JNK1 fusion (dephosphorylated or phosphorylated) remained
unaltered during the final steps of its purification (Fig. 10). We also
intend however to use mass spectrometry to identify and confirm
the phosphorylation states of the JNK1b1 species described above.
Determination of JNK1b1 specific activity
To determine the specific activity of phosphorylated JNK1b1 we
measured the depletion of ATP during the dual phosphorylation of
it substrate, ATF2, using an ATP Bioluminescent Assay Kit (Sigma).
To calculate the rate at which JNK1b1 uses ATP to phosphorylate
ATF2 as a specific activity (in lmol of ATF2/min/mg of JNK1b1),
we first generated an ATP standard curve of the relative biolumi-
nescence intensity of light produced by known concentrations of
ATP (Fig. 11A). After fitting a linear function to the data, the slope
(3.38 ± 0.52 bioluminescence intensity (arbitrary units)/lM of ATP,
R2 = 0.96) was used in calculations to determine the specific activ-
ity of phosphorylated JNK1b1.
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Fig. 11. Determination of the specific activity of JNK1b1. An ATP Bioluminescent Assay Kit was used to determine the specific activity of JNK1b1 by measuring the decrease in
bioluminescence intensity as ATP is depleted during the dual phosphorylation of it substrate, ATF2. (A) ATP calibration curve, produced by measuring the relative
bioluminescence intensity of 550 nm light generated by 90–120 lM of ATP. The slope of the linear function fit to the data (in bioluminescence intensity/lM of ATP) was used
to calculate the amount of ATP hydrolysed at each JNK1b1 concentration in the subsequent kinase assay. The data is the mean of two independent experiments. (B) Level of
ATP hydrolysis by different concentrations of JNK1b1 during the phosphorylation of ATF2. The amount of bioluminescence produced was converted to the concentration of
ATP hydrolyzed using the slope determined in (A) and the initial concentration of ATP. The data was fit to a linear function and the slope of the ppJNK1b1 curve (in lM of ATP
hydrolyzed/nM of JNK1b1), was used to calculate the specific activity of phosphorylated JNK1b1. The ppJNK1b1 kinase assay data is the mean of two independent
experiments. The dephosphorylated JNK1b1 kinase assay was performed once merely for comparison, the shallow slope of which indicates that the dephosphorylation
efficiently deactivated JNK1b1 and highlights the high activity of phosphorylated JNK1b1. Insert – Phosphorylation of ATF2 by ppJNK1b1 was confirmed by Western blot
(using monoclonal anti-pT69/pT71 ATF2 antibodies), and the electrophoretic shift of the phosphorylated form of ATF2 observed during 16% Tricine–SDS–PAGE. 30 lM ATF2
was incubated with 1 lM ppJNK1b1 for P4 h at 25 C.
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to be 3.3 ± 0.4 lmol of ATF2/min/mg of kinase (Fig. 11B), with a kcat
value of 2.4 ± 0.3 s1 (calculated by converting the specific activity
value from lmol of ATF2/min/mg of kinase to lmol of ATF2/min/
lmol of kinase, and dividing by 60 s). The errors reported represent
the mean ± standard error. Repeating the activity assay for dephos-
phorylated JNK1b1 (performing only a single experiment) revealed
that this form of the kinase had no significant activity (shallow
slope of dephosphorylated JNK1b1, Fig. 11B), and thus that the ini-
tial dephosphorylation and inactivation of partially phosphory-
lated GST-JNK1 by SAP was effective. This also reaffirms that the
ability of JNK1b1 to phosphorylate ATF2 is fully re-established
when SAP-dephosphorylated JNK1b1 is re-activated by MKK4
phosphorylation. The enzymatic characterization of the JNK1b1
isoform has been performed only once elsewhere, with a reported
kcat value of 2.2 ± 0.7 min1 for ATF2 [39]. This value equates to a
kcat of approximately 0.04 s1 (converted by dividing by 60), which
is more than 60-fold lower than the kcat value for phosphorylated
JNK1b1 determined in this study. A possible reason why our
JNK1b1 is more active may be due to the efficiency of our in vitro
kinase phosphorylation reactions. The previous authors employed
commercially available active MKK4 and MKK7 for the activation
of JNK1b1 [39]. As we prepared dual phosphorylated, active
MKK4 ourselves using constitutively (and thus completely and
homogenously) -active MEKK-C overnight at 25 C, we suspect that
we generated an almost completely active population of fully
phosphorylated MKK4. Employing our active MKK4 in the subse-
quent in vitro activation of JNK1b1 likely allowed for more efficient
dual phosphorylation of the downstream kinase, generating a high-
er population of completely active JNK1b1 than can be achieved by
the commercially available MKK4/MKK7. Another possibility for
the discrepancy in the kcat values may be the fact that Figuera-Los-
ada and LoGrasso [39] also used a biotinylated Bioease-FLAG tag
ATF2 (residues 2–115) construct within their enzymatic assays,
where we used untagged ATF2 of a different length (residues 17–
96). As the authors did not control for the effect that the large 80
amino acid Bioease(72 residues)-FLAG(8 residues) tag, or the effect
that the biotinylation may have on the ability of ATF2 to be phos-
phorylated, their presence may have influenced the measured
activity.Conclusions
We describe here a purification and activation protocol for
JNK1b1 that can be easily applied to any JNK isoform. Precaution-
ary codon harmonization of its open reading frame may have con-
tributed to the significant quantities of soluble JNK1b1 that was
overexpressed, yet the lack of a non-harmonized JNK1b1 gene con-
trol prevents the increase from being attributed to the codon har-
monization process alone. Nonetheless, this study exhibits
improvements in the soluble overexpression of JNK1b1 when com-
pared to that produced elsewhere. High yields of >99% pure JNK1b1
was purified and proficiently activated by successfully reconstitut-
ing the MEKK1?MKK4? JNK MAPK phosphorylation cascade
in vitro. The methods described therefore provide a potential
means for the acquisition of large quantities of the JNK isoforms
in their most pure and active form, allowing for many additional
biochemical and biophysical studies of the kinases to be performed
in the future.
We hope too that these methods will enable the attainment of
the elusive crystal structure of phosphorylated, active JNK.
Although it is known that JNK is activated by dual phosphorylation
of T183 and Y185, the changes in its structure and stability that oc-
cur upon phosphorylative activation is not fully understood. The
knowledge provided by the crystal structure about the structural
basis of its activation would thus be invaluable, and may facilitate
the development of therapeutics that may combat the pathological
effects of its associated diseases.Acknowledgments
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Table S1. Illustration of the JNK1β1 codon harmonization process. The procedure for recoding the JNK1β1 open reading frame to fully harmonize its 
codon usage frequencies for expression in E. coli is illustrated using the codons encoding its first twenty amino acids (M1-F20). 
 
Native host data Method of recoding JNK1β1 for expression in E. coli Recoded JNK1β1 DNA 
H. sapiens JNK1β1 open reading frame Nearest lower frequency codon 
Nearest higher 
frequency codon 
Nearest matching 
frequency codon Harmonized codon Full harmonization 
Residue 
number 
Amino 
acid Codon 
Usage 
frequency  
in H. 
sapiens (%) 
Usage 
frequency 
in E. coli 
(%) 
Codon 
Usage 
frequency 
(%) 
Codon 
Usage 
frequency 
(%) 
Codon 
Usage 
frequency 
(%) 
Codon 
Usage 
frequency 
(%) 
Synonymous 
codon 
changes 
(X) 
Usage 
frequency 
in E. coli 
(%) 
1 Met ATG 100 100 ATG 100 ATG 100 ATG 100 ATG 100 ― 100 
2 Ser AGC 100 100 TCC 92 AGC 100 AGC 100 AGC 100 ― 100 
3 Arg AGA 100 5 CGC 100 CGC 100 CGC 100 CGC 100 CGC 100 
4 Ser AGC 100 100 AGC 100 AGC 100 AGC 100 AGC 100 ― 100 
5 Lys AAG 100 37 AAA 100 AAA 100 AAA 100 AAA 100 AAA 100 
6 Arg CGT 38 82 CGA 16 CGT 82 CGA 16 CGA 16 CGA 16 
7 Asp GAC 100 54 GAT 100 GAT 100 GAT 100 GAT 100 GAT 100 
8 Asn AAC 100 100 AAC 100 AAC 100 AAC 100 AAC 100 ― 100 
9 Asn AAT 89 89 AAT 89 AAT 89 AAT 89 AAT 89 ― 89 
10 Phe TTT 85 100 TTC 75 TTT 100 TTC 75 TTC 75 TTC 75 
11 Trp TAT 79 100 ― TAT 100 TAT 100 TAT 100 ― 100 
12 Ser AGT 63 42 TCG 48 AGC 100 TCG 48 TCG 48 TCG 48 
13 Val GTA 26 43 ― GTA 43 GTA 43 GTA 43 ― 43 
14 Glu GAG 100 43 GAA 100 GAA 100 GAA 100 GAA 100 GAA 100 
15 Ileu ATT 77 100 ATC 60 ATT 100 ATC 60 ATC 60 ATC 60 
16 Gly GGA 74 28 GGT 63 GGC 100 GGT 63 GGT 63 GGT 63 
17 Asp GAT 85 100 GAC 54 GAT 100 GAT 100 GAT 100 ― 100 
18 Ser TCT 79 33 TCG 48 AGC 100 AGC 100 AGC 100 AGC 100 
19 Thr ACA 78 28 ACG 51 ACC 100 ACC 100 ACC 100 ACC 100 
20 Phe TTC 100 75 TTT 100 TTT 100 TTT 100 TTT 100 TTT 100 
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(See the remaining sequence data of Fig. S1 continued onto the next page, as well as its figure legend) 
- JNK1β1 sequence data - 
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Fig. S1. Codon harmonization of the open reading frame (ORF) of the H. sapiens JNK1β1 gene to replicate as closely as possible its native 
rates of translation when expressed in E. coli. The upper DNA strand shows the natural H. sapiens JNK1β1 open reading frame sequence, while the 
lower highlighted strand shows the redesigned, fully codon-harmonized sequence. Nucleotides changed for synonymous codons are indicated in 
shaded letters. 
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Fig. S2. Recoding the JNK1β1 open reading frame through codon harmonization does not alter the native amino acid sequence of JNK1β1 
as a result of the synonymous codons used. The upper amino acid strand shows the natural H. sapiens JNK1β1 sequence, while the lower 
highlighted strand shows the identical amino acid sequence resulting upon translation of the synthetic, codon-harmonized DNA sequence.  
The phosphorylatable T183 and Y185 residues of JNK1β1 are highlighted in red. 
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SUPPLEMENTARY INFORMATION 
Cloning of synthetic codon-harmonized JNK1β1 and human ATF2 genes into pGEX-4T-1 
vector 
Additional nucleotide sequences containing BamHI and NotI restriction sites were incorporated 
at the 5ʹ and 3ʹ ends, respectively, of both the codon-harmonized JNK1β1 and human ATF2 
(residues 17-96) (accession number: NM_001256094.1) nucleotide sequences to enable 
subcloning into pGEX-4T-1 plasmids (Fig. S3). The redesigned sequences were synthesized and 
individually cloned into pUC57 plasmids (GenScriptTM USA Inc., NJ, USA), and each plasmid 
used to transform E. coli JM109 for propagation. The JNK1β1 and ATF2 gene fragments were 
excised from pUC57 using BamHI and NotI restriction endonucleases and each ligated into 
pGEX-4T-1 to form pGX-JNK1 and pGX-ATF2 recombinant plasmids. pGX-JNK1 and  
pGX-ATF2 were propagated in E. coli JM109, and finally each used to transform both E. coli 
BL21(DE3)pLysS (Stratagene) and T7 Express Iq (New England Biolabs) expression cells for 
the overexpression of recombinant GST-JNK1 and GST-ATF2 fusion proteins (Fig. S3). 
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Fig. S3. Cloning strategy of the synthetic codon-harmonized JNK1β1 (CdHm-JNK1β1) and 
human ATF2 (residues 17-96) open reading frames.  
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Cloning of MEKK-C and wild-type MKK4 into pET-32a vector and generation of 
phosphomimetic MKK4 variant (S257E/T261D) 
Plasmids encoding full-length rat MEKK1 (pCMV5myc-MEKKXuA) and human MKK4 
(pGX-KG-MKK4) were generous gifts from Dr. Melanie Cobb (University of Texas, 
Southwestern Medical Center). MEKK-C, the constitutively-active C-terminal kinase domain 
fragment of MEKK1 (EC 2.7.11.25) [1], was used to phosphorylate and activate full-length 
MKK4 (1-399) (EC 2.7.12.2), which in turn was used to phosphorylate and activate JNK1β1. 
To obtain the MEKK-C fragment of the MEKK1 gene, high-fidelity PCR was used to amplify 
the DNA sequence of pCMV5myc-MEKKXuA encoding the C-terminal 281 amino acids of rat 
MEKK1 (residues 1212-1493) (Fig. S4). The primer sequences were: 
  Forward - 5ʹ CATGGATCCAAAGCGAACG 3ʹ 
   Reverse .- 5ʹ .ATTGCGGCCGCTTACCATG. 3ʹ 
encoding BamHI and NotI recognition sites (underlined), respectively. 
The MEKK-C PCR fragment was ligated into pJET1.2/blunt vector (Fermentas), propagated in 
E. coli DH5α cells, and thereafter subcloned into pET-32a plasmid via the BamHI and NotI 
restriction sites to create pT-MEKK-C recombinant plasmid (Fig. S4). pT-MEKK-C was 
propagated in E. coli DH5α cells and used to transform both E. coli BL21(DE3)pLysS and T7 
Express Iq expression cells for the overexpression of recombinant thioredoxin-His6-MEKK-C 
(TH-MEKK-C) fusion protein (Fig. S4).  
The pGX-KG-MKK4 plasmid was propagated in E. coli DH5α cells, after which the NcoI and 
HindIII fragment was cleaved from the plasmid and subcloned into pET-32a, forming  
pT-wtMKK4 recombinant plasmid (Fig. S4). pT-wtMKK4 was propagated in E. coli JM109 
cells and used to transform both E. coli BL21(DE3)pLysS and T7 Express Iq expression cells 
for the overexpression of recombinant, wild-type thioredoxin-His6-MKK4 (TH-wtMKK4) 
fusion protein. 
In an attempt to produce constitutively-active MKK4 that does not require phosphorylation by 
an active upstream kinase (such as MEKK1) to function, a phosphomimetic form of MKK4 
was generated. This was achieved by replacing its phosphorylatable residues (S257 and T261) 
with negatively charged residues (glutamate and aspartate, respectively) that mimic the 
geometry and charge of the phosphoserine and phosphotheronine (Fig. S5). This S257E/T261D 
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phosphomimetic MKK4 variant (pmMKK4) has been reported previously to be constitutively-
active in transfected cells (in vivo), but has not yet been analysed in vitro [2]. 
This was achieved through PCR-mediated site-directed mutagenesis employing complementary 
primers encoding for both amino acid mutations simultaneously, and using the pT-wtMKK4 
plasmid as a template. The sequence of the forward primer was: 
5ʹ GTGGACAGCTTGTGGACGAAATTGCCAAGGATAGAGATGCTGGCTGTAGG 3ʹ 
while its reverse complement corresponded to the reverse primer (the mutant codons encoding 
the phosphomimetic residues are underlined). The PCR reaction, employing the QuikChange® 
Lightning Site-directed Mutagenesis kit (Agilent Technologies), was conducted according to 
the manufacturer’s instructions. The mutated plasmid (pT-pmMKK4 encoding the pmMKK4 
variant), was propagated in E. coli JM109 and used to transform both E. coli BL21(DE3)pLysS 
and T7 Express Iq expression cells for the overexpression of recombinant  
thioredoxin-His6-phosphomietic MKK4 (TH-pmMKK4) fusion protein. 
The insert of each plasmid described was sequenced by Inqaba Biotech (Pretoria, South Africa) 
to ensure that the DNA sequences encoding for their respective proteins were correct. See 
Supplementary Figures S1-S2 (JNK1β1 sequence data), and Figures S6-S8 (MEKK-C, ATF2, 
and MKK4 sequence data) for the DNA and protein sequences of each protein employed in this 
study. 
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Fig. S4. Cloning strategy of the MEKK-C and MKK4 open reading frames. 
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Fig. S5. The phosphomimetic amino acids, glutamate and aspartate, mimic phosphorylated serine or threonine residues. (A) By substituting 
phosphorylatable serine or threonine residues (whose phosphorylation is known to induce the activation or deactivation of the protein in which 
they are situated) with negatively charged residues such as glutamate and aspartate, one is able to mimic the geometry and charge of their 
phosphoserine and phosphotheronine forms. Recreating the electrostatic and geometric properties of phosphorylated residues through these 
phosphomimetic mutations have been shown, in many instances, to induce structural changes in the protein that is comparable to the changes 
induced upon natural phosphorylation, generating constitutively-active or -inactive enzymes that does not require phosphorylation by upstream 
kinases for their associated regulation. Within this study, a phosphomimetic form of MKK4 (S257E/T261D) was generated through site-directed 
mutagenesis by substituting its phosphorylatable S257 and T261 residues with glutamate and aspartate, respectively. The S257E/T261D MKK4 
variant has been reported previously to be a constitutively-active in vivo [2]. (B) DNA chromatograms of the wtMKK4 and pmMKK4 open reading 
frames, indicating that the nucleotides encoding the two phosphorylatable (P) residues of wtMKK4 (S257 and T261) were successfully mutated to 
nucleotides encoding the phosphomimetic (PM) residues, E and D. 
A B 
CHAPTER 2 – SUPPLEMENTARY MATERIAL 
xii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(See the remaining sequence data of Fig. S6 continued onto the next page, as well as its figure legend)  
- MEKK-C sequence data - 
Page 1 of 2 
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Fig. S6 (Page 2 of 2). MEKK-C sequence data. The coding DNA sequence (top) and the protein product resulting upon its translation (bottom) of 
the constitutively-active C-terminal kinase domain (residues 1212-1493) of rat MEKK1. 
 
 
 
 
 
 
 
 
 
Fig. S7. ATF2 sequence data. The coding DNA sequence (top) and the protein product resulting upon its translation (bottom) of residues 17-96 of 
human ATF2. The phosphorylatable T69 and Y71 residues of ATF2 are highlighted and indicated by red P “flags”.  
- ATF2 sequence data - 
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(See the remaining sequence data of Fig. S8 continued onto the next page, as well as its figure legend) 
 
- MKK4 sequence data - 
Page 1 of 2 
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Fig. S8 (Page 2 of 2). MKK4 sequence data. The coding DNA sequence (top) and the protein product resulting upon its translation (bottom) of  
full-length, wild-type, human MKK4. The phosphorylatable S257 and T261 residues of MKK4 are highlighted and indicated by red P “flags”. 
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Fig. S9. (A) The codon usage frequencies of the native codons (non-codon harmonized) 
encoding the first 20 N-terminus amino acids of JNK1β1 (M1-F20) when expressed in  
H. sapiens (green bars) and E. coli (red bars) illustrates the great discordance in the codon 
usage patterns. (B) The codon usage frequencies of the same codons presented in (A) following 
full codon harmonization and when expressed again in both H. sapiens (green bars) and E. coli 
(blue bars) illustrates the now good agreement in the codon usage patterns. 
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Fig. S10. Expression patterns of GST-JNK1 at low and high induction temperatures. 
Representative samples of the soluble and insoluble cell fractions resulting after overexpression 
of GST-JNK1 at 22 °C and 37 °C were compared using 12.5% SDS-PAGE and Western blot 
(employing anti-JNK1 antibodies). The expression conditions that yielded the greatest quantity of 
soluble GST-JNK1 (1 L of BL21(DE3)pLysS cell cultures in 2×YT media, induced with 0.6 mM IPTG 
for 6 h) was used in the analysis to isolate the effect that temperature has on optimal soluble 
overexpression. Expression at 22 °C results in the production of large yields of soluble GST-JNK1, 
although significant amounts of its insoluble form were also expressed at this temperature. 
Contrastingly, expression at 37 °C results in extensive quantities of insoluble GST-JNK1 being 
produced, with no concurrent production of its soluble form. Expression at 22 °C was therefore 
adopted for large scale expression of soluble GST-JNK1. Samples of the insoluble and soluble 
fraction of cells grown in the absence of IPTG (uninduced) were included as a control for 
overexpression. 
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SUPPLEMENTARY INFORMATION 
GST-JNK1 and GST-ATF2 thrombin cleavage trials 
Off-column thrombin cleavage time-trials were performed to determine the optimal time that 
the GST-JNK and GST-ATF2 fusion proteins should be incubated with thrombin for the 
complete cleavage of each target from the GST-tag, while also avoiding the undesirable 
degradation of JNK1β1 and ATF2. Here, 2 mg of each GST-JNK1 and GST-ATF2 in  
Tris-Lysis Buffer was incubated at 20 °C with 0.8 U of human plasma thrombin possessing an 
activity of 3152.0 U/mg (Merck), each in a 1 ml total reaction volume. Samples were removed 
periodically and immediately treated for reducing SDS-PAGE. 
It should be noted at this point that on-column cleavage of each fusion (cleaving GST-JNK1 or 
GST-ATF2 while still bound to GSH-agarose) resulted in an extensive degree of protein 
aggregation, and thus only off-column thrombin cleavage trials were performed for both. 
Although it is recommended by the suppliers of the protease (SigmaTM) that 1 U of human 
plasma thrombin should be added to 100 µg of test fusion protein for 16 h at 22 °C to allow  
>90% to be digested, within these trials 25× less thrombin than suggested (0.8 U as opposed to 
20 U) was added to 2 mg of GST-JNK1 or GST-ATF2 fusion in a 1 ml reaction volume. 
With respect to GST-JNK1, the SDS-PAGE gel and corresponding Western blot of Fig. S11 
nevertheless indicates that >95% of the 2 mg GST-JNK1 fusion (observed before the addition 
of thrombin at 0 min) was cleaved into its component JNK1β1 (±48 kDa band) and GST  
(±28 kDa bands) proteins within the first 15 min of incubation with 0.8 U of thrombin  
(Fig. S11). Furthermore, while the quantity of the resulting GST remains consistent throughout 
the entire duration of the GST-JNK1 time trial, JNK1β1 progressively and rapidly degrades as 
the time course of the cleavage trial lengthens until very little of the protein is present at 16 h. 
This was not expected considering the recommendation that the fusion protein be incubated 
with much higher concentrations of thrombin for at least 16 h to allow efficient cleavage 
(Amersham Biosciences, 2002). These observations first illustrate the extreme ease at which 
thrombin cleaves the GST-JNK1 fusion into its component proteins, yet more importantly, 
illustrates the exceptionally high susceptibility of JNK1β1 to proteolytic degradation by 
thrombin. 
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Fig. S11. Thrombin cleavage time trials of GST-JNK1. The relative degree of cleavage of 2 mg 
GST-JNK1 into its component JNK1β1 and GST proteins by 0.8 U human plasma thrombin  
over-time at 20 °C was analysed by (A) SDS-PAGE and (B) Western blotting employing anti-JNK1 
antibodies. The data indicates that almost complete cleavage of the fusion occurs within 15 min of 
incubation and illustrates the high susceptibility of JNK1β1 to proteolytic degradation by 
thrombin, observed by the steady decrease in the intensity of the JNK1β1 band. As on-column 
cleavage (data not shown) resulted in protein aggregation, a 15 min off-column cleavage was 
determined to be optimal for separation of JNK1β1 from GST. A thrombin control comprising only 
0.8 U thrombin in buffer was included to indicate the electrophoretic location and size of the 
protease. 
 
Contrastingly, the GST-ATF2 fusion required 6 h for efficient cleavage into its component 
proteins with the same amount of thrombin (Fig. S12). There is additionally no discernible 
proteolytic degradation of ATF2 within the course of the trial, with the amount of the resulting 
ATF2 only steadily increasing over time (Fig. S12). This too highlights the sensitivity of 
JNK1β1 to unspecific cleavage by thrombin. 
Therefore, a controlled 15 min off-column GST-JNK1 thrombin cleavage is optimal for the 
separation of JNK1β1 from GST and the simultaneous prevention of its proteolytic degradation 
by thrombin. Thrombin is thus an extremely efficient and cost effective protease to employ in 
separating JNK1β1 from an invaluable purification and/or solubility tag such as GST. 
However, to prevent avoidable proteolytic degradation, we recommend the use of thrombin 
only in combination with a highly efficient means of removing the protease from JNK1β1, 
such as (the simple and inexpensive) heparin-agarose affinity chromatography as employed in 
this study. 
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Fig. S12. Thrombin cleavage time trials of GST-ATF. Time dependence study of off-column 
thrombin cleavage of GST-ATF2 fusion was analysed by (A) Tricine–SDS-PAGE and (B) Western 
blotting employing anti-GST antibodies. The relative degree of cleavage of 2 mg GST-ATF2 at 
specific times after incubation with 0.8 U of thrombin at 20 °C indicates that the optimal cleavage 
time for the separation of ATF2 from GST is 6 h. No proteolytic degradation of ATF2 is detectable 
within the course of the trial, re-highlighting the high susceptibility of JNK1β1 to unspecific 
cleavage by thrombin. 
 
The high susceptibility of JNK1β1 to proteolytic degradation by thrombin 
Thrombin is one of the most commonly used restriction proteases for the cleavage of  
GST-fusion proteins due to its relatively low cost and optimum cleavage activity at pH 6-8, as 
well as its apparently high specificity [3]. Nevertheless, despite the extensive use of thrombin 
and the fact that it preferentially cleaves polypeptide substrates at R/K-Xaa bonds, thrombin 
has been reported to cleave non-specifically at secondary sites located in some over-expressed 
recombinant proteins [4,5]. Thrombin mediated non-specific cleavage is thus quite common, 
corresponding to the observed high susceptibility of JNK1β1 to its proteolytic degradation by 
thrombin. 
The optimum cleavage site for thrombin comprises either: (a) P4-P3-P-R↓-P1′-P2′, where P3 
and P4 are hydrophobic amino acids and P1′, P2′ are apolar, non-acidic amino acids, or  
(b) P2-R↓-P1′, where P2 or P1′ are G (arrows indicate the sites at which the R/K-Xaa bonds 
are cleaved) [4]. To help understand the basis of the susceptibility of JNK1β1 to degradation by 
thrombin, its R/K-Xaa bonds were examined to assess if they possess the properties of the 
optimum thrombin cleavage site described, and were compared with the sequences of the 
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polypeptides known to be susceptible to thrombin cleavage. Of the 54 R/K-Xaa bonds in 
JNK1β1, 5 were revealed to have characteristics for potential candidacy for thrombin 
recognition and cleavage (see Fig. S13). These sites are also seen to be highly exposed to the 
surrounding environment, making them easily accessible to contact recognition by thrombin. 
Ultimately, the non-specific cleavage sequences described resemble that of the primary 
thrombin cleavage sequence, and hence represent possible non-specific secondary sites within 
JNK1β1 that are recognised for cleavage by thrombin. GST-JNK1 fusion proteins that can be 
cleaved using, for example, the expensive protease enterokinase may be beneficial for its 
purification by reducing the risk of proteolytic degradation, but this will unnecessarily and 
extensively increase the cost of purifying JNK1β1. The use of a purification tag that may not 
require removal (e.g. His-tags) may eliminate the danger of exposing JNK1β1 to cleavage 
agents, yet as has been demonstrated numerous times before, the absence of a highly soluble 
fusion protein partner may result in a decrease in its soluble overexpression and ultimately 
reduce the resulting yield of purified protein. 
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Fig. S13. Possible thrombin susceptible cleavage sites in JNK1β1. The potential thrombin-
cleavage susceptible amino acid sequences and their location within JNK1β1 are indicated in 
green and blue. Possible sequences were identified through sequence comparison with known 
thrombin susceptible R/K -Xaa bonds, and by identifying sequences with properties known to 
promote sensitivity to thrombin cleavage. The known thrombin susceptible sequences and the 
proteins from which they are derived are shown adjacent to their corresponding sequences in 
JNK1β1. Amino acids sequences and protein secondary structure in blue represent those with 
complete sequence identity to their related thrombin susceptible R/K-Xaa sequences, and/or 
those that possess the properties ideal for thrombin cleavage. Sequence and structure in green 
indicate the typical length of the amino acid sequence (a heptapeptide) that may contribute to 
recognition and subsequent cleavage by thrombin. The sites at which the peptide backbone would 
be cleaved by thrombin are indicated by arrows and dashed red lines. Shown in purple is the  
N-terminus at which the optimal thrombin cleavage sequence (LVPR↓GS) was initially located, a 
sequence that linked the GST and JNK1β1 within the GST-JNK1 fusion allowing their later 
separation by thrombin. The image was rendered using PyMOLTM v. 0.99 (DeLano Scientific,  
San Carlos, CA) using the PDB code 3ELJ [6]. 
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The c-Jun N-terminal kinases (JNKs) constitute one sub-group of
the eukaryotic mitogen activated protein kinases (MAPKs) that
mediate the cellular response to an array of extracellular stimuli,
including cytokines and stresses such as UV irradiation [1]. Upon
activation by these stimuli, the multifunctional JNK pathway initi-
ates a variety of transcription events implicated in many physio-
logical processes that include differentiation, apoptosis, and DNA
repair [1].
Three JNK isoforms have been identified; JNK1, JNK2 (both with
broad tissue distribution), and JNK3 (localised predominantly in
the CNS) [1,2]. These kinases are encoded by three alternatively
spliced genes, (JNK1, JNK2, and JNK3), resulting in 10 distinct JNK
splice variants that differ in the length of their N- and C-termini,
as well as in amino acids within and around their substrate binding
sites [2].
JNKs are typically activated by a cascade of MAPK-mediated
phosphorylation events. Within this highly conserved three-tiered
kinase cascade, an upstreamMAP3K (e.g. MEKK1) phosphorylates a
MAP2K (e.g. MKK4 and MKK7), which in turn phosphorylates andll rights reserved.
K, mitogen-activated protein
nase kinase; MKK, mitogen-
anscription factor 2; LC–MS,
t-, wild-type; pp-, dual
r).activates the downstream MAPKs (e.g. JNK, ERK, and p38) [3].
Phosphorylation of the canonical T183/Y185 residues in the activa-
tion loop of JNK1 primes the enzyme for activities that include the
phosphorylation of the transcription factors c-Jun and ATF2 [1,2],
as well as interaction with several non-substrate, regulatory pro-
teins [4]. T183/Y185 phosphorylation is typically catalysed by the
dual-specificity MAP2Ks, MKK4 and MKK7, respectively [5] yet it
has been shown that high concentrations of either kinase, once
activated by upstream MAP3Ks, is sufficient to phosphorylate both
residues [1,5].
In addition to the phosphorylation of its activation residues,
which are topologically conserved across the JNK family (Supple-
mentary Fig. S1), the kinase has been found to be phosphorylated
at a variety of additional S/T/Y residues distributed throughout
its structure (Supplementary Table S1 reports all JNK phospho-res-
idues identified up to date). Unfortunately, the majority of these
possible phosphorylation sites have been assigned using only pro-
teomic-based discovery-mode mass spectrometry (MS), leaving
their functional relevance and the upstream kinases that catalyse
their phosphorylation uncharacterised. Few additional JNK phos-
pho-sites have been determined unequivocally using site-specific
methods such as specific MS strategies, amino acid sequencing,
phosphorylated site-specific antibodies, and site-directed muta-
genesis (Table S1). Many of these additional sites are also not con-
served across the JNK family, suggesting that they may represent a
means of differential phospho-regulation of the JNK variants, and
may be responsible for the diversity in the function of the individ-
ual JNKs. Although the mechanism by which the JNKs are regulated
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in still not fully understood, the involvement of JNKs in various
neurodegenerative and other pathological disorders makes these
kinases attractive therapeutic targets [6], and stress the need to
fully characterise the significance of the non-canonical phospho-
sites.
In this study, we explored the phosphorylation events of the
most abundant yet least studied JNK variant, JNK1b1 [7], that take
place during its heterologous expression in Escherichia coli and that
are catalysed by active MKK4 in vitro. We thus aimed to character-
ise the nature of phospho-regulation of JNK1b1 by MKK4, since the
exact effect that MKK4 has on this JNK variant has not been specif-
ically investigated. Intact protein LC–MS analysis and peptide
sequencing was performed to track the phosphorylation sites and
patterns of the various forms of JNK1b1 obtained, resulting in the
unambiguous identification of novel sites at which MKK4 phos-
phorylates JNK1b1. ATF2 phosphorylation was used as an index
of the catalytic activity of the JNK1b1 phospho-forms. The surpris-
ing patterns of JNK1b1 phosphorylation observed here upon its
purification from E. coli raise important questions that have signif-
icant implications for heterologous protein expression.2. Materials and methods
2.1. Purification and modification of the JNK MAPK phosphorylation
cascade proteins
Overexpression and purification of JNK1b1 from E. coli, dephos-
phorylation and deactivation of E. coli phosphorylated JNK1b1 by
shrimp alkaline phosphatase (SAP), activation of JNK1b1 by recon-
stituting the MEKK1?MKK4? JNK MAPK phosphorylation cas-
cade in vitro, as well as the purification of ATF2 (residues 17–96),
were performed as previously described [8].
2.2. Additional methods
Methods for the mass spectrometric analysis and sequencing of
the JNK1b1 phospho-forms, as well as for determining their rela-
tive catalytic activities, are described in Supplementary Methods.3. Results and discussion
Recently, we have described an improved method to obtain
large quantities of active, phosphorylated JNK1b1 [8]. This method
aimed first to improve the soluble overexpression of JNK1b1 by
harmonising the codon usage frequencies of its open reading frame
to those of an E. coli expression host (full ‘‘codon usage harmonisa-
tion’’ [9]). We were thus able to recreate the natural rate at which
JNK1b1 is translated in its native human host as a precautionary
measure toward increasing the production of soluble, correctly
folded protein in E. coli. Purified JNK1b1 was activated by reconsti-
tuting the MEKK1?MKK4? JNK MAPK phosphorylation cascade
in vitro; MEKK-C (the constitutively active kinase domain of
MEKK1) was used to activate MKK4, which in turn was used to
phosphorylate and activate JNK1b1. MKK4 activated JNK1b1 phos-
phorylated its substrate, ATF2, with high catalytic efficiency [8].
To expand upon the successes of our previous study, we sought
to characterise the nature of JNK1b1 phosphorylation by active
MKK4, particularly since the efficiency and the precise sites at
which the b1 variant of JNK1 is modified for regulation by MKK4
has not been investigated.
MKK4 binds to each JNK isoform selectively, interactions that
are mediated by the docking-domains and common docking-do-
main of MKK4 and JNK, respectively [10]. The affinity of these
interactions exhibit isoform-specificity, with JNK1 displaying thegreatest specificity for its cognate docking-domain in MKK4 [10].
It has therefore been suggested that MKK4 may have distinct affin-
ities and activities toward the different JNK1 splice variants. Since
it has been realised that the effects of MKK4 are splice-variant spe-
cific, it becomes significant to characterise the nature of its phos-
phorylative regulation of each individual JNK variant.
Additionally, although they have been shown to display distinct
biochemical properties, little is known about the functional rele-
vance of the different JNK slice variants. Studying the individual
JNK variants thus expands our understanding of their differences,
and will hopefully lead to elucidating their functional diversity.
This was achieved in this study using mass spectrometric tech-
niques and enzymatic analysis to identify the states and sites of
phosphorylation of the resulting JNK1b1 phospho-forms described
in [8].
Intriguingly, our pursuit to acquire and phosphorylate JNK1b1
revealed that the kinase undergoes a significant degree of phos-
phorylation during overexpression in E. coli (even before JNK1b1
had encountered the components thought necessary for its activa-
tion) (Supplementary Fig. S2) [8]. We thus used similar tools to
provide insight into the means by which JNK1b1 is already par-
tially phosphorylated in E. coli without additional in vitro treat-
ment, stressing important implications for recombinant
expression of kinases in E. coli. Therefore, using intact LC–MS pro-
tein analysis, we determined the relative populations of the
JNK1b1 phospho-forms to provide an indication of the efficiency
at which it is phosphorylated. Peptide sequencing was then per-
formed to identify the amino acid locations that are phosphory-
lated during JNK1b1 overexpression and in vitro by MKK4.
3.1. JNK1b1 phosphorylation during expression in E. coli
Intact LC–MS analysis of the untreated JNK1b1 purified from
E. coli (p⁄JNK1b1) confirmed that the kinase had indeed been phos-
phorylated during overexpression in the bacterium (profile 1,
Fig. 1). Although the majority of p⁄JNK1b1 had not been phosphor-
ylated (74%), its mass profile revealed unexpectedly that a small
percentage of JNK1b1 (8%) had been phosphorylated in E. coli at
no less than 4 sites, with concurrently slightly larger populations
of singularly (11%) and doubly (7%) phosphorylated kinase existing
after expression (Fig. 1).
Peptide sequencing following trypsin digestion of p⁄JNK1b1 re-
vealed that it was in fact phosphorylated at five discrete sites
(Fig. 2; see Supplementary Figs. S4 and S5 for the theoretical tryp-
sin cleavage pattern of JNK1b1 and the high-confidence MS/MS
product ion spectra of the resulting phospho-peptides, respec-
tively). Despite being detected in relatively low abundance,
corresponding to the small population of each p⁄JNK1b1 phos-
pho-species (profile 1, Fig. 1), four unambiguous phospho-peptides
were detected with >99% confidence (Fig. 2). The canonical JNK
T183/Y185 residues were located on the same peptide due to their
proximity and properties preventing the generation of peptides
that contained each residue separately. Nevertheless, the T183/
Y185 phospho-peptides detected were unambiguously and consis-
tently phosphorylated at both residues (Supplementary Fig. S5).
The other phospho-peptides identified each contained a single
phosphorylated residue, revealing that JNK1b1 is also phosphory-
lated by some means at T228, S284, and S377 during expression
in E coli (Fig. 2). While these phospho-sites may initially be consid-
ered nothing more than artefacts common to the recombinant
overexpression of kinases, the significance of these residues be-
came strikingly evident when determining the sites at which active
MKK4 phosphorylates JNK1b1 (discussed below).
To determine if the phosphate groups added to the activation
(T183/Y185) and additional residues (T228/S284/S377) during
expression induce activation of JNK1b1, and to approximate the
Fig. 1. The extent of phosphorylation of each JNK1b1 phospho-form, determined by intact protein LC–MS analysis. Intact protein mass profiles were generated by
transforming the deconvoluted mass spectra of each phospho-form (Supplementary Fig. S3) so that the intensities of each JNK1b1 mass peak are expressed as a percentage of
the total JNK1b1 present. This was calculated using the area under a particular peak relative to the total area under all JNK1b1 mass peaks. Non-phosphorylated JNK1b1 has a
modal mass of 44 165 Da. The additional mass species increasing by multiples of 80 Da correspond to the addition of up to 5 phosphate groups. Profiles are representative of
at least two independent experiments. ‘‘’’ denotes likely contaminants.
Fig. 2. Mapping JNK1b1 residues that are phosphorylated both during expression in E. coli and in vitro by active MKK4. The tryptic phospho-peptides identified and the
location of the canonical (T183/Y185) and novel (T228/S184/S377) phosphorylated residues are shown. As the C-terminal residues L364-Q384 were not resolved in the crystal
structure, an additional serine has been used to indicate the position of S377. The protein structure was rendered using PyMOL™ v. 0.99 (DeLano Scientific, San Carlos, CA)
using the PDB code 3ELJ [18].
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which p⁄JNK1b1 produces an electrophoretic shift in ATF2 ob-
served on a Tricine–SDS-PAGE gel when it is singularly and doubly
phosphorylated (the first report of its kind) (Fig. 3). This novel
approach to an electrophoretic mobility shift assay revealed that
p⁄JNK1b1 was in fact active and able to phosphorylate ATF2, but
at a relatively slow rate (panel A, Fig. 3). JNK1b1 is thus activatedin E. coli by, not unexpectedly, phosphorylation of its T183/Y185
(and possibly the other) residues, yet the small degree at which
it had become modified in the bacterium (Fig. 1) can account for
the low activity displayed.
Considering recent findings, only a few possibilities exist why
JNK1b1 may become phosphorylated during bacterial overexpres-
sion (Supplementary Fig. S6, and discussed briefly in [8]). It is
Fig. 3. Relative catalytic activities of the JNK1b1 phospho-forms. (A–E) The rate at which each JNK1b1 phospho-form induces an electrophoretic shift in ATF2(17–96),
observed on a 16% Tris–Tricine gel, when it is singularly and doubly phosphorylated at T69/T71 (as confirmed in [8]) was used as an indication of their catalytic activities. (A)
The slow phosphorylation of ATF2 by E. coli purified p⁄JNK1b1, and the lack thereof by (B) dephosphorylated, inactive JNK1b1. (C) The slow rate of ATF2 phosphorylation by
pwtJNK1b1 partially phosphorylated by untreated MKK4. (D and E) Efficient ATF2 phosphorylation by p5JNK1b1 phosphorylated by ppMKK4. 1 lM of each JNK1b1 was
incubated with 30 lM ATF2, 0.2 mg/ml BSA, 10 mM MgCl2, and 1 mM ATP for 3 h at 25 C. (F) Graphical comparison of the relative activities determined in A–E, each
expressed as a percentage of the activity of p5JNK1b1.
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phorylation during heterologous protein expression. Shrestha
et al. [11] has suggested that as the cell is flooded with recombi-
nant protein during overexpression, native kinases are capable of
phosphorylating the newly-produced kinase polypeptides during
co- or post-translational folding. This would allow phosphate
groups to be introduced at both canonical and/or non-standard
sites that may or may not be surface exposed. Their study analysed
the conditions under which human kinases exhibit autophospho-
rylation during overexpression, and demonstrated indirectly that
altering the kinetics of protein production and folding by adjusting
the induction temperature and/or inducer concentration, influ-
ences the degree of phosphorylation.Since native, fully folded JNK1 is unable to undergo post-trans-
lational autophosphorylation both in vivo and in vitro [8,12], the
E. coli phosphorylation of JNK1b1 described here may be due to this
‘‘co-folding autophosphorylation’’ phenomenon (Fig. S6). As the
phosphorylation of non-codon harmonised JNK1 during its overex-
pression has not been observed elsewhere or reported before, it is
possible that the unique yet natural kinetics of translation and
folding of our JNK1b1 provided by codon usage harmonisation
[8], may allow phosphorylation to occur during co-translational
folding. Since codon harmonisation is the only noteworthy differ-
ence in our expression system when compared to those used
elsewhere for JNK1, these other systems act as numerous controls
that highlight the absence of phosphorylation of non-codon
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propose that the translation kinetics of JNK1b1 influence its ability
to be phosphorylated during its overexpression, as implied by
Shrestha et al. [11].
We also cannot exclude the idea that unidentified endogenous
E. coli S/T/Y kinases may be responsible for the phosphorylation
of JNK1b1 during expression, as initially suggested by Yang and
Lui [13]. It has been found recently that, while few S/T/Y kinases
have been directly identified in prokaryotes, at least 80 bacterial
proteins are naturally phosphorylated at S/T/Y residues [14]. Con-
sidering the recently realised existence of these eukaryotic-like
bacterial kinases, it is becoming increasingly unwise to assume
that recombinant eukaryotic proteins will purify in a homogenous,
non-phosphorylated form [14,15]. It is therefore a possibility that
E. coli kinases may recognise JNK1b1 in a manner similar to that
of its natural activator, MKK4, thereby catalysing its phosphoryla-
tion (Fig. S6). As this has not been previously observed for JNK, it is
likely that this too occurs during co-translational folding, since the
natural kinetics of translation of JNK1b1 imparted by our codon
harmonisation may now permit bacterial kinases to interact with
phosphorylatable motifs during the translational folding of JNK1b1
(Fig. S6).
Interestingly, only the soluble cell fraction contained phosphor-
ylated JNK1b1 (Fig. S2). It is therefore conceivable too that either
co-translational phosphorylation of JNK1b1 promotes its proper
native folding, or perhaps only the partially folded JNK1b1 poly-
peptides following the native folding pathway are able to be phos-
phorylated during translation.
3.2. Dephosphorylation and deactivation of E. coli purified JNK1b1
We initially dephosphorylated p⁄JNK1b1 using shrimp alkaline
phosphatase (SAP) and monitored the reaction byWestern blotting
[8], yet to verify that the phosphate groups that had been added
during expression had all been removed, we also performed intact
LC–MS on the dephosphorylated JNK1b1. It was important to
establish that this could be achieved because, due to the inaccessi-
bility of some of the phospho-residues upon final folding of the
protein, the incorporated phosphate groups may not be able to
be removed by subsequent treatment with phosphatases [16].
The LC–MS analysis revealed that after incubation of p⁄JNK1b1
with SAP for 5 h, the kinase becomes completely dephosphorylated
as the additional peaks situated at multiples of 80 Da above the
mass of non-phosphorylated JNK1b1 seen in untreated kinase were
no longer detected (profile 2, Fig. 1). Testing the catalytic activity of
the kinase also revealed that dephosphorylation completely deac-
tivates the kinase, as all of it activity toward ATF2 was eliminated
(panel B, Fig. 3). The phosphate groups introduced during expres-
sion were thus all available and susceptible to SAP dephosphoryl-
ation, consistent with the observed external accessibility of the
phospho-residues (Fig. 2).
3.3. JNK1b1 phosphorylation by MKK4 in vitro
Upon acquiring non-phosphorylated JNK1b1, we sought to gen-
erate phosphorylated, fully active JNK1b1 by reconstituting the JNK
MAPK cascade in vitro.
To first control for the effect of unmodified, wild-type MKK4
(that has not encountered MEKK-C), we first incubated untreated
MKK4 with dephosphorylated JNK1b1, and evaluated the change
in its state of phosphorylation by intact LC–MS. Interestingly,
JNK1b1 is able to be re-phosphorylated to a small degree by un-
treated MKK4, producing small populations of singly (18%) and
doubly (12%) phosphorylated JNK1b1 (pwtJNK1b1, profile 3,
Fig. 1). This suggests that MKK4, when recombinantly expressed
in E. coli, also becomes partially phosphorylated. This findingreiterates the value of determining if heterologously expressed
proteins have already undergone co- or post-translational modifi-
cations before performing downstream analyses that may be af-
fected by their presence. pwtJNK1b1 is also partially active and
can phosphorylate ATF2 (panel C, Fig. 3), yet also at a slow rate
due to its ineffective activation and the consequential low popula-
tion of phosphorylated kinase (profile 3, Fig. 1).
Efficient phospho-activation of JNK1b1 was then achieved by
incubating active MKK4 (ppMKK4; previously phosphorylated by
MEKK-C), with dephosphorylated JNK1b1 for P3 h at a 10:1
JNK1b1:ppMKK4 molar ratio. Intact LC–MS indicated that JNK1b1
is phosphorylated in vitro at five sites by ppMKK4, and to a suffi-
cient efficiency that only a small population of JNK1b1 was not
modified at all (p5JNK1b1, profile 4, Fig. 1). Significant levels of
the other phospho-forms existed, with the largest populations
comprising singularly and doubly phosphorylated JNK1b1 (profile
4, Fig. 1).
Peptide sequencing of a tryptic digest of p5JNK1b1 illustrated
that ppMKK4 not only phosphorylates JNK1b1 efficiently and
expectedly at its canonical T183/Y185 residues in vitro, but also
unequivocally at T228, S284, and S377 (Fig. 2, and see Fig. S5 for
the MS/MS product ion spectra of the resulting phospho-peptides).
Curiously, these are the identical sites at which JNK1b1 became
phosphorylated during expression in E. coli, albeit to a significantly
higher degree (Figs. 1 and 2). The initial complete dephosphoryla-
tion of the residues phosphorylated during expression followed by
their subsequent in vitro re-phosphorylation by ppMKK4, suggests
that the E. coli phospho-activation of JNK1b1 is more a systematic
than random event. In other words, the phosphorylation of JNK1b1
in E. coli appears to mimic the events that occur in its natural host
environment, since the canonical and additional sites were phos-
phorylated both endogenously in E. coli and exogenously by recon-
stituting the JNK MAPK pathway.
While S377 has been identified previously as a JNK1b1 phos-
pho-site in MS-based proteomics analysis of the human kinome
(Table S1), its physiological relevance or the regulatory kinase/s
that catalyse its phosphorylation has not been characterised.
T228 and S284 are newly identified JNK1b1 phospho-sites, and no-
vel residues known to be phosphorylated by MKK4. S377 and S284
are fully conserved across the JNK splice variants, while T228 is
conserved within the b variants of JNK1 and the a variants of
JNK2 (Fig. S1). Phosphorylation of S377 and S284 may therefore
represent a general mechanism for JNK regulation, whereas T228
phosphorylation may allow differential regulation of the relevant
JNK variants to induce their divergent and partially contradictory
cellular actions.
A possible explanation for the phosphorylation of these residues
is that, once activated by the ppMKK4-dependent phosphorylation
of T183/Y185, JNK1b1 then phosphorylates itself at T228/S284/
S377. While this may be possible for S377, neither T228 nor
S284 is followed by a proline, a requirement for JNK to phosphor-
ylate other proteins [4]. This strongly suggests that at least T228
and S284 are phosphorylated by ppMKK4.
To begin to understand the biological role of the three addi-
tional JNK1b1 phospho-sites, we intend to determine the condi-
tions under which pT228, pS284 and pS377 naturally occur in
human cells (e.g. 293T cells), and how they affect normal cellular
functioning. We also intend to fully elucidate the structural and
thus functional relevance of T228/S284/S377 phosphorylation,
yet examining the relative activity of p5JNK1b1 indicates that these
modifications, in combination, do not have an overall or net inhib-
itory effect on the kinase. It is clear that p5JNK1b1 is highly active
and phosphorylates ATF2 efficiently (Fig. 3), emphasising the effec-
tiveness at which ppMKK4 generates large quantities of phosphor-
ylated, active JNK1b1 (profile 4, Fig. 1). We have also previously
determined the specific activity of p5JNK1b1, which was measured
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relevance of the three additional phospho-sites may not be known
at present, it is possible that in addition to the effect that they may
have on the activity of JNK1b1, they may play other roles that could
include the regulation of; the interaction of JNK1b1 with its >50
binding partners [4], its translocation between different cellular
compartments, the rate at which T183/Y185 are dephosphorylated,
or the stability of the kinase.
Furthermore, T228 and S284 neighbour the N-capping motifs of
the a-helices comprising N229-L241 and E285-M301, respectively
(Fig. 2). Helix-capping motifs contribute to the conformational sta-
bility of both the a-helix and the overall protein in which they are
situated, and as such the capacity for phosphorylation to regulate
the function of proteins by modulating the stability of their a-heli-
ces is well known (e.g. see [17]). The locations of T228 and S284
therefore allow this mechanism to be a promising means by which
their phosphorylation may affect JNK1b1 functioning.
Evaluating the propensity that each JNK1b1 phospho-site has to
be phosphorylated in vitro by ppMKK4 by comparing the relative
abundance of the phosphorylated and non-phosphorylated popu-
lations of each precursor p5JNK1b1 phospho-peptide (see Supple-
mentary material), the order of their phosphorylation propensity
was determined to be: T183/Y185 > S377 > T228P S284. As T183
and Y185 have, unsurprisingly, the greatest predisposition to be
phosphorylated, p5JNK1b1 likely comprises approximately 60% ki-
nase phosphorylated on at least T183 and Y185.
The relatively low percentage of JNK1b1 phosphorylated at
either pT228 and/or pS284 (each comprising ±10% of the total
phosphorylated kinase population; Table S2) may account for
their previous non-detection in mammalian cells, yet the power
and sensitivity of single-protein mass spectrometry (as per-
formed here) confirm that these phospho-sites are not false
positives.
Our studies provide important insights into the fate of JNK1b1
overexpressed in E. coli, raising interesting new questions of the
possibility that endogenous E. coli kinases may be involved in the
activation of heterologously expressed MAPKs. This points at the
prospect that prokaryotic kinases may recognise eukaryotic phos-
phorylation motifs, or that there may be degree of evolutionary
relatedness between prokaryotes and eukaryotes. We are however
not able to affirmatively conclude that JNK1b1 is subject to phos-
phorylative activation by endogenous bacterial kinases because
this study was not designed to prove this hypothesis. Nevertheless,
future research could be aimed at exploring and identifying bacte-
rial kinases possibly capable of phosphorylating JNK1b1 and other
eukaryotic proteins that undergo post-translational modification.
The concept of using a codon-harmonised JNK1b1 gene to improve
or naturalise its transitional kinetics to prime the protein for co- or
post-translational modification, catalysed either by itself or endog-
enous host proteins, also has significant implications for all heter-
ologous protein expression, highlighting the value of its further
investigation. Furthermore, the functional and biochemical rele-
vance of the novel JNK1b1 phosphorylation sites we have identi-
fied could also give important insights into the molecular
mechanisms by which JNK1b1 is regulated, as well as shed light
on the differential regulation and hence functional relevance of
the different JNK splice variants.Acknowledgments
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Fig. S1. Protein sequence alignment of the 3 JNK isoforms and their related splice variants. The canonical T183 and Y185 phospho-residues 
are indicated in blue, while the newly identified phospho-sites, T228 (not fully conserved) and S284 (conserved), are indicated in red. The 
previously identified yet uncharacterised and conserved phospho-residue, S377, is indicated in green. Identical residues are indicated as dots.
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Table S1. JNK residues found previously to be additional sites of phosphorylation.  
The canonical T183 and Y185 residues (T221 and Y223 in JNK3), the phosphorylation of which 
is known to induce JNK activation, have not been included. 
a 
“SS” denotes phospho-sites that have been unambiguously determined by site-specific 
methods, including specific MS strategies, amino acid sequencing, phosphorylated  
site-specific antibodies, and site-directed mutagenesis. 
b 
“MS” indicates phospho-sites that were assigned by proteomic-based discovery-mode mass 
spectrometry only. 
c 
“―” refers to that which is currently unknown. 
Phospho-
residue 
JNK isoform 
found to be 
phosphorylated 
Residue 
conservation  
in JNKs 
Phosphory-
lation 
catalysed by 
Effect of 
phosphory-
lation 
Site 
assigned 
by 
Reference/s 
S129 JNK1,2 All PKC 
augments JNK 
phospho-
activation by 
MKK4/MKK7 
SSa [1,2,3] 
T131 JNK3 All (T93  in JNK1,2) cdk5 
inhibits the 
kinase activity 
of JNK3 
SS [4] 
S155 JNK1 All ―c ― MSb [5] 
T178 All All (T216  in JNK3) ― ― SS, MS [6,7] 
S179 JNK1,3 JNK1,3 ― ― MS [7,8] 
T188 All All (T226  in JNK3) ― ― MS [8] 
T255 JNK1 All ― ― MS [9] 
T258 JNK1 JNK1 ― ― MS [9] 
Y259 JNK1 All ― ― MS [9] 
Y357 JNK1 All ― ― MS [9] 
T367 JNK1 JNK1,3  ― ― MS [9] 
S377 JNK1,3 All (S415  in JNK3) ― ― MS [5,10-16] 
T404 JNK2 
JNK1α2, 
JNK1β2, 
JNK2α2, 
JNK2β2, 
MKK7 ― SS, MS [5,17] 
S407 JNK2 JNK2α2, JNK2β2, MKK7 ― SS [17] 
S417 JNK3 JNK3 ― ― MS [5] 
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SUPPLEMENTARY METHODS 
Enzymatic assays of JNK1β1 
To approximate the relative catalytic activity of each JNK1β1 phospho-form, the rate at 
which they phosphorylate the substrate, ATF2, was tested. This was achieved by monitoring 
the electrophoretic shift observed in ATF2 over time upon single and dual phosphorylation by 
JNK1β1 when subjected to Tricine–SDS-PAGE. The ATF2 phosphorylation assays were 
conducted as follows: 1 µM JNK1β1 (of each specific form), 30 µM ATF2, 0.2 mg/ml BSA, 
10 mM MgCl2, and 1 mM ATP, in Kinase-Reaction Buffer (10 mM Tris-HCl, pH 8.0, 
comprising 150 mM NaCl, 1 mM DTT, 0.02% (v/v) Triton X-100, and 0.02% (w/v) NaN3) 
was incubated at 25 °C for 3 h. Samples were taken at regular intervals and immediately 
treated for reducing SDS-PAGE. The ATF2 samples were then resolved by  
Tricine–SDS-PAGE on a 16% Tris-Tricine gel [18] and stained with Coomassie Blue R-250. 
Intact protein LC-MS 
Intact JNK1β1 samples were analysed using a Dionex Ultimate 3000 RSLC system coupled 
to a QSTAR ELITE mass spectrometer. Proteins were loaded on a Jupiter C4 column  
(1 × 150 mm, 5 µm particle size) and eluted using a flow-rate of 200 µl/min with a gradient: 
5-60% B  in 25 min (A: 0.1% formic acid; B: 80% MeOH/0.1% formic acid). An electrospray 
voltage of 5.5 kV was applied and MS scans were acquired from m/z 700-2000. The multiply 
charged protein envelopes were deconvoluted using Bayesian Protein Reconstruct tool of AB 
Sciex, Analyst QS 2.0 using mass ranges of 10,000-70,000 Da, an S/N threshold of 20 and 
3% minimum spectral intensity. 
LC-MS/MS-based peptide sequencing 
JNK1β1 samples were digested by incubation with trypsin (ratio of 1:50,  trypsin:JNK1β1) in 
Kinase-Reaction Buffer supplemented with 1 mM CaCl2 and 25 mM NH4HCO3, pH 8.0, for 
18 h at 37 °C. After quenching the reaction with 0.5% formic acid and vacuum drying each 
sample, the JNK1β1 digests were resuspended in 35 µl, 2% acetonitrile/0.2% formic acid and 
analysed using a Dionex Ultimate 3000 RSLC system coupled to a QSTAR ELITE mass 
spectrometer. Peptides were first de-salted on an Acclaim PepMap C18 trap column  
(75 µm × 2 cm) for 8 min at 5 µl/min using 2% acetonitrile/0.2% formic acid, than separated 
on Acclain PepMap C18 RSLC column (75 µm × 15 cm, 2 µm particle size). Peptide elution 
was achieved using a flow-rate of 500 nl/min with a gradient: 4-60% B in 30 min  
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(A: 0.1% formic acid; B: 80% acetonitrile/0.1% formic acid). Nano-spray was achieved using 
a MicroIonSpray head assembled with a New Objective, PicoTip emitter. An electrospray 
voltage of 2.0-2.8 kV was applied to the emitter. The QSTAR ELITE mass spectrometer was 
operated in Information Dependant Acquisition using an Exit Factor of 7.0 and Maximum 
Accumulation Time of 2.5 sec. MS scans were acquired from m/z 400-1500 and the three 
most intense ions were automatically fragmented in Q2 collision cells using nitrogen as the 
collision gas. Collision energies were chosen automatically as function of m/z and charge. 
Protein and peptide identification was performed using NCBI’s msdb database and the 
ParaghonTM algorithm Thorough search in Protein Pilot. An identification confidence of 95% 
was selected during searches. 
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Fig. S2. Phosphorylated JNK1β1 is present predominantly in the soluble cell fraction of  
E. coli BL21(DE3)pLysS after its overexpression. Western blot analyses (using  
anti-pT183/pY185 JNK1 antibodies) of the soluble and insoluble bacterial cell lysates after 
overexpression of GST-JNK1 (subsequently processed and purified as JNK1β1 as described in 
[19]) demonstrates the large quantity of phosphorylated, soluble JNK1β1 expressed. 
Conversely, only a small degree of the insoluble JNK1β1 expressed displayed phosphorylation. 
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Fig. S3. Electrospray ionisation charge state envelopes of the JNK1β1 phospho-forms. Insets show the corresponding deconvoluted intact mass 
spectra presented in Fig. 1. Spectra were obtained and deconvoluted as described in the supplementary materials and methods. 
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MSR ↓ SK ↓ R ↓ DNNFYSVEIGDSTFTVLK ↓ R ↓ YQNLKPIGSGAQGIVCAAYDAILER ↓ 
NVAIK ↓ K ↓ LSRPFQNQTHAK ↓ R ↓ AYR ↓ ELVLMK ↓CVNHK ↓ NIIGLLNVFTPQK ↓ 
SLEEFQDVYIVMELMDANLCQVIQMELDHER ↓ MSYLLYQMLCGIK ↓ HLHSAGIIHR ↓ 
DLKPSNIVVK ↓ SDCTLK ↓ ILDFGLAR ↓ TAGTSFMMTPYVVTR ↓ YYR ↓ APEVILGMGYK ↓ 
ENVDIWSVGCIMGEMIK ↓ GGVLFPGTDHIDQWNK ↓ VIEQLGTPCPEFMK ↓ K ↓ LQPTVR ↓  
TYVENRPK ↓ YAGYSFEK ↓ LFPDVLFPADSEHNK ↓ LK ↓ ASQAR ↓ DLLSK ↓ MLVIDASK ↓ 
R ↓ ISVDEALQHPYINVWYDPSEAEAPPPK ↓ IPDK ↓ QLDER ↓ EHTIEEWK ↓ ELIYK ↓ 
EVMDLEER ↓ TK ↓ NGVIR ↓ GQPSPLAQVQQ 
 
Fig. S4. Simulated trypsin digest of JNK1β1. The location of trypsin cleavage sites (↓) in 
JNK1β1 generate a theoretical cleavage pattern that contains 45 candidate peptide fragments 
(numbered above in italics) of varying length. The fragments and their specific residues found 
to be phosphorylated upon sequencing of the resulting tryptic peptides of JNK1β1 
(phosphorylated both during expression in E. coli and in vitro by MKK4) are indicated in red. 
The amino acids that constitute the N- and C-terminal domains of JNK1β1 are indicated in green 
and blue, respectively.  
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Fig. S5 (Page 4 of 4). Representative product ion MS/MS spectra of each tryptic  
phospho-peptide identified for JNK1β1 phosphorylated both during expression in  
E. coli (p*JNK1β1) and in vitro by MKK4 (p5JNK1β1). A – triply charged 
175TAGTSFMoMpTPpYVVTR189 (doubly phosphorylated (p) at T183 and Y185, with M182 
oxidised (o)); B – triply charged 221GGVLFPGpTDHIDQWNK236 (phosphorylated at T228);  
C – triply charged 274LFPDVLFPADpSEHK288 (phosphorylated at S284); D – doubly charged 
374GQPpSPLAQVQQ384 (phosphorylated at S377). Identified b and y ions are annotated above 
each spectrum, with the amino acids determined unequivocally to be phosphorylated indicated 
with a red p. The predicted (pred) and observed (obs) m/z of each precursor ion and their 
monoisotopic masses, as well as the mass differences are indicated on the top right.  
All phospho-peptides were determined with >99% confidence. 
D 
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Fig. S6. Model for the phosphorylation of codon-harmonised JNK1β1 during expression in 
E. coli. Red crosses denote possible phosphorylation reactions that can be excluded based on 
evidence to the contrary from the literature. Refer to article text for details of the proposed 
model.  
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SUPPLEMENTARY RESULTS AND DISCUSSION  
Phosphorylation propensity of each JNK1β1 phospho-site 
To evaluate the propensity that the JNK1β1 phospho-residues have to be phosphorylated by 
ppMKK4 in vitro, the relative abundance of the phosphorylated and non-phosphorylated 
populations of each relevant precursor phospho-peptide of p5JNK1β1 was compared. The 
area under the peaks of the mass chromatogram corresponding to the phosphorylated and 
non-phosphorylated states of both the +2 and +3 ion species of each phospho-peptide 
fragment was integrated, giving the total number of ions of the particular type in each sample. 
To compare the levels of the phosphorylated and non-phosphorylated forms of each  
phospho-peptide in different replicate samples, the levels of the +2 and +3 ion species of each 
phosphorylated fragment were expressed as a percentage of the combined ion count of both 
the phosphorylated and non-phosphorylated forms of that fragment in that sample, where; 
 % phosphorylated = 
phospho-peptide+2/+3 peak area
unmodified-peptide+2/+3 peak area	+	phospho-peptide+2/+3 peak area  × 100 
This process was repeated for all JNK1β1 phospho-peptide products of trypsin digestion, 
allowing us to compare the level at which each residue is phosphorylated as an indication of 
its relative propensity to be phosphorylated. 
The average degrees of phosphorylation of each JNK1β1 residue found to be phosphorylated 
are presented in Supplementary Table S2. Residues T183/Y185 are undoubtedly the most 
highly phosphorylated residues, with over 60% of the precursor fragments in which they are 
situated being phosphorylated. Residue S377 is phosphorylated to less than half (33%) the 
extent of the canonical phosphorylatable residues, with T228 and S284 phosphorylated to a 
lesser but significant degree (similarly at ±10% each) (Table S2). Thus, the order of their 
propensity to be phosphorylated by ppMKK4 is: T183/Y185 ˃ S377 ˃ T228 ≥ S284. 
Unsurprisingly, these findings confirm that the canonical activation residues of JNK1β1, 
T183/Y185, have the greatest predisposition to be phosphorylated, and that they are likely to 
be phosphorylated first. With this, it can be claimed with confidence that p5JNK1β1 
comprises approximately 60% kinase phosphorylated on at least T183 and Y185 (calculated 
by addition of the 2× to 5× phosphorylated kinase population percentages described in profile 
4 of Fig. 1). 
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Table S2. The degree to which each tryptic phospho-peptide fragment of JNK1β1 is 
phosphorylated after incubation of the intact kinase with ppMKK4 for ≥3 h. Percentages 
are an average of the values obtained for both the +2 and +3 species of each phospho-peptide, 
generated from at least two independent experiments. 
a 
newly identified JNK1β1 phospho-site 
b previously identified but uncharacterised JNK1β1 phospho-site 
Sequence of JNK1β1 tryptic 
peptide fragment found to be 
phosphorylated  
Phosphorylated 
residue/s 
Residues of 
JNK1β1 in 
fragment 
Percentage (%) of 
fragment population 
that is phosphorylated  
(± SD), n ≥ 2 
TAGTSFMMpTPpYVVTR T183/Y185 175-189 61.2 (± 8.4) 
GGVLFPGpTDHIDQWNK T228a 221-236 10.4 (± 5.5) 
LFPDVLFPADpSEHNK S284a 274-288 09.6 (± 2.7) 
GQPpSPLAQVQQ S377b 374-384 33.4 (± 8.5) 
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Many studies have characterized how changes to the stability and internal motions of a protein during activation
can contribute to their catalytic function, even when structural changes cannot be observed. Here, unfolding
studies and hydrogen–deuteriumexchange (HX)mass spectrometrywere used to investigate the changes to the
stability and conformation/conformational dynamics of JNK1β1 induced by phosphorylative activation.
Equivalent studies were also employed to determine the effects of nucleotide binding on both inactive and
active JNK1β1 using the ATP analogue, 5ʹ-adenylyl-imidodiphosphate (AMP-PNP). JNK1β1 phosphorylation
alters HX in regions involved in catalysis and substrate binding, changes that can be ascribed to functional
modifications in either structure and/or backbone flexibility. Increased HX in the hinge between the N- and
C-terminal domains implied that it acquires enhanced flexibility upon phosphorylation that may be a prerequisite
for interdomain closure. In combination with the finding that nucleotide binding destabilizes the kinase, the
patterns of solvent protection by AMP-PNP were consistent with a novel mode of nucleotide binding to the
C-terminal domain of a destabilized and open domain conformation of inactive JNK1β1. Solvent protection by
AMP-PNP of both N- and C-terminal domains in active JNK1β1 revealed that the domains close around
nucleotide upon phosphorylation, concomitantly stabilizing the kinase. This suggests that phosphorylation
activates JNK1β1 in part by increasing hinge flexibility to facilitate interdomain closure and the creation of a
functional active site. By uncovering the complex interplay that occurs between nucleotide binding and
phosphorylation, we present new insight into the unique mechanisms by which JNK1β1 is regulated.
© 2014 Elsevier Ltd. All rights reserved.Introduction
The c-Jun N-terminal kinases (JNKs) are mitogen-
activated protein (MAP) kinases that mediate physi-
ological responses to a number of extracellular stimuli,
including cytokines and UV irradiation [1]. By phos-
phorylating a variety of target proteins, the diverse
JNK signaling pathways regulate transcriptional
events implicated in cellular processes such as prolif-
eration, differentiation, and apoptosis [1].
Ten unique variants of JNK that are encoded
by three alternatively spliced genes (JNK1, JNK2,
and JNK3) have been identified [2]. They are
distinguished by the length of their termini and theer Ltd. All rights reserved.residues that form their substrate binding sites, as
well as by the tissues in which they are predom-
inantly expressed.
Although other sites of phosphorylation have been
discovered, JNK1s are activated primarily through
the dual phosphorylation of the canonical T183 and
Y185 residues located in the activation lip. Phos-
phorylation induces greatly enhanced kinase activ-
ity, leading to the increased phosphorylation of
transcription factors and other downstream target
proteins [3].
The structure of JNK1β1 displays a conserved
bilobal kinase core comprising an active site situated
between an N-terminal domain and a C-terminalJ. Mol. Biol. (2014) 426, 3569–3589
3570 Phosphorylation- and ATP-induced changes to JNK1β1domain [4]. The two domains are connected by a
loop referred to as the hinge as it has been shown to
act as the pivot point for interdomain closure, a con-
formational change required in many kinases for
the formation of catalytically competent active site
[5].
Phosphorylative activation leads to dramatic struc-
tural rearrangements within kinases. The changes
that take place in MAP kinases are best understood
for ERK2, as it is the only member that has had both
its inactive and its active conformations elucidated
[6,7]. Within ERK2, phosphorylation induces exten-
sive remodeling of the activation lip that causes a
high-affinity substrate binding groove to form and the
repositioning of active-site residues into orientations
that facilitate phosphoryl transfer [7].
Complementary studies employing hydrogen–
deuterium exchange (HX) mass spectrometry (MS)
has revealed that regulation of kinases is mediated
through changes to both conformation and con-
formational mobility [8]. Even in the absence of
structural changes, alterations in protein fluctuations
and flexibility have been shown to impact protein
functioning. Studies of ERK2 have illustrated that
activation leads to significantly enhanced HX at
backbone amides within the hinge, and since
conformer interconversions in this regions were not
observable by X-ray crystallography, the change
could only be ascribed to the activation-dependent
regulation of protein motions, particularly enhanced
backbone flexibility [9]. A function for this mediation of
hinge flexibility was initially suggested by measure-
ments of steric protection from HX by 5ʹ-adenylyl-
imidodiphosphate (AMP-PNP), a non-hydrolyzable
ATP analogue. The patterns of solvent protection
describe a model in which the N- and C-terminal
domains of inactive ERK2 is constrained from inter-
domain closure and thus occupy an open conforma-
tion, whereas the domains of active ERK2 instead
adopt a closed conformation around the nucleotide
[10]. These results illustrated that patterns of solvent
protection uponnucleotide binding provide ameans to
detect domain closure and suggested that the
enhanced flexibility of the hinge following activation
of ERK2may enable the interdomain interactions that
close and functionalize the catalytic cleft. More recent
studies have shown that increasing the conformation-
al mobility of the hinge through mutations leads to
activation of mono-phosphorylated ERK2 and phos-
phorylation-independent changes in the mode of
nucleotide binding that is consistent with interdomain
closure [11].
Despite the large diversity in activation lip confor-
mations between the various inactive forms of the
MAP kinases, the similarity found in the structure of
phosphorylated activation lips reveals that the varied
inactive conformers converge toward a comparable
form upon activation [4,7,12,13]. One could expect
that, due to the similarities in these characteristics ofactivation, as well as the conserved sequence
and tertiary structure that the MAP kinases share,
the members of this family would exhibit equivalent
mechanisms of regulation. However, when compar-
ing the information available for the activation-
induced changes in the conformational dynamics of
ERK1 [14], ERK2 [9,10], and p38α [15], it is clear that
the small differences in the MAP kinase sequences
result in significant distinctions in their phosphoryla-
tion-dependent regulation of regional protein mobil-
ity. Therefore, there is increasing evidence that the
closely related MAP kinases diverge with respect
to the mechanisms by which changes to internal
protein motions contribute to regulating their activity.
Due to the differential and pleiotropic effects of MAP
kinase misfunction, fully understanding their distinct
activation mechanisms is crucial if we are to explore
each as potential individual therapeutic targets.
We have previously succeeded in producing high
yields of active, phosphorylated JNK1β1 by recon-
stituting the MEKK1 → MKK4 → JNK MAPK (mito-
gen-activated protein kinase) phosphorylation
cascade in vitro [16]. Upon mass spectrometric
analysis of the active JNK1β1, it was revealed that
the kinase is phosphorylated by MKK4 at no less
than five sites, albeit to varying degrees [17]. These
phospho-sites comprised the canonical activation
loop phosphorylation residues (T183 and Y185), as
well as a recognized yet uncharacterized phospho-
site (S377) and two novel phospho-residues
(T228 and S284). Although we henceforth refer to
the fully phosphorylated kinase as “p5JNK1β1” due
to the five phosphate groups that are added upon in
vitro activation by MKK4, we do not imply that each
phosphorylated residue is present in the population
to the same extent. Nonetheless, we have shown
that p5JNK1β1 is highly active, possessing a specific
activity of 3.3 ± 0.4 μmol/min per milligram of ATF2
[16].
In this study, we investigate the effect that
phosphorylative activation has on the stability and
conformational dynamics of the most abundant JNK
isoform, JNK1β1 [18]. Comparing the changes in
the HX behavior of peptides derived from inactive
and active JNK1β1, we demonstrate how patterns of
exchange may reflect changes in regional confor-
mational mobilities upon phosphorylation, suggest-
ing that activation regulates protein dynamics in
regions important for catalysis and substrate bind-
ing. Additionally, we examined variations in steric
protection from HX upon nucleotide substrate
binding in both forms of JNK1β1 to explore possible
changes in the extent of domain rotation following
activation and to ascertain whether interdomain
closure is required for catalysis. These data provide
novel insight into the distinct mechanisms by which
JNK1β1 is activated and expose the unique interplay
that exists between nucleotide binding and phos-
phorylation for the regulation of its activity.
3571Phosphorylation- and ATP-induced changes to JNK1β1Results
Phosphorylative activation does not alter the
structure of JNK1β1 extensively but increases
the stability of the kinase
We investigated the effect that the addition of the
five phosphate groups (Fig. 1a) has on the global
structure of JNK1β1 using a number of spectroscop-
ic methods. Fluorescence spectral data for unmod-
ified and phosphorylated JNK1β1 are essentially
identical (Fig. 1b), indicating that phosphorylation2
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We carried out several experiments to examine
the effect that phosphorylation has on the stability of
JNK1β1. Temperature-induced denaturation, as well
as urea-induced equilibrium and kinetic unfolding
experiments, revealed that phosphorylation distinct-
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Fig. 2. Phosphorylation increases the stability of JNK1β1, whereas AMP-PNP/Mg2+ binding decreases the stability of
both its unmodified and its phosphorylated forms. (a) Temperature-induced unfolding of JNK1β1 (green) and p5JNK1β1
(blue), as well as their AMP-PNP/Mg2+-bound forms [JNK1 + A/M (orange) and p5JNK1 + A/M (red), respectively], was
monitored by measuring ellipticity at 222 nm. The unfolding data are the average of three replicates and normalized such
that 0 represents the native state and 1 represents the unfolded state. Lines of best fit are presented for clarity, while drop
lines indicate the temperature at which each form begins to unfold (TU). (b) Urea-induced equilibrium unfolding of the
unbound and nucleotide-bound forms of both unmodified and phosphorylated JNK1β1, monitored by tryptophan
fluorescence intensity at 330 nm using an λex of 280 nm. Data points are the average of three replicates and were globally
fitted to an equilibrium four-state monomer model together with the data from other unfolding probes to obtain ΔG°H2O
values (see Fig. S3). The inset shows the total set of fluorescence emission spectra recorded at different urea
concentrations. (c) Unfolding kinetics traces for the JNK1β1 forms, averaged from three unfolding reactions in 8.1 M urea
(see Fig. S2 for the residual plots for each fit). The baselines for the folded and unfolded states are indicated. The inset
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phosphorylated JNK1β1, in both their apo and AMP-PNP/Mg2+-bound forms, is represented as bars in summary.
3572 Phosphorylation- and ATP-induced changes to JNK1β1During temperature-induced denaturation, all forms
of JNK1β1 unfold in a cooperative and irreversible
manner, yet each shows distinct and complex
multi-state unfolding mechanisms as revealed by
the line of best fit describing each dataset (Figs. 2a
and S2a). As a result, single representative Tm values
cannot be accurately assigned to each profile due
to the complex transitions displayed among each
apparent intermediate species. Nevertheless, the
temperatures over which each protein unfolds com-
pletely are distinct and can thus be used as clearindicators of relative protein stability. The thermal
unfolding profile of p5JNK1β1 exhibits a roughly 5 °C
increase in the temperature at which the modified
kinase starts to unfold compared to JNK1β1 (Fig. 2a),
illustrating a clear stabilization by phosphorylation.
By monitoring the urea-induced equilibrium unfold-
ing of JNK1β1 using fluorescence spectroscopy
[as well as by circular dichroism and 8-anilino-1-
naphthalenesulfonate (ANS) binding as detailed in the
Fig. S3], we could also assess the effect that
phosphorylation has on its conformational stability.
3573Phosphorylation- and ATP-induced changes to JNK1β1The reversibility of the chemical denaturation by
urea of all forms of JNK1β1 was first confirmed (see
Fig. S3a), allowing a thermodynamic explanation of
the overall structural transitions to be made. It is
evident that the equilibrium unfolding curves of the
various forms of JNK1β1 are not simple, monophasic
sigmoidal curves but display complex multi-state
characteristics, similarly to its thermal unfolding
profiles. The unfolding data monitored by fluores-
cence and circular dichroism also do not coincide
throughout all transitions for each form (Fig. S3d),
reaffirming the suggestion that intermediate species
exist along their equilibrium unfolding pathways. In
further support to this, ANS binding experiments
illustrated that all forms of JNK1β1 exhibit differential
binding patterns to the amphipathic dye at the varying
urea concentrations as the proteins unfold (Fig. S3c),
confirming that significant populations of differing
intermediate species with unique solvent-exposed
hydrophobic patches accumulate at equilibrium under
mild denaturing conditions.
As the precise number of intermediates that exist
during equilibrium unfolding is not immediately appar-
ent by examining the transitions displayed in the
unfolding curves, we globally fit the intrinsic fluores-
cence intensities at various wavelengths and the
ellipticity at 222 nm data to three-, four-, and five-state
monomeric models. While the attempts to fit the data
to a three-state model were not satisfactory, the data
fit equally well to both four- and five-state models. We
thus selected the simpler model with fewer assumed
intermediate states to describe the physical and
thermodynamic nature of JNK1β1 denaturation. The
analysis and interpretation of the conformational
stability parameters (ΔG°H2O andm values) generated
for each transition by global fitting of the unfolding data
to the proposed four-state monomer model
(N ↔ I1 ↔ I2 ↔ U) is intricate and will be published
independently, but the overall ΔG°H2O values for the
complete unfolding (N ↔ U; ΔG°NU) of each form of
JNK1β1 are used here to describe the effects that
phosphorylation has on their global conformational
stability. Nonetheless, the distinctive patterns dis-
played by each equilibrium unfolding curve (Fig. 2b)
highlight that, while each form of JNK1β1 unfolds via
two apparent intermediate states, the extent and
cooperativity of the structural changes (presented by
changes in fluorescent intensity/ellipticity) and the
changes in free energy that occur between the inter-
mediates are clearly influenced by the presence of
AMP-PNP/Mg2+ and the phosphorylation state of the
kinase.
The overall ΔG°NU of phosphorylated JNK1β1
(17.0 ± 2.2 kcal/mol) was increased relative to that
of the unmodified kinase (13.8 ± 1.4 kcal/mol), with
the range of the predominant unfolding transition
shifted to a higher urea concentration when com-
pared to the same transition of inactive JNK1β1.
Therefore, as p5JNK1β1 is more thermodynamicallystable than JNK1β1, phosphorylation increases the
global conformational stability of the kinase.
Determining the rates of unfolding of JNK1β1 using
a stopped-flow instrument that measures tryptophan
fluorescence allowed understanding of the effect
that phosphorylation has on its kinetic stability. The
unfolding of all forms of JNK1β1 shows tri-phasic
kinetics comprising an initial positive-amplitude burst
phase, followed by two consecutive negative-ampli-
tude phases (Fig. 2c). As the burst phase occurs
within the dead time of the instrument and is wholly
unresolved, it was excluded when fitting the kinetics
data. The phases that follow are well-defined and fit
well to a double-exponential decay function, produc-
ing a distinct fast and slow phase (Fig. 2c).
The two intermediates observed during the kinetic
unfolding reactions, as well as the changes in am-
plitude that exist between each species, are consis-
tent with that predicted by the equilibrium unfolding
studies and the proposed four-state monomer model
(N ↔ I1 ↔ I2 ↔ U). While the formation of the kinetic
unfolding intermediates may represent the same
structural events that are described by the equilibri-
um unfolding model, they cannot be directly com-
pared as we are yet to establish whether the three
kinetic unfolding phases occur sequentially or in
parallel. Comprehensive analyses of the rates of
unfolding of each intermediate and the associated
kinetic cooperativity (m values) for each phase,
specifically in relation to their corresponding thermo-
dynamic parameters determined during equilibrium
unfolding experiments, will also be published else-
where. Nevertheless, we can use the rate constants
for the resolvable phases of unfolding determined as
a function of urea concentration to characterize the
impact of phosphorylation on unfolding kinetics. The
logarithms of the rate constants for the fast phase
increase linearly with urea concentration (Fig. 2c,
inset), while those for the slow phase are indepen-
dent of urea (data not shown). Fitting the unfolding
data to the linear equation described (see Materials
and Methods) yielded kH2Ou values of (1.3 ±
0.03) × 10−3 and (0.9 ± 0.1) × 10−3 s−1 for the fast
phases of JNK1β1 and p5JNK1β1, respectively, with
no significant difference existing between their
kinetic cooperativities (slope of each curve, inset of
Fig. 2c). A similar reduction in the rate of unfolding
upon phosphorylation was seen when comparing
the slow unfolding phases of each species (data not
shown). Phosphorylation therefore reduces the
overall rate of unfolding of JNK1β1, reiterating our
findings that the kinase is stabilized upon activation.
AMP-PNP/Mg2+ binding decreases the stability
of both unmodified and phosphorylated JNK1β1
To investigate the effect that AMP-PNP/Mg2+
binding has on the stability of both inactive and
active JNK1β1, we subjected ligand-bound JNK1β1
3574 Phosphorylation- and ATP-induced changes to JNK1β1and p5JNK1β1 to the same thermal, thermodynamic,
and kinetic stability experiments. Surprisingly, we
found that the presence of AMP-PNP/Mg2+ signifi-
cantly destabilized the global conformational state of
the kinase.
Ligand binding decreased the thermostability of
both JNK1β1 and p5JNK1β1 to a similar degree, low-
ering the temperature at which each form begins to
unfold by ±8 °C (Fig. 2a). With respect to changes
to the thermodynamic stability of the kinase, the
equilibrium unfolding profiles suggest that, while the
binding of AMP-PNP/Mg2+ may stabilize the first
unfolding intermediate of unmodified JNK1β1, it
appears to destabilize the second intermediate
species substantially, with the transition between the
intermediates displaying both an increase in coopera-
tivity and a shift to a lower urea concentration (Fig. 2b).
The effect of ligand binding on p5JNK1β1 is less
distinct, yet it is evident from its unfolding profile that
the I1 ↔ I2 transition is also shifted to a lower range of
urea concentrations. Global fitting of the unfolding
data generated ΔG°NU values of 10.5 ± 1.3 and
14.2 ± 1.8 kcal/mol for the JNK1β1 + AMP-PNP/
Mg2+ and p5JNK1β1 + AMP-PNP/Mg
2+ complexes,
respectively.Whenwecompare these changes in free
energy to that measured for the complete unfolding of
its unbound forms (larger ΔG°NU values of 13.8 kcal/
mol for JNK1β1 and 17.0 kcal/mol for p5JNK1β1), it is
clear that the presence of AMP-PNP/Mg2+ thermo-
dynamically destabilizes both forms of the kinase.
While the unfolding kinetics of the ligand-bound
JNK1β1 forms display the same characteristic
phases exhibited by the uncomplexed kinase
(Fig. 2c), AMP-PNP/Mg2+ binding increases the
rate of the fast phase by ~5- and ~3-fold for JNK1β1
and p5JNK1β1, yielding k
H2O
u values of (6.2 ±
2.4) × 10−3 and (2.2 ± 1.2) × 10−3 s−1, respective-
ly. Despite the decrease in kinetic stability, ligand
binding does not alter the kinetic cooperativity of
each fast phase significantly (Fig. 2c, inset). Addi-
tionally, the slow unfolding phase of each form also
experienced an increase in their rate upon ligand
binding (data not shown), reinforcing the indication of
global kinetic destabilization suggested by the
increases in the rate of each fast phase.
All findings considered, it is evident that the
binding of AMP-PNP/Mg2+ destabilizes the global
conformational state of both unmodified and phos-
phorylated forms of JNK1β1. Nonetheless, even in
the presence of AMP-PNP/Mg2+, the phosphorylat-
ed kinase is still more stable than its unmodified
form.
Conformational dynamics of JNK1β1 as
revealed by HX
To uncover the dynamic changes that occur as a
result of both activation and ATP/Mg2+ binding, as
well as to help rationalize the effect that these eventshave on the stability of JNK1β1, we used amide
HX MS. HX measurements for JNK1β1 and
p5JNK1β1 were made by incubating the kinase in
D2O for varying times, both in the absence and in the
presence of AMP-PNP and Mg2+ ions. After pepsin
proteolysis, 103 and 80 peptides reporting exchange
were identified at 1% false detection rate for JNK1β1
and p5JNK1β1, respectively, accounting for 98%
coverage (at least 381 of 384 residues) of their
primary sequence (the peptides are annotated onto
the sequence of JNK1β1 in Fig. 3). The extent of
back-exchange that occurred during the experiment,
averaged over all peptides, was 26 ± 2.7%.
Firstly, the level of deuteration after 50 min was
used to examine the degree of exchange in localized
regions of JNK1β1, revealing the global conforma-
tional dynamics of the kinase by mapping the data to
its crystal structure (Fig. 4). Generally, HX measure-
ments revealed buried regions within the core of both
N- and C-terminal domains that exhibited slow
exchange, with loops and secondary structure in
the periphery of the kinase displaying much faster
exchange. In the C-terminal domain, regions of low
HX (0–40%) include the catalytic loop (containing
the conserved catalytic base, D152), strand β8,
and the solvent-inaccessible parts of the solid helical
core comprising αE, αF, αG, and αI; these elements
form a network of interactions that extends to the
active site. Low-exchanging regions in the
N-terminal domain were observed in parts of strands
β3, β4, and β5, as well as in helices αC and αL16
with which the aforementioned strands interact,
forming a hydrophobic core. In contrast, regions
displaying high levels of HX comprise the MAPK
insert and helix αH (as well as their intervening
loops), in addition to several other loops that include
the highly flexible activation lip, the DFG motif, and
the Gly-rich flap, all of which possess high solvent
accessibility. Overall, the local patterns of HX and
the implied regional conformational mobility of the
kinase are consistent with that which can be
expected from the tertiary structure of JNK1β1.
Changes to the regional conformational
dynamics of JNK1β1 upon
phosphorylative activation
To identify the regions of JNK1β1 that undergo
changes in their dynamics upon phosphorylation
and to possibly shed light on the mechanism by
which these changes induce kinase activation, we
compared HX measurements of unmodified JNK1β1
to those of fully phosphorylated p5JNK1β1. Proteo-
lytic cleavage sites in the two forms were very
similar, with only a few additional peptides identified
for JNK1β1 (Fig. 3). These differing patterns of
cleavage may be due to phosphorylation-induced
changes in proteolytic specificity. Nonetheless, in
the context of the large pool of shared peptides and
Fig. 3. Peptic fragment coverage map of JNK1β1. Sequence coverage of JNK1β1 by the peptides analyzed in this
study, with residue numbering and secondary-structure elements labeled as previously described by Zhang et al. [6]. The
peptides observed only in the p5JNK1β1 datasets and not in those from unmodified JNK1β1 are shown in blue, reflecting
the differences in pepsin proteolysis caused by phosphorylation. The canonical (T183/Y185) and novel (T228/S184/S377)
phosphorylated residues of p5JNK1β1 are indicated in red and orange, respectively, as well as by asterisks.
3575Phosphorylation- and ATP-induced changes to JNK1β1the comparable peptides that were generated, the
additional peptides do not contribute substantially to
the coverage and resolution of the regional HX data.
We do not yet fully understand the structural
changes that take place following JNK activation, as
a crystal or solution structure of the phosphorylated
kinase that could reveal these modifications has not
yet been solved. It is thus important to note that, since
there is no established structural information to
compare the HX data with, we are unable to assign
the differences observed in HX induced by JNK1β1
activation specifically either to distinct structural
modifications that lead to changes in solvent acces-
sibility or to changes to the conformational flexibility
and internal motions of the native protein. Be that as it
may, several peptides demonstrated significant dif-
ferences in their level of deuteration when comparing
JNK1β1 and p5JNK1β1. As many of these peptides
share sequence overlap, regional changes in HX can
be represented by examining specific characteristic
peptides. Regions in JNK1β1 that were responsive tophosphorylation and that exhibited altered HX behav-
ior following activation are those known to be involved
in substrate binding and catalysis. These include
the Gly-rich flap, the hinge region, the catalytic loop,
the DFG motif and activation lip, helices αG/αH and
the intervening α1L14/α2L14 MAPK insert, and
helices αE/αF and strands β7/β8.
The Gly-rich flap and the flanking β1 and β2
strands, an important site for interaction with nucle-
otide triphosphates that is represented well by
peptide K30-A42 (KRYQNLKPIGSGAQGIVCA), ex-
perienced an increase in solvent accessibility upon
phosphorylation (Fig. 5). It has been proposed that
gating motions of this loop are essential for the as-
sociation and dissociation of nucleotide substrates
[19,20]. Increased protein mobility in this region
following JNK1β1 activation may thus facilitate ATP
binding and/or ADP release, thereby enhancing
catalysis in p5JNK1β1.
The hinge region that separates the N- and
C-terminal domains of JNK1β1 also underwent an
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Fig. 4. Conformational dynamics of JNK1β1 as indicated by regional patterns of HX. The extent of deuteration of
unmodified JNK1β1 after 50 min in deuterium is shown, expressed as a percentage of the total number of exchangeable
amides in each region. Percentages are mapped onto the structure (PDB entry 1JNK) as colors that correspond to the
accompanying color bar.
3576 Phosphorylation- and ATP-induced changes to JNK1β1increase in flexibility upon phosphorylation, illustrat-
ed by the increased deuterium incorporation in pep-
tide E109-L115 (ELMDANL) (Fig. 5). In many
kinases, the hinge represents both a site of contact
for the adenosine ring of ATP [6,21] and the pivot
point at which ridged-body rotations allow interdo-
main closure to occur, facilitating the formation of the
active site [19,22]. In a manner similar to ERK2 [11],
it is possible that enhanced conformational mobility
in the hinge following activation permits interdomain
interactions that promote domain closure that may
be vital for p5JNK1β1 catalysis.
Phosphorylation resulted in a marked decrease
in HX in peptide L136-N156 (LCGIKHLHSA-
GIIHRDLKPSN), which encompasses both the
catalytic loop and much of helix αE (Fig. 5). The
catalytic loop of kinases is a central part of their
active site as it forms ion-pair interactions with
the activation lip upon phosphorylation, bridging
the phosphates with the catalytic base [23]. These
interactions may limit flexibility in the catalytic loop
to constrain the catalytic residue into the correct
orientation for catalysis, which may concomitantly
decrease the conformational mobility of helix αE
through the side-chain interactions that exist be-
tween the two elements. Reduced mobility was alsodetected at a few additional sites within the α-helix
core of the C-terminal domain following phosphory-
lation (see Fig. S4 for their corresponding peptides),
which likely arises from the network of helix inter-
actions that extends throughout the core from the
constrained catalytic loop and helix αE. This broad
reduction in the conformational mobility of the core
would undoubtedly increase the stability of the
C-terminal domain, contributing significantly to the
global stabilization of JNK1β1 that we have ob-
served upon phosphorylation (Fig. 2).
The entire length of the extended loop spanning the
DFG motif and activation lip displayed a decrease in
HX in p5JNK1β1 when compared to its inactive form,
as shown by the representative peptides L165-L172
(LKILDFGL) and M181-Y191 (MMTPYVVTRYY)
(Fig. 5). As reported for many other kinases, the
activation lip of inactive JNK1β1 presumably fluctu-
ates between multiple conformations in solution.
Dual phosphorylation of kinases at the Thr-Xxx-Tyr
activation residues initiates new ion-pair interactions
between the phosphates and neighboring side
chains that induce substantial conformational re-
modeling of the activation lip. Despite the lack of
understanding regarding the conformation of the
activation lip in phosphorylated JNKs, a dramatic
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Fig. 5. Changes in HX in the active site of JNK1β1 induced by phosphorylative activation. Peptides representing the
regions of the catalytic cleft that experienced an increase (red) or decrease (blue) in HX following activation of JNK1β1 by
phosphorylation are mapped onto its structure. The residues phosphorylated in p5JNK1β1 are shown as ball-and-stick
models. The deuteron uptake plot for each representative peptide compares the deuteron incorporation of unmodified
JNK1β1 (green) and p5JNK1β1 (blue) over time. Lines through the points are presented only as guides for the eye. Error
bars represent standard error of the mean of at least three independent experiments, and error bars may be smaller than
the symbol used. Peptides displaying increases in HX upon phosphorylation comprise those derived from the Gly-rich loop
and the hinge region, whereas peptides from the activation lip, DFG motif, and catalytic loop displayed decreased HX.
3577Phosphorylation- and ATP-induced changes to JNK1β1restructuring of this region would also be expected to
occur upon activation of JNK1β1. The conserved
DFGmotif (residues Asp169-Phe170-Gly171) is also
an indicator of the functional state of many protein
kinases, as it is essential in forming metal coordina-
tion interactions with Mg2+-ATP [24–27]. The pre-
dictable structural changes and the accompanying
loss of the high flexibility of the activation lip upon
formation of a more rigid functional conformation
easily account for the decreased HX detected in this
region of p5JNK1β1. It is also probable that these
events participate in the observed stabilization of the
phosphorylated kinase.Helices αG and αH, as well as the intervening
helices α1L14 and α2L14 that form the MAPK insert,
are another major region in which a decrease in
deuteration levels may reflect that an expansive
reduction in conformational mobility occurs upon
phosphorylation. The four peptides G216-Q240
(GEMIKGGVLFPGTDHIDQWNKVIEQ), L241-F248
(LGTPCPEF), M249-T258 (MKKLQPTVRT), and
F280-L298 (FPDVLFPADSEHNKLKASQARDLL)
represent the general decrease in HX displayed by
themany p5JNK1β1 peptides identified for this region
(Fig. 6). Other MAP kinases have shown either no
change (ERK1 [14] and p38α [15]) or an increase in
MAPK insert, 2L14: 249-258
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Fig. 6. HX changes in the C-terminal domain of JNK1β1 induced by phosphorylative activation. Representative
peptides of the C-terminal domain show the regions outside of the active site that experienced a decrease in HX upon
phosphorylation, mapped in blue onto the ribbon structure. The phosphorylated residues of p5JNK1β1 are indicated as
ball-and-stick models. Deuteron uptake plots compare the deuteron incorporation into the relevant peptides of unmodified
JNK1β1 (green) and p5JNK1β1 (blue) over time. Lines through the points are a guide for the eye only, while the error bars
represent standard error of the mean of at least three independent experiments. C-terminal domain peptides exhibiting
decreased HX following activation include those from the MAPK insert and helix αH, as well as the αF-loop-αG and β7-β8
structural elements.
3578 Phosphorylation- and ATP-induced changes to JNK1β1HX (ERK2 [9]) in the MAPK insert following activa-
tion, the latter being attributed to disrupted interac-
tions between the insert and the activation lip after
the structural reorganizations that are triggered by
activation. While the analogous contacts in JNK1β1
may be similarly disrupted, we hypothesize that the
potential increase in the flexibility of the MAPK insert
and the surrounding regions is overturned by the
presence of the phosphate group that we have
recently identified on T228 of p5JNK1β1 [17]. This
novel JNK1β1 phospho-site neighbors theN-capping
motif of helix αG (N229-L241). Since helix-capping
motifs (and the modifications thereof) are known to
influence the stability of the helix and the protein inwhich they are located (e.g., see Ref. [28]), it is
conceivable that the phosphorylation of T228 stabi-
lizes the adjacent helix αG, which by extension
reduces the conformational mobility of the MAPK
insert through the helix interactions that the struc-
tures share. Likewise, it appears that helix αH
(S284-M301) may be stabilized in a similar manner
in p5JNK1β1, as the additional novel phospho-site
we have identified, S284, also forms part of the
N-capping motif of this helix. The MAPK insert has
been shown in other MAP kinases to be required for
interactions with upstream kinases and additional
regulatory proteins [29]. With the JNKs possessing
more than 50 binding partners [3], it would not be
3579Phosphorylation- and ATP-induced changes to JNK1β1surprising if several regulatory proteins also inter-
acted with the MAPK insert of JNK1β1. Decreased
flexibility at these potential sites of interaction upon
phosphorylation might affect the binding of the
appropriate regulatory elements, acting to either
enhance or inhibit the activity of p5JNK1β1 in vivo.
In addition to helix αG, part of helix αF and their
interconnecting loop, as well as strands β7 and β8, all
exhibit decreased solvent accessibility after kinase
activation. The changes in helix αF and its adjoining
loop are depicted in the many peptides akin to
G216-Q240 mentioned above (see Fig. S4), while
the reduced HX in strands β7 and β8 is illustrated in
peptide I157-L165 (IVVKSDCTL) (Fig. 6). These
regions constitute an extended peptide-substrate
binding site, in which the αF-loop-αG and β7-loop-β8
structures respectively interact with, for example, the
D-domain and DEJL docking motif of c-Jun [30,31].
The decrease in HX implies that the conformational
mobility of the binding site decreases upon JNK1β1
phosphorylation, which may act to promote substrate
binding, enhancing catalytic turnover.
Solvent protection and changes to
JNK1β1 conformational dynamics upon
AMP-PNP/Mg2+ binding
The activation of many kinases is dependent on
the formation of a functional active site by inter-
domain closure of the conserved N- and C-terminal
domains upon phosphorylation. Since the “hinge
region” that exists between two domains represents
the pivot point at which these ridged-body rotations
occur [19,22], the observed increase in the HX and
conformational flexibility of JNK1β1 in this region
following phosphorylation (see Fig. 5) suggests that
activation of this MAP kinase may also require inter-
domain closure to form a competent catalytic site. To
test this hypothesis, we investigated variations in
interdomain interactions between JNK1β1 and
p5JNK1β1 by measuring the HX of each form in the
presence of the non-hydrolyzable ATP analogue,
AMP-PNP. Alterations in steric exclusion of bulk
solvent following ligand interactions can be detected
by HX [8], and thus, regions with reduced rates of HX
likely signify protein–ligand binding interfaces. Since
ATP is able to interact with parts of both N- and
C-terminal domains within the catalytic cleft formed
between the two, changes in steric protection from
HX upon nucleotide binding provide a means to
detect possible domain closure. Additional changes
to regional conformational motilities revealed by HX
will also assist in rationalizing the destabilizing effect
that ATP binding has been shown to have on JNK1β1
(Fig. 2).
Four distinct regions within unmodified JNK1β1
displayed significant changes in HX upon ligand
binding. Surprisingly, the patterns of solvent protec-
tion and/or changes in protein mobility correspond toa novel mode of ATP binding that is not present in
the other MAP kinases, ERK and p38. The regions in
ligand-bound JNK1β1 that demonstrated decreased
HX and hence solvent protection relative to its un-
bound form comprised the hinge region and the
adjacent strands β5 and βL5 (represented by the
overlapping peptides I106-L110 andE109-L115), the
catalytic loop (peptide L136-N156), and the DFG
motif (peptide L165-L172) (Fig. 7). Conversely, the
C-terminal end of helix αC shows a marked increase
in HX in JNK1β1 upon AMP-PNP/Mg2+ binding. As
direct interactions between the nucleotide and helix
αC are not apparent in the available structures, the
increased HX is most likely due to increases in
conformational mobility induced upon occupancy of
the active site. The changes can be observed in
peptide R72-I86 (RELVLMKCVNHKNII) (Fig. 7);
since its overlapping peptides (beginning from M77)
do not exhibit a change (Fig. S4), the enhanced HX
can be localized to amide residues R72-L76 (RELVL)
within helix αC.
Active p5JNK1β1 presented decreased HX by
solvent protection in four discrete regions upon
ligand binding. Three of these regions included the
hinge region, the catalytic loop, and the DFG motif,
similarly to that observed in inactive JNK1β1
following binding (Fig. 7). Significant solvent protec-
tion was additionally found in the Gly-rich flap and
the adjoining β1 and β2 strands of p5JNK1β1
(displayed in peptide K30-A42), protection that was
not observed in JNK1β1. Unlike JNK1β1, residues
R72-L76 (RELVL) of helix αC of p5JNK1β1 experi-
enced only a small increase in its degree of HX
following AMP-PNP/Mg2+ binding (Fig. 7). The ex-
tent at which HX decreases in p5JNK1β1 as a result
of solvent protection by nucleotide binding appears
to supplement the reduction in HX caused by the
lowered solvent accessibility/conformational flexibil-
ity that is induced in these regions by phosphoryla-
tion. The differences seen in HX in the C-terminal
domain contact surface when comparing the ligand-
bound forms of JNK1β1 and p5JNK1β1 can thus be
attributed to the decreased exchange into unbound
p5JNK1β1 compared to JNK1β1, rather than dispar-
ities in solvent protection by ligand binding.
All of these regions contain amino acids that are
known across protein kinases to form direct interac-
tions with nucleotide substrates (see Ref. [23] for
review). These contacts are consistent with the
protein–ligand interactions that have been observed
in the co-crystal structure of AMP-PNP bound to
inactive JNK3 (PDB ID: 1JNK) [4]. To understand the
nature of the JNK1β1–nucleotide binding interface
suggested by the steric exclusion of bulk solvent
upon binding, we examined the HX results against
the JNK3-AMP-PNP/Mg2+ co-crystal structure. As it
is the only structure of JNK that has been solved in
the absence of a stabilizing inhibitory peptide (such
as a JIP1 peptide) and as the residues involved in
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Fig. 7. Patterns of altered HX in the active site of JNK1β1 and p5JNK1β1 upon AMP-PNP binding reflect differential
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3581Phosphorylation- and ATP-induced changes to JNK1β1ATP binding are conserved across the various JNK
isoforms [2], we feel that it best represents the native
conformation and interactions present in the ATP-
bound active site. This is primarily because the
inhibitors are well-known to drastically distort the
catalytic cleft such that ligand interactions are
disrupted [32]. Additionally, the crystal structures of
JNK1β1–AMP-PNP–inhibitory peptide ternary com-
plexes that have been solved [33] share similar
ligand binding characteristics with JNK3, supporting
the validity of using this co-crystal structure. None-
theless, significant differences may still exist be-
tween JNK3 and JNK1β1 with respect to the nature
of their individual interactions with ATP.
The hinge region, the catalytic loop, and the DFG
motif represented by the solvent-protected peptides
described above all form key contacts with
AMP-PNP within the C-terminal domain of inactive
JNK3 (see Supplementary Information for a detailed
description of these interactions). The comparable
decreases in deuterium incorporation at the C-
terminal domain side of the ligand–protein interface
upon AMP-PNP binding in JNK1β1 and p5JNK1β1
indicate that stable interactions between the nucle-
otide and the hinge region, the catalytic loop, and the
DFG motif occur in both inactive and active JNK1β1.
In contrast, the N-terminal domain half of the nu-
cleotide binding interface, particularly the Gly-rich
flap, displayed differences in protection from HX
by AMP-PNP binding between inactive and active
JNK1β1 (the potential interactions of nucleotide with
the N-terminal domain, as illustrated by JNK3, are
detailed in Supplementary Information). As solvent
protection of theGly-rich flap was exhibited to amuch
greater degree in the relevant peptides of p5JNK1β1, it
is implied that residues in the flap of the active kinase
establish more stable interactions with AMP-PNP
than the equivalent residues in inactive JNK1β1. The
finding that p5JNK1β1 is able to interact productively
with AMP-PNP at both N- and C-terminal domain
faces of the catalytic cleft, while unmodified JNK1β1
makes contact with the nucleotide predominantly
through the C-terminal domain, suggests that the
ATP-bound conformation of active, phosphorylated
JNK1β1 adopts interdomain interactions that lead to
greater domain closure when compared to its inactive
form.Discussion
By measuring the stability and HX behavior of
inactive and active JNK1β1 in solution, we provide the
first insight into the mechanisms by which phosphor-
ylation regulates the conformational dynamics of the
kinase to induce its activation. Complementary
studies with AMP-PNP/Mg2+-bound kinase revealed
a novelmode of nucleotide binding to the inactive form
of JNK1β1, validating the intriguing destabilizing effectthat nucleotide binding was shown to have on the
kinase and supporting the mechanisms of activation
proposed by the HX measurements of unbound
JNK1β1.
The interpretation of HX data can be assisted
greatly by atomic structural information. However,
while numerous X-ray structures of non-phosphory-
lated and inactive JNK1 have been published
(e.g., see Ref. [34]), a structure of the phosphorylat-
ed, active kinase has not yet been solved. Although
insufficient structural information exists to conclude
unambiguously that the changes in HX upon activa-
tion reflect changes in specifically the structure or
internal motions of the protein, our HX measure-
ments nevertheless describe the effects that phos-
phorylation and nucleotide binding have on the
conformational state of JNK1β1.
Initial HX analysis of JNK1β1 indicates slow-
exchanging core regions in both N- and C-terminal
domains, with higher degrees of HX in peripheral
elements such as loops and solvent-exposed
secondary structure. The regional patterns of HX in
JNK1β1 are thus consistent with its known tertiary
structure and, expectedly, are similar to the HX
patterns displayed by the inactive forms of both
ERK2 [9] and p38α [15]. It is unsurprising that
regional conformational flexibilities are conserved
among the MAP kinases given that they share a
well-conserved tertiary structure.
Phosphorylation-induced changes to the HX
patterns of JNK1β1 provide insight into its
activation mechanisms
HX experiments revealed that, upon phosphoryla-
tive activation of JNK1β1, significant changes to the
structure and/or internal motions occur in localized
regions of the protein that are associated with kinase
regulation, catalysis, and substrate binding. In-
creased HX in the Gly-rich flap upon activation likely
reflects increased flexibility that may enhance activity
by facilitating nucleotide binding or release, as
observed in PKA where flap flexibility is thought to
enhance the rate-limiting release of ADP [19,20]. The
hinge region also experienced enhanced HX, and
since it permits the interdomain closure required
for the formation of a functional active site in many
kinases, increased mobility here following phosphor-
ylation may facilitate this event [11]. Decreased HX
within the activation lip, the DFG motif, and the
catalytic loop is consistent with the structural
reconfiguration of the catalytic cleft into its active
conformation that is expected upon phosphorylation
of JNK1β1. It is probable that reducedmobility and/or
remodeling of the DFG motif is necessary for it to
assist in binding and correctly orienting the nucleo-
tide β- and γ-phosphates for phosphoryl transfer. The
extended peptide-substrate binding site (αF-αG,
strands β7-β8, and the loops between them) also
3582 Phosphorylation- and ATP-induced changes to JNK1β1showed reduced HX in active JNK1β1. Decreased
protein motions at the interface for docking-motif
recognition could contribute to kinase activation and
catalytic turnover by reducing the entropic cost of
substrate binding. A reduction in HX in helices αG-αH
and the intervening helices of the MAPK insert
indicates that it also undergoes a possible decrease
in mobility following activation. It is plausible that the
phosphorylation of the novel JNK1β1 phospho-sites,
T228 and S284, stabilizes these helices through their
capacity as helix-capping residues, which may affect
the binding of the potential regulatory proteins that
have been shown to interact with the MAPK insert in
other MAP kinases [29].
When comparing the patterns of regional HX of
JNK1β1 with ERK2 and p38α, we reveal both
similarities and significant differences. Expectedly,
the MAP kinases all display modifications in their
activation lip and DFG motifs upon phosphorylative
activation as a result of active-site remodeling. The
kinases additionally all exhibit decreased HX in the
extended peptide-substrate binding site formed by
the αF-loop-αG and β7-loop-β8 elements, at which
reduced conformational mobility may modulate
binding of substrate or regulatory proteins. Dispar-
ities in their response to phosphorylation begin at the
hinge and Gly-rich flap, where only JNK1β1 and
ERK2 share patterns of enhanced HX while p38α
remains unaltered. Interestingly, it is within the HX
behavior of the MAPK insert where the active MAP
kinases diverge the most. While activation leads to
enhanced HX in the MAPK insert of ERK2, the insert
of p38α shows no change. Conversely, the insert of
JNK1β1 experiences reduced HX following
phosphorylation.
The differences in the changes to HX in these
regions upon phosphorylation likely represent the
differences in the mechanisms by which each kinase
is activated. Firstly, modulating hinge flexibility in
ERK2 acts to regulate the interdomain closure
required for the creation of the active site [10,11], a
means of activation that we now propose to also take
place in JNK1β1 (as discussed below). In contrast,
p38α is known to remain in an open conformation
whether it has been activated by phosphorylation or
bound by ATP-competitive inhibitors [35,36]. Thus,
while increased hinge flexibility may be necessary
for the domain rotations associated with the activa-
tion of JNK1β1 and ERK2, structural constraints in
the hinge of p38α limit its flexibility and preclude
interdomain closure as a contributor to its state of
activity.
The opposing behaviors displayed by the MAPK
insert of each kinase reflect further dissimilarities in
the mechanisms contributing to their regulation.
Enhanced HX and mobility in the ERK2 insert has
been ascribed to the disruption of its interactions with
the activation lip as the lip undergoes activation-in-
duced remodeling, events that have been proposedto affect phosphorylation-dependent interactions
with other regulatory macromolecules [9]. We
hypothesize that the distinctive decrease in the
flexibility of the JNK1β1 insert implied by the reduced
HX is caused by the helix stabilizing ability of the
uniquely phosphorylated N-capping motifs. Phos-
phorylation at these novel sites of modification (T228
and S284 in JNK1β1) has not been found in other
members of the MAP kinase family, suggesting that
they could act to differentially shift the binding
free-energy landscape of active JNK1β1 to either
permit exclusive binding modes of common regula-
tory macromolecules to occur at the less dynamic
MAPK insert or stabilize the previously energetically
unfavorable binding of unique regulatory elements
that would otherwise not bind to the more flexible
inserts of ERK2 or p38α. Like most unique post-
translational modifications, these effects would
contribute to forms of phosphorylation-dependent
regulation of JNK1β1 that are distinct from the other
MAP kinases and thereby assist in mediating their
divergent functions.
All considered, the distinguishing HX behaviors
of JNK1β1, ERK2, and p38α reveal that, while the
patterns of solvent accessibility of their inactive
forms are well-conserved, the character of activatio-
n-induced changes in conformational mobility is not
fully conserved among MAP kinases despite the
enzymes being closely related in both sequence
and tertiary structure. We therefore echo previous
findings that closely related MAP kinases diverge
with respect to their constraints to activation, as well
as the phosphorylation-dependent regulation of the
internal motions that induce activation.
Steric protection of JNK1β1 by AMP-PNP
reveals that interdomain closure is required
for activation
Monitoring HX in the active site of AMP-PNP-bound
JNK1β1 and p5JNK1β1 revealed a novel mode of
nucleotide binding to inactive kinase that differs from
that of its active form. Patterns of decreased HX
following binding in each kinase form were, in part,
compatible with the steric exclusion of solvent
expected to take place at residues thought to interact
directly with the nucleotide. Both inactive and active
JNK1β1 exhibited solvent protection in the hinge
region, the catalytic loop, and the DFG motif. These
regions represent the C-terminal side of the active site
with which nucleotide has been shown to form
hydrogen bonds in co-crystal structures of AMP-PNP
bound to JNK3, PKA, and other kinases. The com-
parable HX between JNK1β1 and p5JNK1β1 in these
regions indicates that nucleotide forms binding
interactions to the C-terminal domain that are similar
in both inactive and active enzymes.
In contrast, disparities in the nature of nucleotide
binding to the N-terminal domain between JNK1β1
3583Phosphorylation- and ATP-induced changes to JNK1β1and p5JNK1β1 were revealed by the finding that only
active kinase displays reduced HX at its Gly-rich
flap, suggesting that AMP-PNP does not form stable
interactions with the N-terminal domain of inactive
JNK1β1. These results are surprising in that it has
been shown in many other kinases that ATP in-
teracts more productively with the N-terminal domain
Gly-rich “ATP-binding” flap than with the residues of
their C-terminal domain. This purportedly conserved
site of interaction has led to the bilobed structure of
kinases being characterized as comprising an
N-terminal “ATP-binding” domain and a C-terminal
“substrate-binding” domain [37]. Consistent with
this characterization, studies of steric protection
from HX in the MAP kinase ERK2 have revealed
that AMP-PNP binding protects both N- and C-ter-
minal domains of the nucleotide-binding pocket in
active kinase, whereas in the inactive ERK2 form,
AMP-PNP protects only the N-terminal domain [10].
While this suggested that ERK2 undergoes inter-
domain closure upon phosphorylation and ATP
binding, it illustrated that, in the open domain con-
formation of the inactive MAP kinase, the nucleotide
interacts more stably with the N-terminal domain.
Despite these findings and presumptions about
the nature of ATP binding to kinases, there is also
significant evidence indicating that the residues
within the N-terminal domain of the active-site cleft
of many kinases contribute less to nucleotide binding
than initially expected. Measuring the nucleotide
binding affinities and rates at which the γ-phosphate
group is transferred in several Gly-rich flap mutants
of PKA revealed that the flap functions primarily in
stabilizing the transition state required for phospho-
ryl group transfer, indicating that, oddly enough, it is
more important in facilitating catalysis than the
anchoring of either ATP or ADP (Refs. [38] and
[39] and see Ref. [23] for a review). Additional
mutagenesis studies of Lys72 in both human and
yeast PKA (Lys93 and Lys55 in JNK3 and JNK1β1,
respectively), a residue located within the N-terminal
domain that interacts with and stabilizes the α- and
β-phosphates of ATP (Fig. S5), indicated that its
primary function is also to enable phosphoryl group
transfer without affecting the binding of ATP [40].
Conservative substitutions of this highly conserved
Lys residue in Lck and ERK2 created mutant kinases
in which changes in ATP binding could not be de-
tected despite the proteins displaying drastically
reduced turnover numbers [41,42]. Perhaps most
relevantly, the affinities of adenosine, ADP, and ATP
for PKA have been found to be incredibly similar [38].
This suggests that the electrostatic interactions that
arise between the phosphate groups and residues
within either the N- and or the C-terminal domain of
the active site do not exist exclusively to reduce the
ground-state energy level of the ligand–enzyme
complex but instead to finely orient the γ-phosphoryl
group for nucleophilic attack.From the evidence mentioned above, it is clear that
the domain surface with which ATP interacts most
stably in the inactive form of kinases is functionally
unimportant, provided that, upon kinase activation,
conformational changes that allow the nucleotide to
form stable interactions with the catalytically relevant
residues in both N- and C-terminal domain halves of
the active site occur, thereby enabling phosphoryl
transfer. The finding that AMP-PNP interacts mini-
mally with the Gly-rich flap in unmodified JNK1β1 is
therefore not inconceivable, but it is compatible with
the kinase occupying an open conformation in its
inactive form. The simultaneous steric protection of
both N- and C-terminal domains of active kinase by
AMP-PNP then suggests that JNK1β1 adopts a
closed conformation following phosphorylation and
nucleotide binding.
Support for the apparent open conformation of the
domains of inactive JNK1β1 is provided by the ex-
amination of the JNK3–AMP-PNP co-crystal struc-
ture [4]. When compared to the canonical structure
of active PKA C-subunit, it was revealed that the
domains of JNK3 are rotated apart, resulting in the
misalignment of the two halves of the catalytic site.
While residue Lys93 of the N-terminal domain is
oriented similarly to its corresponding residue in
PKA, residue Asp189 in the catalytic loop and
residue Asp207 in the DFG motif of the C-terminal
domain are misaligned [4]. As the conserved Asp189
and Asp207 are thought to be critical for protein
kinase activity, their misalignment suggests that the
open conformation of the domains of JNK3 plays a
role in the low activity on the non-phosphorylated
form of the kinase.
Combining the HX data and comparing the
dynamic motions of inactive and active JNK1β1
with that of the studies of solvent accessibility in
their nucleotide-bound forms, we propose a model
explaining the differential HX protection of the
Gly-rich loop between JNK1β1 and p5JNK1β1. This
model sees that both JNK1β1 and p5JNK1β1 form
stable interactions with ATP/Mg2+ through the
C-terminal domain contact surface of the active site
(comprising the hinge, the DFG motif, and catalytic
loop) (Fig. 8). Interactions between ATP/Mg2+ and
the Gly-rich flap of the N-terminal domain are
transient in the inactive, non-phosphorylated kinase,
consistent with an open solution conformation in
which constraints in the hinge of the kinase prevent
domain closure. Upon phosphorylative activation,
we believe that an increase in the conformational
dynamics of the hinge reflects an increase in its
backbone flexibility that releases the constraints to
interdomain closure and provides the domains a
greater degree of freedom to rotate. The active
kinase is thus able to form interdomain interactions
that lead to greater domain closure, either prior to
nucleotide binding or as a result of contributions by
bridging interactions by the nucleotide itself, inducing
Fig. 8. Model describing the distinct patterns of steric protection from HX between JNK1β1 and p5JNK1β1 upon
AMP-PNP binding. The model proposes that AMP-PNP (ball-and-stick) interacts with the hinge and C-terminal domain
(the DFG motif and catalytic loop) of both JNK1β1 and p5JNK1β1, producing comparable patterns of solvent protection in
these regions between the inactive and active kinase forms. The lack of protection from HX in the Gly-rich loop of
unmodified JNK1β1 upon binding indicates that little interaction takes place between AMP-PNP and this region of inactive
kinase. Increased solvent protection and accordingly more stable interactions occur between nucleotide and the Gly-rich
loop of p5JNK1β1, likely as a result of interdomain closure made possible through the enhanced flexibility in the hinge
induced upon phosphorylation.
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(Fig. 8).We cannot however exclude the possibility of
models in which structural differences in the active
site between JNK1β1 and p5JNK1β1 cause differen-
tial hydrogen bonding interactions with ATP/Mg2+.
A similar proposition has been made for both p38γ
and ERK2, yet as described with respect to the latter,
AMP-PNP has been shown contrastingly to interact
more productively with the N-terminal domain of the
inactive, open form of this MAP kinase prior to the
interdomain closure that accompanies phosphoryla-
tion [10]. Even more divergently, the closely related
ERK1 displays HX behavior suggesting that hinge
flexibility is not regulated by activation and that both
inactive and active forms of this MAP kinase permit
domain closure and creation of a closed active site
upon nucleotide binding [14]. These findings reiter-
ate that these enzymes differ with respect to the
regulation of interdomain closure and their mecha-
nisms of activation although the related MAP
kinases are structurally similar.
A conserved active-site helix displays
activation-dependent changes in its response
to nucleotide binding
It has become evident that regulation via phosphor-
ylation-induced refolding of the activation loop incor-
porates conformational and/or dynamic changes in
other distinct structural elements distal from the
phosphorylation site. One such well-understood
element is helix αC, the only conserved helix in the
N-terminal domain and whose state is directly
associatedwith kinase activity. Inmost inactive kinasestructures, helix αC is displaced from its active
alignment largely as a rigid unit such that important
stabilizing interactions within the active site are
disrupted. For example, phosphorylative activation
of ERK2, cdk2, and InRK (andmany others) triggers a
distinct repositioning of helix αC so that the conserved
Glu (located at the center of the helix) is oriented
correctly to stabilize and form a salt bridge with the
conserved Lys (of strand β3) that interacts with the α-
and β-phosphoryl groups of ATP (see Ref. [23] for an
extensive review). Most active kinases have an intact
Glu-Lys salt bridge as a result of an aligned αC helix,
indicating that the formation of the dyad is a significant
contributor to the enhanced rateof phosphoryl transfer
that is incurred following phosphorylation. Although
mutagenesis studies have shown that substitutions at
the Glu residue creates mutant kinases with drasti-
cally reduced activity, it is important to note again that,
while the replacements resulted in a loss of coopera-
tivity in binding of cofactor and substrate, nucleotide
binding affinities were not affected [43]. This reiterates
the finding that residues in the N-terminal of the active
site may contribute more to catalysis than nucleotide
binding.
While the positioning of αC helix appears to be
critical for the functioning of most protein kinases, as
its displacement is nearly always involved in kinase
inactivation, the mechanism by which each kinase
repositions the helix is not conserved. The structural
changes in αC can be linked to the phosphorylation of
the activation residues through numerous interac-
tions, but its position has also been shown to be
affected by nucleotide binding. Additional HX studies
of PKAhave illustrated that binding of ADP is sufficient
3585Phosphorylation- and ATP-induced changes to JNK1β1to alter the environment of helix αC to display
decreased HX [44]. The finding by Resing and Ahn
that active MKK1 demonstrates increased mobility in
helix αC compared to its inactive form [45] further
attests to the dynamic flexibility of this helix in different
kinases and reveals that its behavior can depend on
both phosphorylation and nucleotide-bound state of
the kinase.
We found that, in JNK1β1, a C-terminal fragment of
helix αC containing the catalytic Glu73 experiences
a distinct increase in conformational mobility upon
AMP-PNP binding. This suggests that either nucle-
otide binding induces changes to the structure and/
or conformational mobility of the helix through the
interactions that exist between theC-terminal domain
of the active site and helix αC or the nucleotide
preferentially binds a conformer or native-like inter-
mediate species of JNK1β1 in which helix αC is
more flexible or oriented such that it is more solvent
exposed. The potential conformational selection and
stabilization of an intermediate state was suggested
initially in the equilibrium unfolding experiments by a
much greater signal produced by the first intermedi-
ate when compared to unbound JNK1β1 (Fig. 2).
In the inactive form of JNK1β1, the orientation of
helix αC may place catalytically relevant/irrelevant
residues into unknown positions that have enthalpi-
cally unfavorable binding energies to nucleotide,
thus causing subtle structural shifts and/or enhanced
conformational mobility to occur in helix αC upon
ATP binding that produces a favorable contribution
to entropy. Energetically unfavorable ATP binding
and the resulting distortions of the phosphate groups
and of active-site residues from catalytic geometries
is a common means of kinase inactivation [43].
With respect to the alternative possibility of confor-
mational selection by nucleotide (preferential binding
to one of the ensemble of exchanging protein
conformers in equilibrium), helix αC may first need
to adopt a less rigid structure prior to ATP binding to
reduce the local entropic penalties of association.
This may be necessary because the proposed open
conformation of the inactive kinase permits less
favorable contributions to enthalpy upon binding as a
result of the nucleotide being able to interact with only
a single side of the active site. A protein conformer
with a more flexible αC helix may also allow the
transient opening of the Gly-rich flap thought to be
necessary for access to the nucleotide-binding
pocket, an effect possibly transmitted through strand
β3 with which each structural element interacts. The
catalytically relevant Glu73 is also situated in the
segment of helix αC that undergoes increased HX in
inactive JNK1β1 following nucleotide binding, sug-
gesting that the changes in this region may hold or
further displace Glu73 away from its catalytically
aligned orientation, preserving the kinase in its
inactive form until it is activated by phosphorylation.
In support of these suggestions, Vogt and Di Cerahave recently argued that this form of conformational
selection can in fact account for the behavior of
almost all ligand binding events [46].
The R72-L76 fragment of helix αC in p5JNK1β1
experiences a much smaller increase in HX upon
nucleotide binding when compared to unmodified
JNK1β1. While the presence of AMP-PNP may
cause increases to the conformational mobility of
helix αC in p5JNK1β1 in a manner similar to that
proposed for non-phosphorylated kinase, the ex-
pected repositioning of the helix into catalytic
alignment following activation is also likely to
stabilize it through the catalytically important inter-
actions that arise (such as the newly formed Glu73–
Lys55 dyad, as well as their interaction with the α-
and β-phosphates of AMP-PNP). The changes to
helix αC that are triggered by nucleotide in JNK1β1
may therefore also occur in p5JNK1β1 but would
take place to a much lesser degree.
Regardless of the means by which the enhanced
flexibility of helix αC arises in nucleotide-bound
JNK1β1 and p5JNK1β1, it is highly probable that it
disturbs the network of interactions that extend from
the helix throughout the core of the N-terminal
domain and into the Gly-rich flap. As the helix is
the only major structural element that has a marked
increase in its conformational mobility upon nucleo-
tide binding, it is likely to be the main source of the
destabilization observed in AMP-PNP-bound kinase.
The enhanced dynamic motions in helix αC could be
coupled by a network of contacts to the N-terminal
β-sheet and helix αL16, inducing a “loosening” of the
internal structure of the entire N-terminal domain.
The dynamics of the individual structural elements
may not increase significantly enough to be detected
unambiguously by the HX experiments, but in com-
bination, they conceivably decrease the overall
stability of the domain.
Since the N-terminal domain of the active kinase
provides catalytically important interactions with ATP,
increased dynamics in this domain of p5JNK1β1 upon
nucleotide binding could enable the conformational
changes that take place during phosphoryl transfer
and ADP release. Again, the finding that ADP release
is the rate-limiting step during catalysis in PKA sup-
ports this hypothesis [47]. Activation-induced in-
creases in the conformational mobility of domains
are not uncommon in protein kinases. For example,
phosphorylation of InRK destabilizes the kinase
toward guanidine-induced unfolding [48], while HX
experiments in MKK1 indicates that its N-terminal
domain becomes more flexible following phosphory-
lative activation [45].
In an independent publication, we will be exploring
the implications of the conformational stability pa-
rameters (ΔG°H2O and m values) measured for the
formation of each observed intermediate in terms of
the stabilizing or destabilizing effect that nucleotide
binding and phosphorylation has on each species, all
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in the activation and catalytic functioning of JNK1β1.
Nevertheless, our findings indicate that nucleotide
alone can induce far-reaching structural effects that
include altering the position and/or conformational
dynamics of a critical active-site helix, and in doing
so, it reduces the thermal, conformational, and kinetic
stability of the kinase. Further studies will be required
to fully understand the mechanisms by which binding
triggers these events or their exact functional rele-
vance, but since similar effects of nucleotide binding
on helix αC have been reported in other kinases,
including PKA [44], this behavior is not a completely
isolated or unique phenomenon.
Conclusion
The effects of nucleotide binding on the stability of
JNK1β1, as well as the associated patterns of solvent
protection and/or changes in protein mobility, corre-
spond to a novel mode of ATP binding that is, in some
part, incompatible with what we think we understand
about the nature of binding and of the sites that
inactive kinases use tomake contact with nucleotides.
The JNK1β1 HX data are nonetheless consistent with
the prevailing model for protein kinase activation in
which interdomain closure through rotation of the
N-terminal domain with respect to the C-terminal
domain produces a functional active site. However,
nucleotide-dependent destabilization and the con-
comitant detection of enhanced HX in a conserved
active-site helix within the interface between the two
domains revealed that the model for the activation of
JNK1β1 is much more intricate. In the inactive form of
JNK1β1, nucleotide may possibly select for a kinase
conformation inwhich the domains aremoreopenand
the N-terminal domain is transiently destabilized,
preventing the domain from forming a more stable,
catalytically functional structure until the kinase is
phosphorylated. Ultimately, it is clear that there exists
complex and unique interplay between the effects of
phosphorylation and nucleotide substrate binding for
the regulation of JNK1β1 activity.
Materials and Methods
Expression, purification, and phosphorylation of
JNK1β1
Overexpression and purification of JNK1β1 from
Escherichia coli and preparation of its non-phosphorylated
and fully phosphorylated forms were achieved as previ-
ously described [16].
Spectroscopic measurements
Fluorescence emission spectra were measured in
triplicate with a Jasco FP-6300 fluorescence spectropho-tometer at 20 °C, using an excitation wavelength of 280
and 295 nm. Far-UV circular dichroism measurements
were recorded using a Jasco J-810 circular dichroism
spectropolarimeter and represent an average of 10
accumulations. Measurements were performed at 20 °C
with 2 μM JNK1β1 in “Characterization Buffer” [10 mM
Tris–HCl buffer, pH 8.0, comprising 150 mM NaCl, 1 mM
DTT, and 0.02% (w/v) NaN3] for both methods. All spectra
were corrected for solvent. Circular dichroism data were
averaged and normalized by calculating the mean residue
ellipticity, [θ] (degrees square centimeters per decimole)
using the equation:
θ½  ¼ 100θ
Cnl
where θ is the measured ellipticity (millidegrees), C is the
protein concentration (millimolar), n is the number of
residues in the protein, and l is the path length (centimeters).
Stability studies
Temperature-induced unfolding
Temperature-induced denaturation of protein was mon-
itored by measuring the amount of α-helical structure
present using ellipticity at 222 nm, employing a Jasco
J-810 circular dichroism spectropolarimeter over a tem-
perature range of 20–95 °C. Thermal unfolding profiles
were recorded using 5 μM JNK1β1 in Characterization
Buffer, both with and without the addition of 1 mM
AMP-PNP and 10 mMMgCl2 (protein solutions with ligand
added were pre-equilibrated at 20 °C for 30 min before
unfolding to allow binding). The temperature was increased
at a rate of 1 °C/min, which was controlled by a Jasco
PTC-423S Peltier-type temperature control system. The
temperature unfolding profiles were performed in triplicate,
averaged, and normalized by converting the data to mean
residue ellipticity. To describe the thermal unfolding
profiles, we calculated lines of best fit using SigmaPlot
v11.0 (SPSS Science, Chicago, IL, USA).
Urea-induced equilibrium unfolding and refolding
Equilibrium unfolding experiments were performed by
incubating 1 μMprotein (in Characterization Buffer) with 0–
9 M urea, either with or without the addition of ligand (1 mM
AMP-PNP and 10 mM MgCl2). Refolding and reversibility
experiments were conducted by diluting 10 μM protein
unfolded in 8 M urea (with and without ligand added) to
1 μM containing 0.8–7.9 M urea. After allowing the
solutions (prepared in triplicate) to equilibrate for 30 min
at 20 °C, we monitored the changes to the global structure
of JNK1β1 that occur upon unfolding and refolding using
three different probes: (i) fluorescence spectroscopy
to monitor the tertiary structure (λex = 280 nm and λem =
310–347 nm), (ii) far-UV circular dichroism at 222 nm to
monitor the secondary structure, and (iii) ANS binding to
monitor the environment of the proposed ANS binding sites
determined in this study (see Fig. S1). Measurements of
ANS binding were conducted by adding 200 μM ANS to
protein unfolded in 0–9 M urea and determining the
fluorescence of ANS excited at 390 nm and emitting at
475 nm. To ensure the absence of aggregation during
unfolding and refolding experiments, we monitored
3587Phosphorylation- and ATP-induced changes to JNK1β1Rayleigh scattering by setting both excitation and emission
wavelengths at 340 nm. Fluorescence and circular dichro-
ism equilibrium unfolding data were globally fit [49] to a
four-state monomer model (N ↔ I ↔ I2 ↔ U) using the
linear extrapolation method [50] provided by Savuka
version 6.2.26 [51] to calculate the conformational stability
parameters, ΔG°H2O (free energy of unfolding in the
absence of urea, in kilocalories per mole) and m value
[cooperativity factor (kcal mol−1 M−1)].
Urea-induced unfolding kinetics
Unfolding kinetics data were measured by intrinsic
fluorescence at 20 °C using a stopped-flow mixing
instrument with a 2-ms dead time (Applied Photophysics
SX-18MV). Protein was excited at 280 nm, and the
emission was monitored using a 320-nm-longpass filter.
JNK1β1 in characterization buffer was diluted 6-fold with
urea in buffer, producing a final protein concentration of
0.4 μM in 7.8–8.3 M urea. For ligand-bound protein
unfolding experiments, 1 mM AMP-PNP and 10 mM
MgCl2 were added to both urea and protein solutions
and allowed to equilibrate prior to unfolding. No less than
three kinetic traces were recorded and averaged at each
urea concentration, which were then analyzed and fit to a
triple exponential equation by the nonlinear least-squares
method using the Applied Photophysics software version
4.47. The dependence of the observed rate constants on
urea concentration was fit to the equation:
logku ¼ logkH2Ou þ
m‡u urea½ 
2:303RT
where ku is the observed unfolding rate constant, k
H2O
u is
the unfolding rate constant in the absence of urea, and mu
‡
is the m value for the unfolding of the native state to form
the transition state.
Hydrogen–deuterium exchange mass spectrometry
To conduct the HX reactions, we diluted 15 μL of
unmodified or phosphorylated JNK1β1 at a concentration
of 2.8 mg/mL [in 20 mM phosphate buffer (pH 7.8) with
150 mM NaCl, 1 mM DTT, and 0.02% NaN3] with 35 μL of
100% D2O at 20 °C for 10, 30, 100, 300, or 3000 s before
the simultaneous quenching of exchange and proteolysis
of the protein. Ligand-bound protein exchange reactions
were conducted similarly, except that 1 mMAMP-PNP and
10 mM MgCl2 were added to both D2O and protein
solutions. An equal volume (50 μL) of ice-cold quench
buffer [20 mM phosphate buffer (pH 2.2) with 150 mM
NaCl, 1 mM DTT, and 0.02% NaN3] containing 4 M
guanidinium chloride and 0.5 mg/mL pepsin (Sigma) was
added to the reaction buffer. A fully deuterated control was
achieved by allowing deuteration to occur overnight, while
a non-deuterated control experiment was performed by
replacing the D2O with MilliQ H2O. Proteolysis was
allowed to proceed for 5 min on ice upon addition of the
quench buffer, after which the samples were injected
onto an Aeris PEPTIDE 3.6-μm XB-C18 RP column
(Phenomenex) that was submerged in ice and coupled to
an AB SCIEX QSTAR Elite mass spectrometer. Peptides
were eluted at a rate of 300 μL/min with a linear acetonitrile
gradient (5–95%) over 15 min. Collision-induced dissoci-ation was performed for the initial identification of peptides,
while all subsequent samples were analyzed in MS mode.
MS resolution was in the range 13,000–15,000 full width at
half maximum, and all exchange reactions were performed
at least in duplicate. PEAKS 6 (Bioinformatics Solutions,
Inc.) was used to sequence the initial peptide pool, and
HDExaminer 1.3 (Sierra Analytics) was used to process
the deuterium exchange data. Statistically significant
differences in deuteration behavior between the JNK1β1
forms were established by calculating a Student's t-distri-
bution at a 95% confidence level using all of the replicates
and charge states available.Acknowledgment
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Fig. S1. ANS binding to JNK1β1 and p5JNK1β1. (A) Emission spectra of ANS bound to JNK1β1 (green) 
and p5JNK1β1 (blue) indicates that the dye interacts similarly with the inactive and active form of the 
native kinase (the emission spectra display equivalent increases in fluorescence intensity and 
hypsochromic shifts relative to free ANS in grey), but the dye does not interact with their unfolded states 
(left panel). Although we do not yet fully understand the nature or location/s of the JNK1β1-ANS 
interaction, the finding that the presence of AMP-PNP/Mg2+ (+A/M) does not affect ANS binding 
(indicated by the overlaying ANS emission spectra shown in the right panel), reveals that the dye does not 
interact within the active site of the kinase. (B) In silico molecular docking of ANS to determine potential 
sites at which the dye interacts with JNK1β1. ANS was docked to the crystal structure of JNK1β1 (PDB 
entry 2SX0) using AutoDock Vina 1.1.2 [1] to perform the docking calculations. Polar H-atoms were 
computed and added to JNK1β1 using AutoDock Tools 1.5.6 [2] prior to performing the docking 
calculations. The search space comprised a large, XYZ-coordinates aligned box with margin sizes of 54 Å 
(X) × 64 Å (Y) × 88 Å (Z) that encompassed the entire protein. The exhaustiveness of the search was set to 
20, whilst all other parameters were kept at their default values. ANS was allowed to be fully flexible with 
all bonds rotatable, while JNK1β1 was treated as rigid during docking. To evaluate the interaction of the 
flexible ligand with the protein and identify its putative binding modes, the resulting docked structures 
were ranked according to their calculated docking energies and inspected. Four potential sites of 
interaction were identified. 
A 
B 
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Fig. S2. Residual plots for the fits to the thermal (A) and kinetic (B) unfolding data of the 
apo and AMP-PNP/Mg2+ bound forms of JNK1β1 and p5JNK1β1. The residuals show 
excellent fits to the unfolding data illustrated in Figure 2. 
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(Figure S3 continues onto the next page; see page viii for its legend) 
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(Figure S3 continues onto the next page; see page viii for its legend) 
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Fig. S3 (Page 5 of 5). Complete urea-induced equilibrium unfolding analysis of the apo 
and nucleotide bound forms of JNK1β1 and p5JNK1β1. 
(A) Confirming that the unfolding process of the JNK1β1 forms attain equilibrium and do not 
exhibit unfolding-refolding hysteresis (allowing definition of the thermodynamic 
parameters, ΔG°H2O and m-value, for the structural transitions), the equilibrium unfolding 
and refolding pathways were coincident and thus reversible when monitored by both 
circular dichroism (top panel) and fluorescence (middle panel). The native states were also 
completely recoverable once they had been unfolded in urea, as the insets show that both 
the circular dichroism and fluorescence spectra of the refolded proteins, recovered upon 
dilution of the denaturant, overlay with the spectra of the native states. The lack of protein 
aggregation was determined using fluorescence scatter at 340 nm (bottom panel). Data 
points are an average of three replicates. 
(B) The complete set of fluorescence emission spectra (λex of 280 nm) for the protein unfolded 
in the various urea concentrations, illustrating that there is both a significant decrease in 
fluorescence intensity and a ±13 nm shift in λmax when JNK1β1 is unfolded in urea. 
(C) Varying degrees of ANS fluorescence during urea-induced unfolding of the JNK1β1 forms 
indicate that ANS binds differentially to the kinases as they unfold, reaffirming that various 
and distinct intermediate species with solvent exposed hydrophobic patches exist along 
their unfolding pathway. The data are an average of three replicates and were corrected for 
the contribution of free ANS in buffer. Scatter data indicates that the ANS binding peaks 
were not due to protein aggregation occurring along the unfolding transition (bottom 
panel). 
(D) Global fitting of equilibrium unfolding data obtained using fluorescence and circular 
dichroism. The unfolding data that were analyzed were monitored using intrinsic 
fluorescence intensity (λex of 280 nm) at 310 nm (blue - F310), 320 nm (red - F320),  
330 nm (orange - F330), 334 nm (purple - F334), 337 nm (cyan - F337), and 347 nm  
(grey - F347), as well as by mean residue ellipticity at 222 nm (green - E222) (all presented 
in the top panel). Additional data derived from the fluorescence spectra, including the 
ratios of unfolded to folded protein (brown - F347/330, and light grey - F347/337) and the 
intensity averaged emission wavelength (black - IAEW, calculated using the equation:  
IAEW = Σλi×Fi/ΣFi, where λi is the wavelength and Fi is the fluorescence intensity), were 
also analyzed (bottom panel). Buffer-corrected data were plotted as the average of  
3 replicates, and were globally fit using Savuka v. 6.2.26 [3]. The lines represent the best fits 
of the four-state model to the data. 
(E) Light scatter data indicated the lack of protein aggregation (top panel), whilst residual plots 
for the fits of each of the data sets used for global analysis of equilibrium unfolding indicate 
good fits to the data. 
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Fig. S4 (Page 4 of 4). Complete HX-MS analysis, illustrating the deuteron uptake plots for 
each of the peptides identified for apo and AMP-PNP/Mg2+ bound JNK1β1 and p5JNK1β1. 
Peptides are labelled by their residue numbers, as well as by their corresponding amino acid 
sequence. The kinase forms are indicated as follows: JNK1β1 in green, p5JNK1β1 in blue,  
JNK1β1+AMP-PNP/Mg2+ in orange, and p5JNK1β1+AMP-PNP/Mg2+ in red. Lines are guides for 
the eye only. Error bars indicate the standard error of the mean of at least 3 independent 
experiments, and many error bars are smaller than the symbol used.  
- Supplementary Figure S4 - 
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SUPPLEMENTARY INFORMATION 
The interactions of AMP-PNP/Mg2+ nucleotide substrate within the active site of 
inactive, non-phosphorylated JNK3 
The N6 and N1 atoms of the adenine base of the nucleotide interact with backbone elements 
of both Glu147 and Met149 (Figure S5), corresponding to Met109 and Glu111 in JNK1β1, 
located within the hinge and its preceding strand β5. The side chain of Asn152 and the 
carbonyl group of Ser193 (Asn114 and Ser155 in JNK1β1) situated in strand βL5 and the 
catalytic loop, respectively, from a hydrogen-bonding network to the O2′ and O3′ hydroxyls 
of the ribose sugar. Many other hydrogen bonds, both direct and indirect, are formed between 
the triphosphate group and residues found in the C-terminal domain half of the active site. 
Like most kinases, the JNK-ATP complex also requires two magnesium ions (M1 and M2) 
for functional binding. In JNK3, M2 make contact with the side chain of Asn194 (Asn156 in 
JNK1β1) within the catalytic loop, allowing it to bridge the oxygens of the α- and γ-
phosphoryl groups of AMP-PNP, while M1 interacts via a water molecule with the 
carboxylate oxygens of Asp207 (corresponding to Asp169 in JNK1β1) of the DFG motif, 
allowing it to chelate the β- and γ-phosphoryl group oxygens (Figure S5). M1 also interacts 
with the carboxylate oxygen of Glu111 (Glu73 in JNK1β1) located in helix αC via an 
additional water molecule, chelating the β- and γ-phosphate groups in assistance to Asp207. 
The main chain amide and side chain carbonyl oxygen of Gln75 (Gln37 in JNK1β1) in the 
Gly-rich flap, as well as the side chain amine of the conserved Lys93 (Lys55 in JNK1β1) of 
strand β3, interact with the β- and α-phosphate oxygen atoms, respectively (Figure S5). 
According to this JNK3–AMP-PNP co-crystal structure [4], the nucleotide is thus predicted 
to interact with the Gly-rich flap of inactive JNK3. Our HX measurements reveal however 
that interactions between these elements within inactive JNK1β1 do not occur stably in 
solution, or, at most, occur only transiently. JNK3 may then differ from JNK1β1 in the extent 
to which interdomain closure occurs in its inactive form, perhaps with JNK3 possessing a 
more closed active site that allows AMP-PNP to interact productively with both the N- and 
C-terminal domains. This is conceivable given the diversity seen in the constraints to 
activation among the closely related isoforms of other MAP kinases. Alternatively, the 
structure of the JNK3–AMP-PNP co-crystal might be complicated by crystal packing defects 
that may distort the conformation of the active site and misrepresent the solution structure of 
the kinase. Furthermore, since X-ray structures represent only one of the energetically 
favourable conformations the protein can occupy in solution, the potentially greater stability 
of a closed domain conformation may prevent crystallography from detecting an average 
open solution conformation.   
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Fig. S5. The nucleotide-bound active site of JNK3. The residues of JNK3 that interact via hydrogen bonds 
and electrostatic forces with the ATP analogue, AMP-PNP, within the active site of inactive (non-
phosphorylated) JNK3 are illustrated. The two essential divalent metal ions, Mg2+, required for the 
coordination of the phosphoryl oxygen atoms of AMP-PNP are labelled M1 and M2 (A & B) and 
represented by orange spheres (B). The water molecules involved in the indirect hydrogen bonds formed 
between selected residues and AMP-PNP are indicated by W1 and W2 (A & B), and shown as cyan spheres 
(B). (A) A schematic representation of the binary complex formed between AMP-PNP (green) and non-
phosphorylated JNK3 (PDB entry 1JNK [4]). Hydrogen bonds and electrostatic interactions are 
represented by blue and red dotted lines, respectively, yet are not drawn to scale. (B) A three-
dimensional representation of the binary complex, in which the relevant interactions are indicated by 
green dashed lines. Oxygen, nitrogen, and phosphorus atoms are shown in red, blue, and green, 
respectively. 
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CHAPTER 5 
GENERAL DISCUSSION 
The improper or unregulated activation of the JNK signalling pathway has been discovered in 
several diseases, providing the justification for targeting this MAPK pathway for rational 
drug design. For example, the erosion of cartilage and bone associated with rheumatoid 
arthritis is induced by the excessive production of matrix metalloproteinases, a process that is 
mediated by the activation of AP-1 through the JNK signalling cascade [60-62]. The JNK 
pathway is also over stimulated in the susceptible neurons of individuals with Alzheimer’s 
disease, implicating the MAPK in the pathophysiology and pathogenesis of the disease  
[63-66]. Moreover, the JNKs have been shown to be important mediators of insulin resistance 
and obesity, and have thus been proposed as possible targets for type II diabetes [31,67,68]. 
Although a number of JNK inhibitors targeting its inactive form have already been 
discovered [69], if we hope to find medical benefit in the therapeutic regulation of JNKs and 
potentially develop effective therapies against the diverse array of its associated diseases, we 
first need to understand the mechanisms by which JNK becomes activated. Since the effects 
that activation has on the structure, stability, and dynamics of the MAPK have not yet been 
elucidated, this investigation sought to characterise the changes that take place upon 
phosphorylation of the most abundant JNK isoform, JNK1β1. 
5.1. Implications for the possible co-translational phosphorylation of JNK1β1 
Previously, the soluble overexpression and efficient purification of the JNK isoforms for 
subsequent study had been notoriously difficult, with the various strategies used in attempt to 
acquire large yields of highly pure kinase proving to be largely unsuccessful [70]. Aiming 
then to first improve the soluble overexpression of JNK1β1, this study illustrated that by 
harmonising the codon usage frequencies of its open reading frame to those of the E. coli 
expression host (codon usage harmonisation), in combination with its expression as a fusion 
protein with the highly soluble GST as well as by altering the kinetics of its folding by 
reducing the cultivation temperature, large quantities of soluble JNK1β1 could be expressed 
(Chapter 2, [71]). 
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This effective and novel JNK1β1 expression strategy resulted however in unexpected and 
highly significant consequences to the modification state of the kinase post translation. It was 
revealed that under these expression conditions, JNK1β1 is partially activated by 
phosphorylation at five distinct sites in E. coli, an environment lacking the eukaryotic kinases 
thought necessary for its phosphorylative activation. These phospho-sites comprised the 
canonical T183 and Y185 activation residues, S377 (a previously recognised yet 
uncharacterised phospho-site), in addition to T228 and S284 (novel phospho-residues) 
(Chapter 3, [72]). The significance of these phospho-residues and the fact that they are not 
random artefacts of the recombinant expression of JNK1β1 became clear when the identical 
sites (following their complete dephosphorylation) were found to be phosphorylated in vitro 
by active MKK4 (Chapter 3, [72]). 
After excluding the possibility of post-translational phosphorylation occurring in any form 
during expression, this study suggested that the unique yet natural kinetics of translation and 
folding of JNK1β1 imparted by the codon harmonisation facilitates the phosphorylation 
events that are proposed to take place during co-translational folding. Whether catalysed by 
co-translational trans auto-phosphorylation or by eukaryotic-like endogenous E. coli protein 
kinases, the systematic, “co-folding” phosphorylation of JNK1β1 in E. coli appeared to 
mimic the events that occur in its natural human host environment (Chapter 3, [72]). It has 
been established that altering the rate of production and folding of a protein can influence its 
degree of phosphorylation [73], and it indeed appears that JNK1β1 has a predisposition to be 
phosphorylated during co-translational folding when the kinetics of its translation are at their 
natural rate. It is therefore conceivable that during the natural expression of JNK1β1 in 
human cells, active MKK4 (and perhaps other modifiers of JNK1β1) recognises and interacts 
with the specific phosphorylatable motifs of JNK1β1 during its translation and subsequent 
folding (Figure 8), in a manner not unlike the events that were detected in E. coli. 
Alternatively, fully folded and native JNK1β1 could possibly act upon the partially folded 
phosphorylatable motifs of newly synthesised JNK1β1 polypeptides in a co-translational 
trans auto-phosphorylation process (Figure 8). In this case, JNK1β1 could either be 
unmodified, or previously activated through phosphorylation by MKK4 or the 
aforementioned co-folding auto-phosphorylation process in a positive feedback loop  
(Figure 8).  
  
CHAPTER 5 – GENERAL DISCUSSION 
30 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. Possible means by which JNK1β1 may become phosphorylated in human cells. Evidence 
suggests that either active MKK4 or native, fully-folded JNK1β1 (unmodified or previously 
phosphorylated) is able to phosphorylate the nascent JNK1β1 polypeptide as it grows and folds  
co-translationally (grey arrows). Active MKK4 is also able to phosphorylate either unbound or ATP-bound 
native JNK1β1 post-translationally (black arrows).  
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Co-translational modification of nascent polypeptides is a well-documented phenomenon. 
Insights into the process have been gained predominantly through the study of secretory and 
membrane proteins, which undergo extensive co-translational glycosylation. Glycosylation 
represents a largely conserved protein modification that many mammalian cells employ  
co-translationally to facilitate the correct folding, processing, assembly, trafficking, and thus 
functioning of non-cytosolic proteins [74,75].  
Mechanisms of co-translational modification of cytosolic proteins are however less 
understood. Nonetheless, phosphorylation during translation has recently been found to be 
important regulatory events in the cellular functioning of many kinases, including Akt and 
PKA. mTOR has been shown to mediate the constitutive phosphorylation of specific residues 
of Akt during its translation, modifications that enable the correct co-translational folding of 
the nascent Akt  polypeptide [76]. These phospho-residues are thus critical for the newly 
synthesized kinase to attain its proper conformation, where after they are required for its 
subsequent maturation and stability [76]. Within PKA, cis auto-phosphorylation of the C-
terminal Ser338 residue occurs co-translationally, an event that precedes and is a prerequisite 
to the activating post-translational auto-phosphorylation of the activation lip Thr197 [77]. 
Phosphorylation of Ser338 is also essential for the processing, maturation, and solubility of 
PKA, as the kinase is prone to aggregation in the absence of the modification [77]. 
Given that phosphorylated JNK1β1 was detected in large quantities only in the soluble cell 
fraction after recombinant overexpression (Chapter 2, [71]), it is possible that co-translational 
phosphorylation of one or more of the newly identified (non-activation lip) phospho-residues 
may occur in human cells to promote the correct folding, solubility, and stability of JNK1β1 
in a means similar to Akt and PKA. The finding in this study that phosphorylation 
significantly stabilises JNK1β1 lends support to this possibility (Chapter 4, [78]). Indeed, the 
decrease in the flexibility of critical α-helices and the C-terminal domain as a whole upon 
phosphorylation of JNK1β1 appeared to be contributed to by the phosphorylation of the novel 
phospho-sites, T228 and S284 (Chapter 4, [78]). 
With respect to the recognised phosphorylation of fully-folded, native JNK1β1 by active 
MKK4, it is probable that MKK4 would interact with and phosphorylate the nucleotide 
bound form of inactive JNK1β1. Although they may possess different affinities for ATP, if 
active MKK4 is to be bound by nucleotide in preparation for phosphorylating JNK1β1, it 
follows that the MAPK would also bind an ATP molecule from the pool of nucleotide 
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substrate likely to be in the vicinity of the two kinases. The concurrent binding of individual 
ATP molecules to both MKK4 and JNK1β1 may be a critical factor contributing to the 
efficient phosphorylation of the latter, because the presence of nucleotide significantly 
destabilises inactive JNK1β1 (Chapter 4, [78]). The accompanying increase in the dynamics 
and conformational mobility of JNK1β1 upon nucleotide binding may allow enthalpic 
contributions to the formation of the MKK4–JNK1β1 complex to be enhanced; a more rigid 
structure may either exclude kinase conformations that allow selective interactions to form, 
or may not allow interactions that could arise through an induced-fit mechanism.  
The destabilising effect that nucleotide has on JNK1β1 could thus also function to promote 
the binding of the kinase to MKK4, thereby increasing the catalytic turnover of JNK1β1 
phosphorylation. 
5.2. Mechanisms contributing to the activation of JNK1β1 upon phosphorylation 
This study details the distinct changes in the stability and dynamics of JNK1β1 that take 
place upon both nucleotide binding and/or phosphorylation, providing insight into the 
mechanisms by which the kinase is activated. Firstly, the increased flexibility in the Gly-rich 
flap implied by the enhanced rate of hydrogen-deuterium exchange following 
phosphorylation reflects that which occurs in PKA, where high mobility in the corresponding 
flap is hypothesized to facilitate both ATP binding and the rate-limiting release of ADP 
product [79,80]. Additionally, the increased motions in the backbone of the hinge observed 
upon JNK1β1 activation, likely provides the flexibility required for the domain closure that 
occurs when nucleotide binds to the active form of the kinase, detected during HX protection 
studies using AMP-PNP. The effects of nucleotide binding and phosphorylation on JNK1β1 
are summarised in Figure 9. 
It is uncertain at present whether phosphorylation alone can induced any degree of domain 
closure without ATP binding, or if the presence of nucleotide within the active site cleft 
causes the rotation of the domains after the restraints to closure are removed by 
phosphorylation. The increased HX accompanying enhanced flexibility in the Gly-rich flap 
observed in the active form of unbound JNK1β1 could prevent the detection of any potential 
decreases in HX at the domain interface that would accompany domain closure. Nevertheless, 
the finding that AMP-PNP simultaneously protects residues in both the C-terminal domain 
and the Gly-rich flap in p5JNK1β1 indicates that, at the very least, active kinase adopts a 
closed domain conformation around nucleotide upon binding (Figure 9). 
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Figure 9. Summary of the major changes to JNK1β1 that occur upon nucleotide binding and/or phosphorylative activation. The open or closed state of the N- and 
C-terminal domains, as well as the effects to the structure and conformational flexibility of key kinase elements are indicated. Features common to specific forms of the 
kinase are stated. 
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The patterns of protection from HX observed when nucleotide is bound to active JNK1β1 are 
consistent with the closed domain conformation of co-crystal structures of ATP/ADP bound 
PKA (Figure 10). Similarly, the limited interactions detected between the Gly-rich flap and 
AMP-PNP in unmodified JNK1β1 are consistent with the open domain conformations 
observed in structures of unbound PKA (Figure 10) [81]. Although the catalytic subunit of 
PKA is constitutively active in the absence of its N-terminal regulatory subunit (in contrast to 
JNK1 and the other MAP kinases), the domain closure required for the formation of the 
active site is thought to be triggered by binary complex formation with nucleotide substrate 
[79,82,83]. These structures can thus be used in example to demonstrate the structural 
changes associated with the proposed JNK1β1 domain closure and the relative positions of its 
N- and C-terminal domains in their open and closed conformations (Figure 10). The dynamic 
and responsive nature of the two kinase domains and the Gly-rich flap can be further 
demonstrated by examining the co-crystal structure of PKA bound to ADP-AlF3  
(PDB: 1L3R) (Figure 10). This structure mimics the kinase reaction transition-state and 
represents the structural changes that the protein is likely to undergo during catalysis [84], 
emphasising the dynamic properties of these kinase conformers. 
 
 
 
 
 
 
 
 
Figure 10. Crystal structures of the catalytic subunit of PKA in various forms, illustrating the 
conformational changes accompanying kinase domain closure and catalysis. Unbound PKA (PDB 
code: 1J3H) [81], adenosine-bound PKA (1BKX) [79], and the transition-state mimetic, ADP-AlF3 bound 
form of PKA (1L3R) [84] were structurally fit using Swiss-Pdb Viewer [85]. The Gly-rich flap and helix αB 
of the PKA forms are coloured blue (1L3R), green (1BKX), and red (1J3H) to demonstrate the closure of 
the domains and changes to the dynamic flap that occur during nucleotide binding and catalysis. The 
position of ADP in the closed domain conformation of PKA is indicated (orange ball-and-stick structure). 
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5.2.1. Functional implications for nucleotide-binding induced destabilisation of JNK1β1 
JNK1β1 was found to experience significant destabilisation upon binding to AMP-PNP/Mg2+ 
(Chapter 4, [78]), suggesting that the nucleotide binds with higher affinity to a partially 
folded intermediate state of the kinase. HX MS data revealed that AMP-PNP binding also 
leads to a related increase in the conformational mobility of the conserved active site helix, 
αC (Figure 9), whose disruption arguably causes destabilisation of the N-terminal domain and 
the kinase as a whole. The results indicate that the loss of stability in nucleotide bound 
JNK1β1 is most compatible with enhanced dynamic motion throughout the core of one 
domain of the protein, rather than large rigid body movements or significant unfolding 
events. 
Enclosure of the catalytic cleft by the Gly-rich flap presents a clear disadvantage to the kinase 
as it restricts access to the active site. Since these and other steric factors play a crucial role in 
the access of substrates to the ATP binding pocket, decreased stability and increased mobility 
in the nucleotide-bound kinase could enable the conformational changes in its common 
docking-domain necessary for interaction with its regulators and protein substrates, as well as 
assist in phosphoryl transfer and ADP release. In support of this, Figuera-Losada and 
LoGrasso have shown that the presence of ATP significantly increases the affinity of both 
unmodified and phosphorylated JNK1β1 for protein substrates such as ATF2 and c-Jun [86]. 
Their study also proposes that, once the kinase has completed catalysing the phosphorylation 
of the immobilized protein substrate in the presence of bound ATP, decreased stability could 
facilitate the rapid dissociation of JNK1β1 from the substrate. The free energy difference of 
the nucleotide-bound form could conceivably also promote (or prevent) the binding and/or 
release of other regulatory elements involved in mediating JNK1β1 activity. 
It is also probable that reduced stability and enhanced protein dynamics allow for the 
conformational changes, both large and small, that are required for the complete catalytic 
cycle to proceed. While it has been established that phosphorylation initiates changes to the 
structure and mobility of JNK1β1 to enable the enzymatic reaction it catalyses to take place, 
the changes in the conformational dynamics of its catalytic residues following 
phosphorylation and/or nucleotide binding may also be important for enhancing the rate of 
phosphoryl transfer itself. Changes in the rate of the chemical step of enzyme-catalysed 
reactions have long been correlated with alterations in the dynamics of the proteins in which 
they occur. For example, studies on glucose oxidase have shown that glycosylation-induced 
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reductions in conformational flexibility leads to decreases in the rate of hydrogen tunnelling 
during the hydrogen transfer step of the reaction [87]. This is due to the vibrational states of 
the hydrogen donor/acceptor atoms determining the degree to which the hydrogens are 
tunnelled [87]. 
Relatedly, the enhanced conformational mobility following nucleotide binding and the 
proposed concomitant loosening of the internal structure of the N-terminal domain, can also 
suggest that the molecular volume of JNK1β1 increases in the presence of nucleotide. Studies 
have shown that increases in molecular volume (referred to as increased enzyme 
compressibility) is associated with enhanced enzyme activity in several mutant proteins [88].  
Thus, as fluctuational movements in enzymes are thought to contribute to the lowering of 
energy barriers that exist along reaction coordinates, it is not unreasonable to implicate the 
nucleotide-binding induced increases in flexibility within helix αC, containing the 
catalytically important Glu73, in enzyme catalysis. It also appears that helix αC may in effect 
act as an important transducing element, allowing modifications to the structure, stability, 
and/or conformational dynamics of the active site that are induced by nucleotide binding to 
alter the stability and dynamics of the N-terminal domain to assist in the enhancement of 
kinase activity upon phosphorylation. 
5.3. Conclusions 
Due to the diversity of signals and pathways that impinge upon the JNK signalling cascade 
and its consequent involvement in many human diseases, an understanding of the 
mechanisms that activate the MAP kinase has long been sought after. Previous difficulties in 
its acquisition and phosphorylation have however impeded its investigation, and as such, the 
mechanisms by which phosphorylation activates JNK is poorly understood. In this research, a 
novel and robust method that considerably improves upon the purification of highly pure and 
phosphorylated JNK1β1 is first described. Acquiring large yields of active JNK1β1, this 
study identified the exact sites at which its activator, MKK4, phosphorylates the kinase, 
revealing novel and uncharacterised phospho-residues that appear to have functional and 
biochemical significance. Concurrently, these findings raise unique questions that have 
significant implications for all heterologous protein expression, and highlight the important 
role of translation kinetics in the natural co-translational modification of kinases.  
The molecular and biophysical consequences of nucleotide binding and phosphorylative 
CHAPTER 5 – GENERAL DISCUSSION 
 
37 
  
activation of JNK1β1 were then established. The results indicate that the full activation of 
JNK1β1 is coupled to the regulation of its stability and conformational dynamics by both 
ATP binding and phosphorylation, and reveal that activation involves altering the flexibility 
of the hinge to allow the kinase to shift from an open to a closed domain conformation.  
In addition, the far-reaching changes to the mobility of the kinase detected upon activation 
provide novel insight into the dynamic motions necessary for initiating enzyme catalysis. 
This work thus offers a detailed characterisation of the regulation of JNK1β1 function by 
nucleotide binding and phosphorylation by MKK4, and represents the first step towards 
elucidating the mechanisms that contribute to inducing its activation.  
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